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Objectives: The correct function and structure of cornea is essential for vision. Cornea is 
maintained by limbal epithelial stem cells (LESCs), and the lack of functional LESCs in a disease 
called limbal stem cell deficiency (LSCD) can lead to blindness. The traditional treatment for 
corneal blindness is a corneal transplant. However, there is a severe shortage of cornea donors 
and the transplants lack functional LESCs. Thus, a corneal transplant cannot be used as a 
treatment for LSCD. The field of tissue engineering aims to restore, replace and regenerate 
damaged native tissues, such as develop artificial corneas. Yet, the conventional methods fail to 
mimic the native-like cellular variety and specific microstructure. Moreover, they lack the ability 
for precise positioning of cells and materials into a three-dimensional (3D) environment. 3D 
bioprinting offers a possibility to overcome these issues due to its better control, accuracy and 
customizability. The main challenge in 3D bioprinting is the lack of bioprintable, cell-laden bioinks 
with suitable properties to guide the desired cell behaviour. The aim in this thesis was to design 
and optimize a novel bioink and bioprinting conditions in order to 3D bioprint human pluripotent 
stem cell (hPSC) -derived corneal epithelium mimicking tissue. 
 
Materials and methods: A novel bioink composition was done combining human and 
recombinant sourced extracellular matrix proteins. The native human cornea was used as a 
source of inspiration in the development. Moreover, two crosslinking strategies were combined. 
First, the printability of the bioink and the printing parameters for extrusion-based bioprinting were 
tested and determined. The hPSC-derived LESCs (hPSC-LESCs) were produced, and the 
bioprinting conditions, including the ultra violet (UV) light exposure and printing substrate, were 
optimized. The response to different bioprinting conditions and behaviour of the bioprinted hPSC-
LESCs were analysed with phase contrast microscopy, proliferation and live/dead assays, and 
immunofluorescence analysis. Finally, the bioink was characterized by analysing its swelling 
behaviour, transparency and rheological properties. 
 
Results and conclusions: Overall, the developed bioink was well extrudable and had good 
transparency. The bioink supported the proliferation and maturation of the hPSC-LESCs. UV 
exposure did not decrease the cell viability (> 88%), however, it was observed to affect the 
crosslinking density and the stiffness of the material considerably. The bioprinted hPSC-LESCs 
preferred softer, highly viscous material, and bioprinting without UV exposure resulted in the most 
stratified epithelium. From the printing substrates, MatrigelTM coating provided the best results in 
regards to the cell proliferation and adhesion. However, due to the softness of MatrigelTM, the 
bioprinted epithelium showed shrinkage leading to partially ruptured epithelium. Therefore, further 
optimization of the printing substrate is required. Furthermore, due to the low crosslinking degree 
of the bioink without UV, rheological measurements were challenging to perform, and require 
further optimization in the future. This was the first study in which the stratification of hPSC-LESCs 
was observed after extrusion-based 3D bioprinting. Thus, the novel bioink showed great potential 
for 3D bioprinting corneal epithelium mimicking structures and should be further studied in ocular 
surface reconstruction.  
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Tutkimuksen tavoitteet: Virheetön sarveiskalvon toiminta ja rakenne ovat näkökyvyn 
kannalta oleellisia. Sarveiskalvon toiminnallisuutta ylläpitävien limbaalisten kantasolujen puutos 
voi johtaa sokeutumiseen. Perinteinen hoitomuoto sarveiskalvon vaurioitumisesta johtuvaan 
sokeuteen on sarveiskalvon kudossiirre kuolleelta luovuttajalta, mutta kudossiirteistä on vakava 
puute, eikä siirteissä ole toiminnallisia limbaalisia kantasoluja. Siksi kudossiirre ei ole toimiva 
hoitokeino limbaalisten kantasolujen puutoksesta johtuvaan sokeuteen. Kudosteknologian 
tavoitteena on palauttaa, korvata ja uudistaa vaurioitunutta kudosta, kuten kehittää keinotekoisia 
sarveiskalvoja. Nykyiset menetelmät eivät kuitenkaan pysty mimikoimaan alkuperäisen kudoksen 
solutason tarkkaa rakennetta. Lisäksi perinteisillä 3D-biovalmistustekniikoilla ei ole mahdollista 
saavuttaa solujen ja materiaalien yhtäaikaista sijoitusta kolmiuloitteiseen (3D) ympäristöön. 3D-
biotulostus tarjoaa tähän ratkaisun ja mahdollistaa sarveiskalvon kaltaisten, kolmiulotteisten 
kudosten valmistuksen. Suurin haaste 3D-biotulostuksessa on puute biotulostettavista, soluja 
sisältävistä biomusteista, jotka tukevat solujen kypsymistä ja järjestäytymistä toiminnalliseksi 
yksiköksi. Tämän työn tavoite oli suunnitella ja optimoida uudenlainen biomuste ja 
biotulostusolosuhteet ihmisen erittäin monikykyisistä kantasoluista valmistetun sarveiskalvon 
epiteelin kaltaisen kudoksen 3D-biotulostukseen. 
 
Materiaalit ja menetelmät: Uudenlainen biomuste valmistettiin yhdistämällä ihmislähtöisiä 
rekombinanttisoluväliaineproteiineja. Lisäksi biomusteessa yhdistettiin kaksi erilaista 
ristisilloitustekniikkaa. Ensin biomusteen soveltuvuus paineavusteiseen ekstruusio-
biotulostukseen tutkittiin. Ihmisen erittäin monikykyisistä kantasoluista erilaistetut limbaaliset 
kantasolut tuotettiin, ja biotulostuksen olosuhteet, kuten tulostuspaine ja -nopeus sekä 
ultraviolettisäteilyn (UV) määrä ja tulostusalusta, optimoitiin. Biotulostettujen kantasolujen vaste 
tulostusolosuhteisiin analysoitiin optisella mikroskoopilla, proliferaatio- ja elävyys/kuolleisuus-
analyysien sekä immunofluroesenssivärjäysten avulla. Lopuksi ristisilloittamaton biomuste 
karakterisoitiin analysoimalla sen turpoamista, läpinäkyvyyttä sekä reologisia ominaisuuksia.  
 
Tulokset ja johtopäätökset: Biomuste tulostui hyvin ja oli läpinäkyvää, eikä 
biotulostusprosessi vaikuttanut kantasolujen proliferaatio- tai erilaistumiskykyyn. UV-altistuksen 
määrä ei vaikuttanut elävien solujen osuuteen (> 88%), mutta sillä oli huomattavia vaikutuksia 
musteen ristisilloittumisen tiheyteen ja materiaalin jäykkyyteen. Biotulostetut kantasolut suosivat 
pehmeää, nestemäistä materiaalia, ja eniten kerrostunutta epiteeliä saavutettiin biotulostamalla 
ilman UV-alistusta. Tulostusalustoista Matrigeeli-pinnoituksella saatiin paras soluadheesio ja 
proliferaatio. Matrigeeli oli kuitenkin pehmeää, jonka vuoksi biotulostettu kerrostunut epiteeli 
kutistui ja osittain repeytyi viljelyssä. Siksi tulostusalustan optimointia tarvitaan tulevaisuudessa 
lisää. Lisäksi biomusteen nestemäisen rakenteen vuoksi reologisten ominaisuuksien 
määrittäminen oli haastavaa, joten reologiset mittaukset vaativat myös lisää tutkimusta ja 
optimointia. Tämä oli ensimmäinen tutkimus, jossa ihmisen erittäin monikykyisistä kantasoluista 
erilaistetut limbaaliset epiteelin kantasolut saatiin kerrostumaan extruusio-biotulostuksella. Siksi 
tutkimuksessa käytetyllä uudenlaisella biomusteella on potentiaalia sarveiskalvon epiteelin 
kaltaisen kudoksen biotulostuksessa ja koko sarveiskalvon rekonstruktiossa.  
 
Avainsanat: sarveiskalvo, sarveiskalvon epiteeli, sarveiskalvon kudosteknologia, 3D-
biotulostus, biomuste, ihmisen erittäin monikykyinen kantasolu, limbaalinen epiteelin kantasolu 
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1. INTRODUCTION 
As the outermost, transparent layer of the eye, the cornea has a key role in vision. The 
corneal epithelium is the smooth surface of the cornea, and together with the tear film, it 
provides most of the refractive power. Moreover, the epithelium acts as a barrier against 
chemicals and microbes. (Sridhar, 2018) Due to its critical role, corneal epithelium 
requires constant maintenance, which is done by limbal epithelial stem cells (LESCs). 
The most superficial cells of the epithelium are shed from the surface and replaced by 
differentiating LESCs. If this stem cell pool is lost or damaged, the maintanance of the 
corneal epithelium, and thus vision, is jeopardized. Subsequently, the dysfunction of 
LESCs can result in limbal stem cell deficiency (LSCD), which can lead to blindness 
(Jackson et al., 2020). In Europe, LSCD is caused by ocular burns in 30 people per 
million (Medicines Agency, 2015), and other less common causes include infections and 
autoimmune diseases, such as Stevens-Johnson syndrome (Jackson et al., 2020)  
Severe LSCD requires surgical treatment, however, a traditional corneal transplant 
cannot be used as a treatment option due to lack of functional LESCs in the transplant 
(Baylis et al., 2011). In addition, there is a severe shortage in donor material, and it is 
estimated that there is only one cornea available for 70 people who needs the corneal 
transplantation (Gain et al., 2016). Thus, there is a huge need for artificial corneas, which 
is the main problem corneal tissue engineering (TE) is aiming to solve (Fernández-Pérez 
and Ahearne, 2020). Boston keratoprosthesis is the most common artificial cornea 
(Ahearne et al., 2020), however, its poor adhesion to the host tissue (Mobaraki et al., 
2019) is only one of its limitations. Subsequently, there are several different stem cell -
based therapies used to treat LSCD, which usually include harvesting tissue from the 
healthy eye of the patient. This type of treatment causes two surgical operation sites and 
it cannot be used to treat bilateral LSCD, where both of the eyes are damaged. Moreover, 
the stem cell -based treatments using allogous donor tissue have the risk of rejection. 
(Jackson et al., 2020)  
The conventional TE methods cannot mimick the native environment of the cells because 
the cells are cultured on flat substrates as monolayers (Torras et al., 2018). Moreover, 
when the cells are seeded afterwards on a prefabricated substrate, the precise 
positioning of cell types and components of the native tissue is not achieved. 
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Subsequently, three-dimensional (3D) bioprinting have gained interest in the field of TE 
to mimic the complexity and organization of the native tissue (Cui et al., 2020). With 3D 
bioprinting, it is possible to fabricate personalized artificial corneas with high precision 
and controllability (Ahearne et al., 2020). Combined with the use of human pluripotent 
stem cells (hPSCs) with unlimited self-renewal capacity, 3D bioprinting offers a possibility 
to create tissues with the native-like cellular variety and cytoarchitecture (Salaris and 
Rosa, 2019) as well as to overcome the donor shortage (Ahearne et al., 2020).  
The aim of this thesis was to design a novel bioink for extrusion-based 3D bioprinting of 
stratified corneal epithelial tissue by using human pluripotent stem cell -derived limbal 
epithelial stem cells (hPSC-LESCs). The thesis began by optimizing the novel bioink 
composition and the printing parameters in order to achieve convenient printability. In 
addition to the bioink composition, the printing conditions were optimized based on the 
reaction of the bioprinted hPSC-LESCs. The printing conditions included the printing 
substrate and the UV exposure time. Subsequently, the bioink was characterized with 
transmittance and rheological measurements. The viability, proliferation, differentiation 
and maturation of the bioprinted hPSC-LESCs were analyzed with phase contrast 
microscope and with LIVE/DEAD, PrestoBlue and immunofluroescence analyses. 
The thesis consists of theoretical and experimental parts, and begins with providing 
background information of the physiology of the human cornea, LESCs, LSCD, hPSCs 
and corneal TE. Thereafter, the thesis introduces 3D bioprinting, its main strategies and 
the commong components used in bioinks. Moreover, the main crosslinking strategies 
for hydrogel bioinks are described. The theoretical part concludes by introducing state-
of-the-art 3D bioprinting of ocular tissues. In the experimental part, the materials and 
methods used in this thesis are described in detail, and finally, the results of the 
performed study are reported, discussed and concluded. 
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2. HUMAN CORNEA 
The cornea is the anterior part of the eye forming a primary protective coat for it. The 
main function of the cornea is to provide protection from for example microbes, and act 
as a refractive surface, which is enabled by its structural properties described next. 
(DelMonte and Kim, 2011) This chapter begins with describing the basic anatomy and 
physiology of the human cornea with the focus on the corneal epithelium. Next, the 
LESCs and how they are involved in the corneal epithelial defects are discussed. Since 
human pluripotent stem cell -derived cells are used in this thesis, they are shortly 
described in this chapter. Finally, the most common corneal TE methods are introduced. 
2.1 Structure of the cornea 
The cornea is avascular and consists of three parts, the central, paracentral and 
peripheral zones (B. Zhang, Xue, Li, et al., 2019). Around the cornea, there is the limbus 
and the conjunctiva. The cornea has curved shape and is horizontally oval with the 
thickness increasing from the central zone towards the peripheral zone (Sridhar, 2018). 
Moreover, the cornea is transparent tissue with light transmittance varying from 80% to 
96% at wavelengths 400 – 900 nm (Beems and Van Best, 1990).  
Figure 1. The structure of the cornea and limbus. LESCs = Limbal epithelial stem cells. 
Modified from https://discovery.lifemapsc.com/library/images/the-anatomy-and-
structure-of-the-adult-human-cornea, 21.07.2020. 
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The cross section of the cornea consists of different layers, which are epithelium, stroma, 
endothelium and two acellular interfaces, Bowman’s membrane and Descement’s 
membrane (Figure 1). The epithelium is the outermost layer of the cornea and consists 
of 5 – 7 layers of non-keratinized, stratified squamous epithelial cells, which create about 
50 µm thick structure and have a lifespan of 7 to 10 days. In the peripheral cornea, the 
epithelium is slightly thicker, 7 – 10 layers. The epithelium is composed of three types of 
epithelial cells with different structures, attached to each other through desmosomes. 
The 2 – 6 μm thick, flat superficial cells form 2 – 3 layered structure with tight junctions 
between the cells and have microvilli on the surface increasing the surface area. Beneath 
the superficial cell layer is the wing cells, which have a wing-like shape. The most 
deepest layer of the epithelium is composed of a single layer of 20 μm tall basal cells, 
which can undergo mitosis, and thus act as a source of wing and superficial cells. The 
basal cells in the central cornea are columnar, whereas in the peripheral cornea they are 
cuboidal. (Sridhar, 2018) 
On the top of the superficial epithelial cells is a tear film, which covers the corneal 
epithelium, providing a smooth optical surface and most of the refractive power 
(DelMonte and Kim, 2011), and protects the cornea from dehydration (Sridhar, 2018). 
As the epithelium, the gel-like tear film is composed of three layers, the lipid, aqueous 
and mucin layers. The superficial lipid layer preventing evaporation is secreted by the 
meibomian glands on the eyelid. The aqueous middle layer is produced by the lacrimal 
gland located in the upper part of the eye socket. The deepest mucin layer is produced 
by conjunctival goblet cells. (Gipson, 2007) 
Below the basal cells of the epithelium, there is the basement membrane, where the 
basal cells are attached to the membrane through hemidesmosomes (Sridhar, 2018). 
The epithelial basement membrane (EBM) is an important structure for epithelial cells, 
as it is involved in regulation of tissue development, function and repair. It gives the cells 
support as they proliferate, migrate and differentiate, and in addition, it regulates the 
polarity of epithelial cells. The EBM consists mainly of collagen type IV (ColIV) and 
laminins. ColIV provides structural stability for the EBM, and it has six α chains, which 
can assembly into different heterotrimers. Laminins are heterotrimeric glycoproteins and 
composed of three different chains, α, β and γ. Currently, there are five α, three β and 
three γ peptides known in humans, and the identification of laminin isoforms can be done 
according to the chains. (Wilson, Torricelli and Marino, 2020) For example, a 
nomenclature laminin 521 means that the laminin is composed of five α chains, two β 
chains and one γ chain. 
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The ColIV and laminins self-polymerize into networks, which are crosslinked with 
proteins called perlecan and nidogens 1 and 2. Perlecan is a proteoglycan which 
regulates the cell migration, proliferation and differentation by controlling the availability 
of different growth factors, such as fibroblast growth factors (FGF), bone morphogenic 
proteins (BMP), and transforming growth factor β-1 (TGFβ1). Nidogens 1 and 2 are 
sulfated glycoproteins creating links between other components and seem to 
compensate each other if other one is deficient. (Wilson, Torricelli and Marino, 2020) 
Beneath the corneal epithelium and the EBM is the 15 μm thick Bowman layer, which 
maintains the shape of the cornea (DelMonte and Kim, 2011). It is composed of Type I 
and V collagens (ColI and ColV) and proteoglycans (Sridhar, 2018). Beneath, there is 
the stroma, which comprises the most of the cornea, 80 – 85%. The stroma is composed 
of ColI, ColV, proteoglycans and keratocytes. It povides mechanical strength and 
transparency due to the organized arrangement of the collagen fibrils into parallel 
bundles embedded in hydrated matrix. (DelMonte and Kim, 2011) In addition, the 
keratocytes contain crystallins, which reduce backscattering of light, and thus provide 
transparency (Jester et al., 1999).  
Descement membrane is an elastic, 7 μm thick structure located beneath the stroma and 
consisted of ColIV and laminin. Beneath the Descement membrane, there is the 
endothelium, which is a 5 μm thick, honeycomb-like monolayer. Its main function is to 
regulate the water content of the cornea. The hexagonal endothelial cells are attached 
to the Descement membrane through hemidesmosomes, and their density decreases 
from 3000 to 4000 cells/mm2 to 2600 cells/mm2 throughout adult life. (Sridhar, 2018)  
The cornea is surrounded by the conjunctiva, which is 1-2 cell layers thick (Dua et al., 
2000). Between the conjunctiva and the peripheral cornea is the limbal zone, the limbus, 
which prevents the conjunctiva and its blood vessels to overgrow onto the cornea (Osei-
Bempong, Figueiredo and Lako, 2013). The limbus contains limbal epithelial stem cells 
(LESCs) in its basal layer. These cells maintain the cornea and differentiate into corneal 
epithelial cells when migrating out from the stem cell niche. (Gesteira et al., 2017) 
2.2 Limbal epithelial stem cells 
LESCs are located at the limbus (Figure 1), and their proliferation, migration and 
differentiation depends on the limbal niche, which is the specialized microenvironment 
for LESCs. In the limbal niche, there are ridges called palisades of Vogt, where the 
epithelium extends deeper in the limbus creating limbal epithelial crypts in the basal layer 
(Figure 2). In addition to LESCs, the limbal niche contains other cell types, such as 
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melanocytes, Langerhans cells, nerve cells and mesenchymal stem cells (MSCs). 
(Yazdanpanah et al., 2019) 
The main role of LESCs is to maintain the cornea by replacing the cells on the corneal 
surface, and thus, deficiency of these cells has a significant effect on the renewal of the 
cornea (Dua et al., 2000). The theory of maintaining corneal homeostasis is the XYZ 
hypothesis proposed in 1983. According to this theory, the basal cells proliferate (X), 
cells migrate towards the center (Y) and cells are lost from the surface (Z). (Thoft and 
Friend, 1983) At the limbus, LESCs undergo asymmetric division into stem-like daughter 
cells (other LESCs) and transient-amplifying cells (TACs), which represents the X. TACs 
then migrate towards the centre of the cornea, undergoing mitosis and differentiating into 
post-mitotic cells (PMCs) (Y).  PMCs migrate through the basal epithelium of the cornea, 
differentiating into terminally differentiated cells (TDCs) (Figure 2). TDCs are superficial 
squamous epithelial cells, which exfoliate and shed from the surface (Z), and thus new 
cells are needed constantly. (Yazdanpanah et al., 2019) 
The cells are constantly sensing and reacting to their environment through 
mechanotransduction, which means converting mechanical stimulus into biochemical 
activity (Iskratsch, Wolfenson and Sheetz, 2014). Intraocular pressure, eyelid and tear 
Figure 2. Schematic of the limbal niche and the maintanance of cornea by LESCs. The 
corneal epithelium extends deeper in in the limbus, creating Palisades of Vogt and limbal 
epithelial crypts. In the Palisades, LESCs undergo asymmetric division into stem-like 
daughter cells (another LESC) and transient amplifying cells (TACs). TACs migrate 
towards the the peripheral cornea and divide into post-mitotic cells (PMCs), which then 
are differentiated into terminally differentiated cells (TDCs) and shed from corneal 
surface. Modified from  (Yazdanpanah et al., 2019). 
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film motion and eye rubbing are examples of mechanical stimuli the cells experience in 
the corneal epithelium in vivo (Masterton and Ahearne, 2018). Therefore, the conditions 
in vitro and the mechanical properties of biomaterials can be used to affect the behaviour 
of LESCs. It has been demonstrated that the substrate stiffness affects the migration, 
proliferation and stratification of LESCs in vitro, stiffer substrate promoting migration and 
softer substrate promoting proliferation and stratification. Softer matrix has been shown 
to promote the expression of limbal markers, whereas the expression of differentation 
markers is decreased. (Gouveia, Lepert, et al., 2019) This information can be utilized in 
the design of biomaterials for LESCs and corneal tissue engineering. 
2.3 Corneal epithelial defects and current treatments 
Since the cornea is the outermost layer of the eye, it is vulnerable to external damage or 
organisms, such as bacteria. If the epithelium, the protective barrier of the eye, is 
damaged, it can cause infections, perforation, scarring and decreased vision. The 
epithelial defect can be acute, which heals within 7 – 14 days. However, if the normal 
healing process does not occur, the epithelial defect becomes persistent. There, the 
stroma is affected in addition to the epithelium, the epithelial cells cannot migrate to the 
damaged area and the basement membrane becomes thinned. Persistent epithelial 
defect (PED) can be caused by for example defective epithelial adhesion to the 
basement membrane, over-activity of inflammatory cytokines or recurrent mechanical 
damage. (Vaidyanathan et al., 2019)  
If the LESCs maintaining the corneal epithelium are damaged or lost, it can lead to LSCD, 
which is one of the conditions resulting in PED (Vaidyanathan et al., 2019). The main 
causes for LSCD are physical or chemical burns, infections (trachoma) and autoimmune 
diseases, such as Stevens-Johnson syndrome. (Utheim, 2013; Jackson et al., 2020), 
and it can be aquired or hereditary (Yazdani et al., 2019) LSCD is caused by ocular burns 
in 30 people per million in Europe (Medicines Agency, 2015). In LSCD, the function of 
the limbus is lost completely or partially due to insufficient stromal microenvironment or 
external damage which destroys the LESCs. Subsequently, the barrier function of the 
limbus is lost, and the conjunctival epithelium invades the cornea. (Osei-Bempong, 
Figueiredo and Lako, 2013) The corneal epithelium is replaced with conjunctival 
epithelium, and scarring and vascularization occur. This decreases the transparency of 
the cornea, and therefore can lead to corneal blindness. (Samoila and Gocan, 2020) 
Limbal basal cell density decreases (Chan et al., 2015), and moreover, LSCD causes 
corneal stiffening (Gouveia, Lepert, et al., 2019). The stiffening affects the ability of 
LESCs to maintain their phenotype, as the expression of limbal markers decrease and 
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the expression of differentiation markers increase (Gouveia, Lepert, et al., 2019). 
Depending the extent of the damaged LESCs, LSCD can be partial or total. In addition, 
it can be bilateral or unilateral, depending if the both eyes are damaged or just the other 
one. (Samoila and Gocan, 2020)  
Traditionally, corneal blindness is treated with corneal transplantation (keratoplasty) from 
a donor. The successive rate of a donor cornea is higher than many other tissues due to 
the reduced risk of immune rejection, because there are no vascular or lymphatic vessels 
in the cornea (Ahearne et al., 2020). However, for every 70 people in need there is only 
one donor cornea available (Gain et al., 2016). Moreover, corneal transplantation cannot 
be used to treat LSCD due to the lack of functional LESCs in the transplant (Baylis et al., 
2011). Subsequently, alternative options to develop artificial corneas have been studied. 
The most common artificial cornea is the Boston keratoprosthesis (Ahearne et al., 2020), 
which has been used for treating LSCD (Shanbhag et al., 2018). 
The Boston keratoprosthesis is a device, which consists of a front and back plates made 
of polymethyl methacrylate (PMMA). A donor cornea is placed between the plates and a 
titanium ring locks them in place, and the device is implanted to replace the damaged 
cornea. (Mobaraki et al., 2019) The Boston keratoprosthesis had the U.S. Food and Drug 
Administration (FDA) approval in 1992, and over 12 000 devices have been implanted 
since then (Saeed, Shanbhag and Chodosh, 2017). However, a major disadvantage in 
Boston keratoprosthesis is the poor adhesion between the PMMA and the host tissue 
(Mobaraki et al., 2019). Other limitations of keratoprosthesis include discomfort, complex 
transplantation process, limited visual field and unsatisfying appearance (B. Zhang, Xue, 
Li, et al., 2019) 
Due to the poor long-term outcomes of corneal transplants and problems of the previous 
artificial corneas, the development of alternative treatments with successful 
transplantation of functional stem cells is important. Subsequently, there are different 
cell-based surgical techniques currently available for the treatment of LSCD. However, 
most of these treatment options use autologous limbal tissue (Jackson et al., 2020),  
which means the tissue is harvested from the same individual, or in this case, the healthy 
or less damaged eye. Therefore, these techniques can be used only for unilateral LSCD. 
The first technique using autologous tissue was introduced in 1989 by Keivyon and 
Tseng and is called conjunctival-limbal autograph (CLAU). In CLAU, two conjunctival-
limbal biopsies are harvested from the healthy eye and transferred into the damaged 
eye, without the need for any transplant substrate (Keivyon and Tseng, 1989). In the 
second technique, cultured limbal epithelial transplantation (CLET) introduced by 
Pellegrini et al. in 1997, the harvested biopsies are cultured to produce cell sheets, which 
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are then transplanted (Pellegrini et al., 1997). CLET technique includes the first stem cell 
-based theraphy for LSCD called Holoclar, which has been approved by the European 
Union in 2015 (Pellegrini et al., 2018). 
However, these techniques have challenges, such as the expensive and time-consuming 
ex vivo cultivation in CLET and possible risks due to taking two large biopsies in CLAU. 
Therefore, Sangwan et al. introduced the third treatment option for LSCD in 2012, called 
simple limbal epithelial transplantation (SLET). In SLET, a small biopsy is harvested from 
the healthy eye of the patient, and the biopsy is cut into eight pieces. A human amniotic 
membrane (AM) is fixed with fibrin glue onto the damaged eye, and the biopsy pieces 
are placed onto the AM and fixed with fibrin glue. (Sangwan et al., 2012) 
If LSCD is bilateral, it is not possible to use tissue from the patient’s own eye, and 
therefore other techniques have been studied. In 1994, Tsai and Tseng introduced 
keratolimbal allograft (KLAL), where the tissue is harvested from deceased donors or 
living relatives. However, the use of allogous tissue requires immunosuppression to 
prevent rejection. (Holland, 2015) Cultured oral mucosal epithelial transplantation 
(COMET) is an alternative, autologous technique for treating bilateral LSCD (Jackson et 
al., 2020). In COMET, autologous oral epithelial cells are harvested and cultured on a 
denuded human AM carrier, and after 2-3 weeks, the resultant cell sheet is transplanted 
onto the damaged eye (Nakamura et al., 2004). COMET overcomes the challenges of 
risk of rejection and large biopsies, however, the production of the cell sheets is the main 
challenge, as in CLET (Jackson et al., 2020). In addition, peripherical corneal 
vascularization have been reported in many cases (Prabhasawat et al., 2016). Moreover, 
the number of functional LESCs in these treatments is low. For example, the 
commercially available treatment for LSCD, Holoclar, has only 3.5% of functional LESCs 
on average (European Medicines Agency, 2019). Therefore, better techniques for 
treating LSCD are studied to overcome these challenges. 
2.4 Human pluripotent stem cells  
Stem cells are responsible for constructing every tissue in the human body, and they are 
defined with two main characteristics. Stem cells need to have unlimited ability to 
proliferate into cells, which are the same as the stem cell itself, in a phenomenon called 
self-renewal. Moreover, stem cells need to give rise to one or more differentiated cell 
type. The self-renewal can be symmetric, meaning one stem cell divides into two 
daughter stem cells increasing the stem cell pool, or asymmetric, meaning one stem cell 
divides into one daughter stem cell and one differentiated daughter cell. If the stem cell 
does not divide or differentiate, it remains quiescent maintaining the stem cell pool. The 
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fourth option for the stem cell is to divide into two differentiated daughter cells without 
self-renewal, however, this results in a decrease in stem cell pool. (Bozdağ, Yüksel and 
Demirer, 2018) 
Stem cells can be divided into categories based on their differentiating potency. 
Totipotent stem cells can differentiate into any cell type, including embryonic and 
extraembryonic tissues. Pluripotent stem cells can differentiate into all cell types in 
embryonic tissue, such as the three germ layers, endo-, meso- and ectoderm. 
Multipotent stem cells can differentiate only into cell types of one germ layer. Unipotent 
stem cells can differentiate only into a specific cell type. (Bozdağ, Yüksel and Demirer, 
2018) Human pluripotent stem cells (hPSCs) can self-renew and differentiate into all cell 
types, and they mainly include human embryonic stem cells (hESCs) and induced 
pluripotent stem cells (hiPSCs). (Rehakova, Souralova and Koutna, 2020) 
First hESCs were derived from human blastocysts in 1998 by Thomson (Thomson et al., 
1998). In 2007, the first hiPSCs were derived from adult human somatic cells by 
reprogramming them with specific transcription factors (Takahashi et al., 2007; Yu et al., 
2007). The ethical issues and limited supply of hESCs are avoided due to the possibility 
to reprogram adult somatic cells into hiPSCs, and in addition, the use of autologous cells 
enables personalized cell therapies (Ortuño-Costela et al., 2019). Due to their 
capabilities to proliferate and differentiate into any cell type in the human body, hPSCs 
are advantageous in cell-based therapies and overcome the limitations of using other 
stem cells, such as mesenchymal stem cells, which can differentiate only into a few 
specific cell types and have limited proliferation capacity. (Rehakova, Souralova and 
Koutna, 2020) Therefore, the use of hPSC have gained attention in corneal cell therapy 
as they reduce the need of donor corneas and provide almost unlimited source of cells 
due to the ability to self-renew (Chakrabarty, Shetty and Ghosh, 2018). The LESCs 
derived from hPSCs are shown to be similar to the native LESCs, and thus they offer an 
alternative cell supply for LSCD treatments (Mikhailova et al., 2015).  
The challenge of using hPSCs rises from the reproducibility issues and variability for 
example in methodologies and cell lines (Salaris and Rosa, 2019). To produce clinical-
grade hPSCs, careful characterization, standardization and quality control are required. 
There are several methods for characterization of hPSCs, such as determining the 
genetic stability with karyotype analysis and pluripotency with flow cytometry, as well as 
ensuring their sterility and viability. (Rehakova, Souralova and Koutna, 2020) In addition, 
the production of clinical-grade autologous hiPSCs is expensive, up to 40-80 times more 
costly than the production of research-grade hiPSCs (Bravery, 2015). Despite of the 
challenges, there have been clinical trials using hPSCs derived cells. In 2010, Geron 
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was able to proceed to the first clinical trial using hESCs in the treatment of acute spinal 
cord injury. The first clinical trial using hiPSC-derived cells was launched in 2013 by a 
Japanese company RIKEN CBD. (Ilic et al., 2015) In May 2019, a clinical trial of hiPSCs 
derived corneal epithelial cell sheet transplantation for patients with LSCD was started 
in Japan (ICTRP Search Portal, 2020).  
2.5 Corneal tissue engineering 
The main target of tissue engineering (TE) is to restore, replace or regenerate defective 
tissues (Ovsianikov, Khademhosseini and Mironov, 2018). Therefore, the field of corneal 
TE aims to develop artificial corneas to overcome the corneal transplant shortage and 
immune response, which can lead to rejection of the transplant (Fernández-Pérez and 
Ahearne, 2020). In addition to the biocompatibility, biodegradability, and the physical 
structure, such as porosity, the main aspects to consider when developing a TE cornea 
are the transplant location and its cell type as well as the transparency of the scaffold 
material (Ahearne et al., 2020).  
There are two main approaches to fabricate the TE construct. In scaffold-based 
approach, the goal is to fabricate a biomimetic structure which supports the cells until 
the new tissue is formed. Scaffold-free, or cell-based, approach has an opposite point of 
view, as there the cellular construct is fabricated from prefabricated cell sheets, 
spheroids or tissue strands. (Ovsianikov, Khademhosseini and Mironov, 2018) In corneal 
tissue engineering, the scaffold-free approach be can used to produce cell sheets on a 
substrate and transplant them without an additional carrier (Syed-Picard et al., 2018). 
The structure of the desired tissue affects the selection of the TE approach. For example, 
the corneal epithelium mainly consists of cells associated to the EBM and there is only 
a little ECM, whereas the corneal stroma has only 10 % of its volume composed of cells. 
Therefore, the cell-based approach is better choice for the epithelium and the scaffold-
based for the stroma. (Matthyssen et al., 2018) 
In many TE approaches, such as using a hydrogel scaffold or electrospun polymers, the 
cells are seeded afterwards on the fabricated scaffold. This multistep process is time-
consuming and results flat 2D structures, and thus other approaches to mimic the native 
tissue better are under research. 
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2.5.1 Hydrogels 
Hydrogels are widely studied group of biomaterials for TE due to their hydrophilic and 
cell-friendly properties as well as the large range of material and modification options. 
Hydrogels are formed through chemical or physical crosslinking, which creates a highly 
hydrophilic polymeric network with ability to swell, and in fact, from 70 % to 99 % of 
hydrogels can consist of water (Chimene, Kaunas and Gaharwar, 2020). Hydrogels can 
consist of natural or synthetic polymers and can be fabricated as films, sponges and gels 
(Chen et al., 2018). Moreover, hydrogels are biodegradable and provide a 3D 
environment (Mahdavi, Abdekhodaie, Mashayekhan, et al., 2020), which is desired in 
tissue engineering. Because hydrogels usually have too weak mechanical properties, 
different reinforcement strategies have been studied (Chimene, Kaunas and Gaharwar, 
2020). For example, combining hydrogels and with polymer electrospinning can be used 
to reinforce hydrogels (Tonsomboon, Strange and Oyen, 2013). In addition, different 
nanofibers and nanotopographies have been studied in order to provide highly porous 
3D framework and to better mimick the native environment of corneal cells (Sahle et al., 
2019). 
There are several hydrogel materials studied in corneal TE, and especially hydrogel-
forming ECM components are the common choice. Collagen is the most abundant ECM 
component in the cornea, and thus, it has gained popularity as a material choice 
(Matthyssen et al., 2018; Ahearne et al., 2020). Collagen can be fabricated as films, 
sponges or hydrogels, or compress it to reduce the water content of the hydrogel and 
improve the mechanical properties. (Ahearne et al., 2020) It has been fabricated as films 
and membranes (Ye et al., 2014; Chae et al., 2015; Y. Liu et al., 2019), or as compressed 
gel to improve the mechanical strength of the scaffold (Rafat et al., 2016; Cen and Feng, 
2018; Miotto et al., 2019). Corneal substitutes of collagen have been tested in phase I 
clinical trials (Fagerholm et al., 2010).  
Silk fibroin is a natural polymer with good biocompatibility, mechanical strength and 
transparency. It can be formed as hydrogels, sheets, fibers and sponges, which makes 
it an interesting material for corneal TE. (Ahearne et al., 2020) To produce a hydrogel, 
silk fibroin solution can be crosslinked with riboflavin (Applegate et al., 2016) or genipin 
(H. Zhou et al., 2019). Silk fibroin has been used to fabricate film substrates for corneal 
epithelial cells (Higa et al., 2011; Liu et al., 2012; Li et al., 2017), stromal cells (Wu et al., 
2014; Bhattacharjee, Fernández-Pérez and Ahearne, 2019) and endothelial cells 
(Vázquez et al., 2017; Song et al., 2019), as well as a co-culture for corneal epithelial 
and stromal cells with innervating neurons at an air-liquid interface (Wang et al., 2017). 
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In addition, silk fibroin films can be stacked after culturing stromal cells on single films to 
mimic the native physiology of corneal stroma (Ghezzi et al., 2017) 
Gelatin is a low-cost, natural polymer, which has been used as a hydrogel scaffold 
material in corneal TE (Ahearne et al., 2020). For example, gelatin has been used to 
prepare cell substrates (Goodarzi et al., 2019), blended membranes (Xu et al., 2018) or 
cell loaded slabs for in vivo study (Kilic Bektas et al., 2019). In addition, it can be modified, 
for example by acrylation or thiolation, which enhances its mechanical properties and 
provides variability and control in crosslinking (Li et al., 2018). 
Another common ECM component, hyaluronic acid (HA), has gained attention as a 
hydrogel biomaterial for corneal TE due to its hydrophilicity and possibility to tailor its 
properties, even though it is not yet as widely studied (Yazdani et al., 2019). HA has 
been shown to regulate differentiation of LESCs (Gesteira et al., 2017), and thus it has 
been studied in the treatment of LSCD (Yazdani et al., 2019). For example, HA-based 
hydrogel substrates have been used for human epithelial limbal cells, replacing AM as 
the carrier (Fiorica et al., 2011), and co-culturing human adipose stem cells (hASCs) with 
human corneal epithelial cells (hCECs), resulting in enhanced growth and differentiation 
of hCECs (Kiiskinen, 2016). Later, HA has been shown to support the expansion of 
hCECs in a xeno-free culture, resulting in stratified epithelium (Chen et al., 2017).  
2.5.2 Decellularized cornea 
Decellularized tissue means removing the cells and their debris, which results a ECM 
scaffold and thus reduces the risk of rejection. Since the scaffold is composed of native 
ECM, it mimics well the native environment of the cells with a suitable composition and 
organization. However, there is batch-to-batch variation, which is a common 
disadvantage when using natural materials. (Ahearne et al., 2020) 
There are several methods to decellularize tissue, and they can be divided into three 
categories. Physical decellularization can be done with freeze-thawing or supercritical 
carbon dioxide, usually combined with mechanical agiation. Chemical decellularization 
can be done for example with different detergents, such as sodium dodecyl sulphate, or 
hypertonic solutions of sodium chloride. Biological decellularization is done with 
enzymes, such as trypsin, and an additional incubation with nucleases to degrade the 
released DNA. (Fernández-Pérez and Ahearne, 2020) The use of chemicals creates a 
risk of chemical residues in the scaffold, which is one disadvantage of this method 
(Ahearne et al., 2020). 
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In cornea TE, decellularized porcine cornea is the most commonly studied. It is well 
available and has similarities in the anatomy with the human cornea. However, there is 
a risk of rejection, if the decellularization is insufficient. To overcome the problems of 
using xenogenic tissues, human corneas unsuitable for corneal transplantation have 
been decellularized. (Fernández-Pérez and Ahearne, 2020) 
2.5.3 Amniotic membrane 
AM can be used together with the cell-based surgical techniques, such as SLET, to treat 
LSCD. AM is a semi-transparent, the innermost layer of the placenta, which consists of 
the monolayered epithelium, a basement membrane rich in collagen types IV and VII, 
fibronectin, laminins and HA, and the avascular stroma (Jirsova and Jones, 2017). AM 
can be transplanted alone, however, usually it is combined with the surgical techniques 
described above. There, it is used as a substrate for ex vivo LESC expansion and as a 
carrier of the cell sheet to provide physical support when it is transplanted onto a 
damaged ocular surface. (Le and Deng, 2019) 
AM can be applied directly onto the damaged eye by a surgeon and fixed with sutures 
or glue. There, it either acts as a basal membrane for the corneal epithelial cells or 
protective cover for the ocular defect, depending on the surgical technique. Fresh AM 
can be used, however, to rule out the possibility of disease transmission, it is usually 
preserved. Typical methods are lyophilization (drying under vacuum and rehydrating 
when used) and cryopreservation at - 80 °C. (Lacorzana, 2020) The common long term 
complications of using AM alone to treat ocular surface are eyelid-related and dry eye 
(Shanbhag et al., 2020). In addition, the availability of AM is limited and mouse fibroblast 
feeder cells are used in co-culture when using AM as a stem cell carrier, which is why 
other carriers are under research (Oliva, Bardag-Gorce and Niihara, 2020). Other 
disadvantages include batch-to-batch variation, difficulties in storage, costly donor 
screening and possibile immunological rejection (Nguyen et al., 2018). 
2.5.4 Electrospinning 
Electrospinning has been used in corneal TE to fabricate and study alternative scaffolds 
for corneal constructs (Kong and Mi, 2016; Ahearne et al., 2020), and it has been used 
as a technique to fabricate nanofiber scaffolds for corneal TE (Sahle et al., 2019). In 
electrospinning, the scaffold is fabricated from thin fibers, which are drawn from a syringe 
due to high voltage (Ortega et al., 2012), ranging from 5 to 50 kV (Kong and Mi, 2016). 
Electrospinning technology uses an electrostatic field for the repulsive force between 
particles to overcome the solution surface tension. This results the solution droplet to 
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stretch and finally jet from the syringe as a fiber when the solvent evaporates, and the 
fiber is then collected on a collector slide. (Kong and Mi, 2016)  
The syringe containing the polymer solution is typically a hypodermic syringe needle 
(Kong and Mi, 2016), however, there are different options for collectors. For example, 
the collector can be a plate wrapped in aluminium foil (Aslan et al., 2018; Fernández-
Pérez et al., 2020; Sanie-Jahromi et al., 2020) a polymeric structure produced by 
stereolithography (Ortega et al., 2012) or a pre-treated glass plate (Alexander et al., 
2019). To obtain the curved shape of cornea, a hemispherical collector has been studied 
(Kim, Kim and Park, 2018). In addition, the collector can be static (Z. Zhou et al., 2019) 
or rotating (Sanie-Jahromi et al., 2020). Whereas the fiber orientation is usually random, 
by altering the electrical potential on the collector, it is possible to orientate the fibers 
radially or perpendicularly (Montero et al., 2012; Fernández-Pérez et al., 2020).  
In addition to the collector design, other electrospinning parameters, such as the applied 
voltage, the polymer solution and the humidity, can be altered to fabricate different kind 
of fibers and scaffolds (Kong and Mi, 2016). For example, the fiber can have smooth of 
rough surface (Cui et al., 2008). In addition, by varying the collector height, it is possible 
to affect the diameter of the electrospun fibre as well as the density and thickness in the 
inner and outer areas of the scaffold (Ortega et al., 2012). The electrospun polymer mat 
can be post-processed for example with laser perforation to regulate its mechanical 
strength and transparency, and combine with collagen gel to increase biocompatibility 
and enchance the mechanical strength of the collagen alone (Kong et al., 2017).  
Electrospinning has been used to fabricate nanofiber scaffolds with highly porous 
structure for corneal regeneration (Sahle et al., 2019). Moreover, due to the possibility of 
controlling the fiber orientation, electrospinning can be used to mimic for example the 
organization of collagen fibrils in the corneal stroma (Ahearne et al., 2020). Several 
different synthetic polymers have been used to fabricate scaffolds for corneal constructs 
by electrospinning, such as poly(lactic-co-glycolic acid) (PLGA) (Ortega et al., 2012; 
Kong et al., 2017; H. Liu et al., 2018), poly L-lactic acid (PLLA) (Aslan et al., 2018) and 
polycaprolactone (PCL) (Sharma et al., 2011; Z. Zhou et al., 2019; Fernández-Pérez et 
al., 2020; Sanie-Jahromi et al., 2020).  
In addition to synthetic polymers, natural polymers have been studied in electrospinning 
due to their better biocompatibility (Ahearne et al., 2020). For example gelatin (Montero 
et al., 2012; Sanie-Jahromi et al., 2020) and silk fibroin (Biazar et al., 2015) have been 
used to fabricate corneal scaffolds, however, the mechanical properties are usually too 
weak for the use of natural polymers alone.Therefore, a more common method is to 
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electrospin blends, such as PCL and PLLA copolymer with silk fibroin (Chen et al., 2015), 
or PCL with chitosan (Stafiej et al., 2017) or collagen (Kim, Kim and Park, 2018). In 
addition to blends, natural polymers can be electrospun together with a synthetic polymer 
without blending, such as electrospinning collagen in between electrospun PLGA 
(Arabpour et al., 2019). Table 1 provides examples of the recent study of fabricating 
scaffolds by electrospinning for corneal regeneration. 
 
 Table 1. Examples of electrospun scaffolds for corneal regeneration. 
  
Electrospun material Cells 
Target corneal 
tissue 
Reference 
PCL with chitosan 
PCL with poly 
glycerol sebacate 
(PGS) 
Human corneal 
epithelial cells 
Human corneal 
keratocytes 
Epithelium (Stafiej et al., 2017) 
PCL with PGS 
Human corneal 
endothelial cells 
Human conjunctival 
epithelial cells 
Endothelium 
Epithelium 
(Salehi et al., 2017) 
PCL, PLA and PLGA 
on decellularized AM 
Rabbit limbal stem 
cells 
Epithelium 
(Liu et al., 2018; 
Z. Zhou et al., 2019) 
PCL with 
decellularized cornea 
Human corneal 
stromal cells 
Stroma 
(Fernández-Pérez et al., 
2020) 
PCL with gelatin Human LESCs Epithelium 
(Sanie-Jahromi et al., 
2020) 
PLLA 
Bovine stromal 
keratocytes 
Stroma (Aslan et al., 2018) 
PLLA-PCL 
copolymer with silk 
fibroin 
Human corneal 
endothelial cells 
Endothelium (Chen et al., 2015) 
Silk fibroin Human LESCs Epithelium (Biazar et al., 2015) 
PLGA layered with 
collagen type I 
Human endometrial 
stem cells 
Whole cornea (Arabpour et al., 2019) 
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2.5.5 Scaffold-free cell sheets 
During the development of the body, the cells are organized into appropriate 3D 
structures without scaffolds. Thus, a scaffold-free approach is gained attention in TE, as 
cell sheets are first cultured as a monolayer on a substrate and then removed physically 
or chemically. For example, surface-patterned polydimethylsiloxane (PDMS) can be 
used as a substrate for corneal stromal cells, which form a mechanically removable and 
transplantable tissue sheet. (Syed-Picard et al., 2018) Even though the cell sheet 
culturing is done as monolayers, 3D structure can be created by stacking the cell sheets 
layer-by-layer (Priyadarsini, Nicholas and Karamichos, 2018). The advantages of using 
scaffold-free technique are that there is usually more uniform cell distribution and no 
harmful degradation products are produced, which may occur during the biodegradation 
of some scaffold materials. (Li et al., 2019)  
As ECM has a major role in connecting and holding the cells together in a scaffold-free 
cell sheet, enzymatic treatment for cell sheet removal should be avoided due to its ECM-
damaging effect (Li et al., 2019). A common method for producing and harvesting cell 
sheets is to culture the cells on temperature-sensitive substrate (Kobayashi et al., 2013; 
Madathil, Kumar and Kumary, 2014; Kasai et al., 2020; Venugopal et al., 2020). Typical 
substrate material is N-isopropylacrylamide (NIPAAm), which is hydrophilic at higher 
temperatures (> 32 °C), enabling cell adhesion. At lower temperatures (< 32 °C), the 
cells cannot adhere due to rapid hydration and swelling of the NIPAAm, which results in 
detachment of the cell sheet. (Li et al., 2019) 
In addition to the thermo-responsitivity, the response of the substrate and ermoval of the 
cell sheet can be caused for example by electrical activation, light, the change in pH or 
magnetic force, depending on the substrate material and its modification (Li et al., 2019). 
Recently, peptide amphiphile -coated substrates have been studied in corneal TE to 
fabricate removable, scaffold-free cell sheets. These cell sheets are called Self-Lifting 
Auto-generated Tissue Equivalents (SLATEs), and they were fabricated by using human 
corneal epithelial and stromal cells. (Gouveia, González-Andrades, et al., 2017) 
18 
 
3. 3D BIOPRINTING 
In many conventional TE methods, the cells are typically cultured on a flat substrate to 
grow as monolayers to create a two-dimensional (2D) structure. However, in the body, 
most of the cells grow in a 3D environment, and therefore, the 2D systems lack the 
specific 3D structure of the native tissue. (Torras et al., 2018) In addition, the 
prefabricated substrates, where cells are seeded afterwards, cannot to mimic the precise 
positioning of cell types and components of the native 3D structure, which is why layer-
by-layer additive manufacturing techniques have gained interest in the field of TE (Cui et 
al., 2020).  
3D bioprinting offers a high-precision method to position biomaterials, molecules and 
cells in a predefined 3D model layer-by-layer, and the use of several printer heads 
enables the deposition of multiple materials and cell types in the same structure. In 
addition, due to the use of computer-aided process, 3D bioprinting offers better control 
and reproducibility. As the desired geometry is designed with a software beforehand, 3D 
bioprinting provides great customizability. (Selcan Gungor-Ozkerim et al., 2018) 
Moreover, 3D bioprinting overcomes the challenge with the traditional techniques 
enabling the fabrication of structures with interconnected pores, and thus sufficient 
exchange of gas and nutrients (Matai et al., 2020). 
3D bioprinting can offer a method to reduce animal tests, as it can provide a more 
accurate model of human physiology and its responses to drug and material testing 
(Matai et al., 2020). In addition, patient-specific treatments and precision medicine are 
potential fields for utilizing 3D bioprinting (Prendergast and Burdick, 2020), and by 
combining it with stem cell therapy, the possibilities to create personalized therapies is 
unlimited (Ong et al., 2018). As there is a constant shortage of donor organs, 3D 
bioprinting has a great potential as a solution for the crisis, and has increasingly gained 
attention over the years (Vijayavenkataraman et al., 2018). In fact, from 2000 to 2015, 
the number of research publications related to 3D bioprinting has increased 3300% (from 
24 to 792) (Rodríguez-Salvador, Rio-Belver and Garechana-Anacabe, 2017), and the 
market potential of 3D bioprinting is estimated to grow from USD 411.4 million in 2016 
to USD 1332.6 million by 2021 (MarketsandMarketsTM INC, 2017). Thus, in addition to 
the potential in regenerative medicine and TE, there is a considerable market potential 
in the field of 3D bioprinting. 
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3.1 3D bioprinting strategies 
3D bioprinting is an additive manufacturing method, where cells embedded in biomaterial 
are bioprinted layer-by-layer on a substrate or into a supportive bath/matrix by an 
automated dispensing system  (Matai et al., 2020). In 3D bioprinting, the desired 
geometry is first designed with a software, and then the structure is fabricated from a 
bioink containing biomaterials and cells. Typically, a computer-aided design (CAD) 
software is used to create the 3D model and to design its characteristics in detail. In 
addition to creating the design from the beginning, it can be based on imaging of real 
tissue or organ using computed tomography (CT), magnetic resonance imaging (MRI), 
ultrasound imaging or optical microscopy. The model is converted into stereolithography 
(STL) format for the 3D bioprinter, and it is processed to design the internal structure of 
the model. (Vijayavenkataraman et al., 2018) After designing the 3D structure, the 
components for creating the structure are selected, combined together as a bioink and 
printed (Prendergast and Burdick, 2020). The printing movement and bioink deposition 
as well as the possible crosslinking are controlled by the software (Selcan Gungor-
Ozkerim et al., 2018), and this step requires optimization of the bioink components and 
concentrations along with the printing parameters. There are several different 3D 
bioprinting strategies with differences in working principles, and the most common 
technologies are described next. 
3.1.1 Inkjet-based bioprinting 
Inkjet-based bioprinting is a non-contact method, where droplets of bioink are positioned 
on a substrate. The volume of the droplet is usually 1 – 100 pl and contains 104 – 304 
cells. Inkjet-based bioprinting is divided into drop-on-demand (DOD) bioprinting and 
continuous inkjet (CIJ) bioprinting. In CIJ, printing is done with a continuous stream of 
electrically conductive bioink drops, which are steered with an electric or magnetic field 
to form the desired structure. In DOD, the drops are created and ejected only when 
needed. The major advantages of DOD compared to CIJ are that there is no need for 
conductive bioinks and the waste of the bioink is greatly reduced. (Matai et al., 2020) 
There are different approaches in DOD bioprinting depending on the method to create 
and eject droplets, including thermal and piezoelectric approaches (Figure 3). In thermal 
approach, the bioink chamber is heated with an electric pulse, which creates a bubble 
into the printing nozzle. When the heat is removed after the pulse ends, the bubble 
inflates. The change between expansion and inflation ejects the droplets out from the 
nozzle. In piezoelectric approach, a pressure pulse instead of electric is created by 
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mechanical actuation of piezoelectric material, and the pressure ejects the droplets out 
from the nozzle. (Matai et al., 2020) 
There are specific aspects, which are important to consider in inkjet-based bioprinting. 
Inkjet-printable bioinks require rheopectic characteristic, which causes the droplets to 
thicken when they are jetted. In addition, the printing substrate and its coatings will affect 
the spreading and deformation of the droplet, which will affect the printing result. 
(Morgan, Moroni and Baker, 2020) The advantages of inkjet-based bioprinting are its 
affordability, speed and high resolution (50 μm) (Derakhshanfar et al., 2018). However, 
it can be used only for bioinks with low viscosity (< 10 mPa∙s), which limits the used cell 
density (< 106 cells/ml) (Hölzl et al., 2016). Moreover, the vertical printing ability is poor 
(Derakhshanfar et al., 2018), which limits the size of the 3D bioprinted structure 
(Prendergast and Burdick, 2020).  
Inkjet-based bioprinting has been used for example to create neural networks (Tse et al., 
2016), and bone (Gao et al., 2015; Duarte Campos et al., 2016), cartilage (Gao et al., 
2015; Nguyen et al., 2017), skin (B. S. Kim et al., 2018) and liver tissue (Faulkner-Jones 
et al., 2015). In addition, inkjet technology has been used to bioprint endothelial cells to 
create vascular-mimicking structures with capillary networks (Kreimendahl et al., 2017) 
and endothelialized lumen (Tröndle et al., 2019). Moreover, it has been used to fabricate 
photocurable drugs (Acosta-Vélez et al., 2017) and hierarchical porous scaffolds (Ng et 
al., 2018). 
  
Figure 3. The two DOD bioprinting techniques, thermal and piezoelectric. Bioink 
bubbles are ejected either by increased temperature or mechanical actuation created 
by piezoelectric material. Modified from (Cui et al., 2020) 
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3.1.2 Extrusion-based bioprinting 
Extrusion-based bioprinting is well-known and widely used strategy in 3D bioprinting. It 
is a widely available and affordable, and currently there are several commercially 
available extrusion-based 3D bioprinters, such as 3D-Bioplotter (EnvisionTEC, 
Germany), BioX and INKREDIBLE (CELLINK, Sweden), 3DDiscovery (RegenHU, 
Switzerland), NovoGen MMX (Organovo, USA), BioScaffolder (GeSiM, Germany) and 
Brinter (3DTech Oy, Finland). In addition to their good availability, they offer compatibility 
with a wide range of different materials and cells, which is a notable advantage compared 
to other 3D bioprinting technologies (Prendergast and Burdick, 2020) 
In extrusion-based bioprinting, the filament is extruded continuously into a 3D structure 
and solidified after printing.  Pneumatic pressure or mechanical force is used to extrude 
the bioink from a disposable plastic syringe onto a substrate (Figure 4), and the 3D 
bioprinted structure can be crosslinked after extrusion. The mechanical force can be 
generated with a piston or a rotating screw. (Matai et al., 2020) When using pneumatic 
dispensing system, the air pressure acts as the driving force for the extrusion, whereas 
in mechanical dispensing systems, the piston or the screw create mechanical force, 
which extrudes the filament (Derakhshanfar et al., 2018). The crosslinking of a hydrogel 
bioink can be done before, after or during the bioprinting process (Lim et al., 2020), which 
increases the flexibility of the technology. 
Compared to other 3D bioprinting strategies, the resolution of extrusion-based 
bioprinting is relatively low, around 100 μm (Zhang et al., 2017). The range of extrudable 
bioinks is wide (Lim et al., 2020), however, the bioinks for extrusion-based bioprinting 
require specific rheological properties, such as shear-thinning characteristics, which 
Figure 4. The two extrusion-based bioprinting techniques, pneumatic and mechanical. 
The bioink is extruded from the syringe onto a substrate. Modified from (Cui et al., 2020). 
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prevents cell damage by protecting them from shear stress and provides control during 
printing (Cui et al., 2020). Moreover, it is important that the bioink does not solidify before 
extrusion. The method enables bioprinting of bioinks with high viscosities, up to 6 x 107 
mPa∙s, which is a major advantage of this 3D bioprinting strategy as bioinks with high 
cell densities can be printed (Derakhshanfar et al., 2018). High viscosity of the bioink can 
enhance the result of extrusion-based 3D printing, as it prevents the collapse of the 
printed structure, however, this increases the risk of nozzle clogging (Cui et al., 2020).  
In addition to the properties of the bioink, extrusion-based bioprinting has specific printing 
parameters, which affect the printability and cell viability. For example, the nozzle 
diameter, the printing pressure and the speed of the nozzle and the dispenser head affect 
the quality of the extruded fiber (Van Hoorick et al., 2019). The printing resolution can be 
increased by using smaller diameter, however, higher pressure might be necessary (Kyle 
et al., 2017). Moreover, an increase in the printing speed decreases the filament 
diameter (Liu et al., 2017), and an increase in pressure increases the flow rate of the 
bioink, which consequently increases the shear stress, and thus the damage for the cells 
(Cui et al., 2020). The cell viability of extrusion-based bioprinting is relatively low 
compared to other 3D bioprinting techniques, ranging from 40 – 80% (Cui et al., 2020), 
however, due to the possibility to use high cell density bioinks, the amount of viable cells 
remain sufficient after printing (Matai et al., 2020). 
There are several techniques of extrusion-based bioprinting, of which the simpliest is the 
direct extrusion on a substrate (Figure 5 A). This technique enables simple and 
repeatable extrusion of highly concentrated bioinks, however, pronounced shear-
thinning behaviour is required. Instead of extruding the bioink directly on a substrate, it 
A B C D 
Direct extrusion Coagulation bath Support bath Co-axial extrusion 
Figure 5. Different techniques for extrusion-based bioprinting. (A) Direct extrusion of 
bioink on a substrate. (B) Extrusion in a coagulation bath, which triggers the gelation. (C) 
Extrusion in a granular or colloidal bath, which acts as a support for the bioprinted 3D 
structure. (D) Co-axial extrusion, where bioink and crosslinking agent are dispensed 
simultaneously with a co-axial needle assembly. Modified from (Costantini et al., 2019). 
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is possible to use liquid coagulation bath, which acts as a trigger for the gelation of the 
bioink (Figure 5 B). This requires fast gelation ability, which can clog the nozzle during 
printing. In addition, as liquid bath is used, the turbulence and buoyancy affect the 
adhesion and precision of the printed filament. However, the advantage of using 
coagulaton bath is the independency of printability from the rheological properties. 
(Costantini et al., 2019) 
Freeform reversible embedding is a technique which uses a granular or colloidal bath 
with soft micro/nanoparticles at high volume fraction instead of the coagulation bath 
(Figure 5 C). The granular or colloidal bath provides structural support for the extruded 
bioink and the 3D structure, as the bath locally fluidises around the nozzle tip, while the 
bioink is extruded, and solidifies fast, when the nozzle moves on. This techniques 
enables more freedom in the bioink composition than the techniques described above, 
however, the surface roughness of the printed construct decreases the resolution and 
the removal of the bath can be complicated. (Costantini et al., 2019) 
Due to the limitations and drawbacks of the described techniques, new extrusion-based 
bioprinting techniques are studied. Co-axial extrusion combines the extrusion of the 
bioink and the dispension of the crosslinking solution by using a co-axial needle 
assembly (Figure 5 D). Here, the needle has a core and shell filled with the bioink and 
the crosslinking agent, which are then simultaneously extruded on a substrate. The 
dispension of both solutions can be controlled individually, which provides better 
tunability. In addition, this techniques enables printing of a bulk fiber (bioink in the core 
and crosslinking agent in the shell) or a hollow fiber (bioink in the shell and crosslinking 
agent in the core). (Costantini et al., 2019) 
Extrusion-based bioprinting has been used for example in cardiac (Zhang et al., 2016; 
Kang et al., 2017), muscle (Kim and Kim, 2019), bone (Ojansivu et al., 2019), neural 
(Salaris et al., 2019) and adipose TE (Tytgat et al., 2019), to create vascular-mimicking 
constructs (Jia, Gungor-Ozkerim, et al., 2016; Ding and Chang, 2018) and to bioprint 
osteochondral tissue (J. Liu et al., 2019; Kilian et al., 2020). In addition, extrusion-based 
technology has been used to print multiple bioinks into different layers to create gradient 
scaffolds (Frost et al., 2019; J. Liu et al., 2019; Kilian et al., 2020) or to use coaxial 
extrusion to print different bioinks simultaneously (Duchi et al., 2017; W. Liu et al., 2018). 
Duchi et al. developed a handheld device, Biopen, for cartilage repair. Moreover, 
extrusion has been used to bioprint hiPSCs for post-printing expansion and 
differentiation (Gu et al., 2017) and to create aligned collagen structures to provide 
topographical cues for cell differentiation (Kim and Kim, 2019). 
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3.1.3 Laser-based bioprinting 
Laser-based bioprinting uses laser radiation to pattern bioink with the cells, and the most 
common type of laser-based method is laser-induced forward transfer (LIFT). In LIFT, 
there are two coplanar substrates, donor- and collector-slides (Vijayavenkataraman et 
al., 2018). The donor-slide is a laser-transparent substrate, usually glass or quarzt, 
coated with a layer of laser-absorbing metal, usually gold or titanium. The bioink is 
deposited onto the metal layer of the donor-slide. (Matai et al., 2020) As the laser pulse 
comes through the donor-slide, the metal layer absorbs it, which generates pressure. 
The pressure causes the bioink droplets to leave the donor-slide and attach to the 
collector-slide (Figure 6). (Vijayavenkataraman et al., 2018)  
Another laser-based bioprinting technique is laser guided direct writing (LGDW), 
however, the size of the 3D structure and the scalability are limited (Morgan, Moroni and 
Baker, 2020), and it is not as widely studied and used as LIFT. In LGDW, laser is focused 
onto a target area containing the cell-laden bioink. The laser beam generates force in 
the cell-media interface, causing the bioink droplets to leave the suspension. When 
coupled with a hollow fiber, the droplets can be deposited through the fiber as a steady 
stream onto a substrate. (Odde and Renn, 1999) 
Laser-based bioprinting is a nozzle-free approach, and thus there are no clogging 
problems (Vijayavenkataraman et al., 2018). In addition, it can be used for bioinks with 
different viscosities, ranging from 1 to 300 mPa∙s, and with high cell density (108 cells/ml) 
(Matai et al., 2020). It offers high resolution (10-100 μm), however, to reach the high 
resolution, the bioink used for laser-based bioprinting requires compatibility of working 
Figure 6. Laser-induced forward transfer method, where a laser pulse is used to 
generate pressure, causing the bioink droplets to leave from the donor-slide (ribbon) 
onto a collector-slide (receiving substrate). Modified from (Cui et al., 2020) 
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wavelengths, fast gelation (Matai et al., 2020), and adhesion to the printing substrate 
(Morgan, Moroni and Baker, 2020). The viscoelasticity of the bioink is required for the 
ejected droplets to keep their shape (Morgan, Moroni and Baker, 2020). Moreover, the 
printing speed is low (Prendergast and Burdick, 2020), the method is costly and complex 
(Vijayavenkataraman et al., 2018), and thus it is not commercially as easily available.  
LIFT technology has been used in cardiac (Gaebel et al., 2011) and skin regeneration 
(Koch et al., 2010), as well as for creating vascular-like network (Gruene et al., 2011). 
LGDW technology has been used to bioprint multipotent adult progenitor cells (Nahmias, 
Gao and Odde, 2004) and endothelial cells (Nahmias et al., 2005; Nahmias and Odde, 
2006) (Nahmias and Odde, 2006). 
3.1.4 Lithography-based bioprinting 
Lithography-based bioprinting uses light to cure the 3D structure, and thus requires the 
use of light-sensitive bioinks. This method is divided into two main techniques, 
stereolithography (SLA) and digital light processing (DLP) (Figure 7). In SLA, the bioink 
is cured with a laser beam, which is focused onto the bioink from above. In DLP, the 
bioink is cured by light projected from below onto a build stage, which moves vertically 
upward, creating the 3D structure layer-by-layer. (Lim et al., 2020) DLP has been used 
to bioprint for example vascular structures (Zhu et al., 2017), and cardiac (Yu et al., 
2019), cartilage (Lam et al., 2019; Chen et al., 2020) and liver tissue (Ma et al., 2016; Yu 
et al., 2019; Mao et al., 2020). 
Stereolithography Digital light processing 
A B 
Figure 7. Two techniques for lithography-based bioprinting. (A) Stereolithography, 
where a scanning laser is used to cure the bioink on a platform. (B) Digital light 
processing, where projected light is used to cure the bioink on a vertically moving 
platform. Modified from (Lim et al., 2020). 
Bioink 
Platform 
Platform 
Bioink 
Scanning laser 
Lens 
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26 
 
Lithography-based bioprinting is a nozzle-free approach (Vijayavenkataraman et al., 
2018), and the printing time is independent of the complexity of the structure (Matai et 
al., 2020), resulting in efficient printing process with good ratio of spatial resolution to the 
time required (Prendergast and Burdick, 2020). The resolution is high (25 – 50 μm), and 
lithography-based tecnology offers possibilities to create structures, which are not 
possible with extrusion-based bioprinting (Lim et al., 2020). However, as the technique 
requires light radiation, only inks with photo-crosslinkable polymers can be used 
(Prendergast and Burdick, 2020).  
3.2 Bioinks 
The term bioink was first introduced in 2003 in the context of organ printing, and it 
originally reffed to cellular components which were in 3D on or within hydrogels (Groll et 
al., 2018). Today, a bioink is defined as a cell-laden, printable biomaterial (Matai et al., 
2020; Morgan, Moroni and Baker, 2020), and it is distinct from the term biomaterial ink, 
in which the cells are not a mandatory component as they are seeded afterwards on 
within the pre-printed scaffold (Groll et al., 2018). Even though there are increasing 
number of studies done in 3D bioprinting, the development of a printable, cell-laden 
bioink remains a challenge due to several bioink requirements discussed next. 
The main objectives of a bioink are to maintain the cell viability, to direct the desired cell 
behaviour and to be bioprintable (Morgan, Moroni and Baker, 2020), which make 
designing bioinks the key in the development of 3D bioprinting tissues. Cells are sensing 
and responding to their environment through mechanotransduction, and depending on 
the tissue type, the cells are subjected to different forces (Williams et al., 2018), and 
different tissues have different mechanical properties (Handorf et al., 2015). The 
mechanical stimuli of the environment and surrounding ECM guide the proliferation and 
differentiation of the cells, and if there occurs a change in the mechanical properties of 
the ECM, such as in stiffness, the homeostasis might be shifted, leading in disease 
(Handorf et al., 2015). Thus, in addition to the bioprintability of the bioink, the properties 
of the bioprinted structure, such as the stiffness or composition of the bioink, need to 
mimic the microenvironment of the target cell niche (Williams et al., 2018). 
The physical and rheological properties of the bioink affect greatly its bioprintability as 
well as the environment the cells experience (Morgan, Moroni and Baker, 2020), which 
makes them important for the design and characterization of the bioink. Moreover, the 
properties of the bioink and the printing parameters can have cooperative effects on the 
printability. For example, when using temperature-sensitive bioink components, such as 
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gelatin, the temperature of the cartiridge and the printing platform affect the printability 
and the cell viability (Gu et al., 2018).  
The physical properties, such as the viscosity, surface tension and density, can be 
altered for example by changing the composition and concentration of the bioink 
components or modifying it chemically (Morgan, Moroni and Baker, 2020). The viscosity 
describes fluid’s resistance to flow (Zimmerman Jones, 2019), and if the viscosity is too 
low, the printed structure does not keep its shape, however, with too high viscosity the 
shear stress increases, which is harmful for the cells (Chimene, Kaunas and Gaharwar, 
2020). The rheological properties of the material describe its flow behaviour, and include 
for example yield stress or shear-thinning characteristics. Yield stress means the 
minimum stress, which is needed for the material to flow, and for the material to be fluid-
like, its need to be higher than the shear stress. (Chimene, Kaunas and Gaharwar, 2020) 
Shear-thinning means the viscosity is decreased when the material is subjected to shear 
stress (Morgan, Moroni and Baker, 2020).  
Figure 8. The main aspects to consider when designing bioinks. The bioink has two roles 
from the biocompatibility side, to direct cell behaviour and response, and to maintain cell 
viability. The third role of the bioink is to be bioprintable, which is affected by its physical 
and rheological properties, such as viscosity, yield stress, density and shear-thinning 
behaviour. All these aspects are affected by the composition and concentration of the 
bioink components, the crosslinking method and density, porosity, shear stress, cell 
density and the temperature and pH. 
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Figure 8 summarizes the main properties guiding the design of bioinks considering the 
cell and biology aspect and the bioprintability aspect. Extrusion-based bioprinting has 
special requirements for properties of bioinks, as these properties are essental for 
printability and shape fidelity. Table 2 summarizes these properties presented by Cui et 
al. 2020. 
 
 
Table 2. The summary of bioink criteria for extrusion-based bioprinting.   
 
  
Property Explanation Determined by Impacts 
Viscosity 
The fluid’s resistance 
to flow under applied 
stress 
Polymer 
concentration 
and molecular 
weight 
Solubility 
Shear rate 
Temperature 
High viscosity prevents the 
printed structure from collapsing 
and the bioink dropping from the 
nozzle, however, the risk of 
nozzle clogging increases 
Shear 
thinning 
Viscosity decreases 
under increased stress 
due to 
disentanglement of 
polymer chains 
The ability of 
polymer chains 
to reorganize 
Affects printability and structural 
integrity after printing 
Protects cells from shear stress 
Essential in direct extrusion 
Yield stress 
The minimum value of 
stress which is 
required for the fluid to 
flow 
Shear thinning 
behaviour 
Crosslinking 
mechanism 
Affects printability 
Prevents the cells from settling 
in the bioink solution  
Prevents printed structure from 
collapsing 
Shear 
recovery 
The recovery of 
mechanical properties 
after shear thinning 
Bioink 
composition 
Stabilizes the printed filament 
Gelation or 
crosslinking 
mechanism 
Solidification of the 
bioink solution 
Creation of physical or 
chemical crosslinks 
which link polymer 
chains together 
Composition of 
the bioink 
Crosslinking 
strategy 
Affects the density and stiffness 
of the printed structure 
Stabilizes the printed filament 
Affects the cell viability and 
functionality 
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The biomaterial component of a bioink can be a natural polymer, synthetic polymer or a 
composite, and usually it is in hydrogel form (Matai et al., 2020). The advantages of 
hydrogels are their aqueous environment and porosity, which enable sufficient oxygen 
and nutrient diffusion as well as the cell migration. A single component bioink is not 
capable of meeting the bioink requirements, which is why most of the bioinks combine 
multiple materials (Cui et al., 2020). In addition, the possibility of adding proteins and 
other ECM components to hydrogel bioinks allow them to mimic the native 
microenvironment of the bioprinted cells and guide the stem cell growth (Chimene, 
Kaunas and Gaharwar, 2020).  
Even though hydrogels have become a popular choice for cell-laden bioinks, many 
hydrogels alone are mechanically too weak to support the bioprinted structure. 
Subsequently, their polymer content and crosslinking density are modified, or other 
components are added to the bioink as rheological modifiers. In addition to these more 
conventional techniques, hydrogel bioinks can be reinforced by polymer 
functionalization, nanocomposites and thermoplastic reinforcement. (Chimene, Kaunas 
and Gaharwar, 2020) 
The cells are an important component of the bioink, and in the field of 3D bioprinting, the 
number of recent studies using hPSCs is increasing due to the possibility to mimic the 
native cellular variety and cytoarchitecture. Yet, they have specific characteristics, which 
makes them challenging to use in bioprinting. Even though cell spheroids can be 
bioprinted with specific method called Kenzan method, most of the bioprinting techniques 
require the cells to be dissociated as single cells for 3D bioprinting. However, hPSCs 
survive poorly as singe cells, and thus, they tend to form clusters. This can cause 
challenges with nozzle-based bioprinting approaches, such as extrusion-based 
bioprinting. In addition, because hPSCs are highly sensitive to their environment and its 
cues, the composition and properties of the bioink need careful research and design. 
(Salaris and Rosa, 2019)  
There are several different biomaterials studied in developing bioinks, however, this 
thesis can cover only few of them. Moreover, there is research done to 3D bioprint cells 
as shperoids without any biomaterial (Moldovan et al., 2017; Ong et al., 2017), however, 
this thesis concentrates on bioinks combining cells and biomaterials. Table 3 presents a 
summary of different bioink components, crosslinking and 3D bioprinting techniques as 
well as the bioprinted cell types. The common biomaterial components used in bioinks 
are discussed next. 
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Table 3. Summary of recent research in the field of 3D bioprinting. Col = Collagen, 
hMSCs = Human mesenchymal stem cells, GelMA = Gelatin methacrylate, HA = 
Hyaluronic acid, HAMA = Hyaluronic acid methacrylate, hACS = Human adipose stem 
cells, hUVECs = Human umbilical vein endothelial cells, PEG = Polyethylene glycol. 
Bioink Crosslinking 
3D 
bioprinting 
technique 
Cell type Reference 
Alginate – 
Carboxymethyl 
chitosan – 
Agarose 
Ionic  Extrusion hiPSCs 
(Gu et al., 
2017) 
Alginate Ionic  Inkjet hiPSCs 
(Faulkner-
Jones et al., 
2015) 
Alginate – Matrigel  Ionic  Extrusion 
hiPSC-derived 
neurons and glial 
cells 
(Salaris et 
al., 2019) 
Alginate – Gelatin 
– Fibrinogen  
Ionic  
Covalent  
Extrusion hMSCs 
(Henrionnet 
et al., 2020) 
Alginate – GelMA 
Ionic  
Photocrosslinking  
Extrusion hUVECs 
(Zhang et al., 
2016) 
     
Alginate – 
Methylcellulose – 
O2-sensitive 
luminescent 
nanoparticles 
Ionic  Extrusion hMSCs 
(Trampe et 
al., 2018) 
Alginate – 
Nanocellulose 
Tyramine-
functionalized HA 
– Nanocellulose  
Ionic  
Covalent  
Inkjet hiPSCs 
(Nguyen et 
al., 2017) 
Alginate – 
Nanocellulose  
Ionic  Extrusion 
Human fibroblasts 
Human nasal 
chondrocytes 
(Thayer, 
Orrhult and 
Martínez, 
2018) 
Alginate – 
Methylcellulose  
Ionic  Extrusion 
Human 
chondrocytes 
(Kilian et al., 
2020) 
Alginate – 
nanocellulose – 
carboxymethyl 
cellulose  
Ionic  Extrusion 
Human skin 
fibroblasts 
(Zidarič et 
al., 2020) 
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Col type I – 
Alginate  
Ionic  Extrusion 
Human 
preosteoblasts and 
hACS 
(Lee et al., 
2015) 
Col type I – 
Agarose 
Fibrinogen - 
Agarose 
Thermal Inkjet 
hUVECs and 
human fibroblasts 
(Kreimendahl 
et al., 2017) 
Col type I - 
Agarose 
Thermal  Inkjet hMSCs 
(Duarte 
Campos et 
al., 2016) 
Col type I  
Thermal 
Covalent 
Extrusion Myoblasts 
(Kim and 
Kim, 2019) 
Decellularized liver 
tissue 
Thermal Extrusion 
Human 
hepatocellular 
carcinoma cells 
(Lee et al., 
2017) 
Decellularized 
cardiac tissue – 
GelMA 
Decellularized liver 
tissue – GelMA 
Photocrosslinking 
Digital light 
processing 
hiPSC-derived 
cardiomyocytes 
and hepatocytes 
(Yu et al., 
2019) 
Decellularized liver 
tissue - GelMA 
Photocrosslinking 
Digital light 
processing 
hiPSC-derived 
hepatocytes 
(Mao et al., 
2020) 
Decellularized skin 
tissue 
Thermal 
Extrusion 
Inkjet 
Human fibroblasts 
and keratinocytes 
hMSCs 
Human endothelial 
progenitor cells 
(B. S. Kim et 
al., 2018) 
Decellularized 
pancreatic tissue 
Thermal Extrusion 
Primary islet cells 
from rat pancreas 
(J. Kim et al., 
2019) 
GelMA  Photocrosslinking  Extrusion Human fibroblasts 
(Kolesky et 
al., 2014) 
GelMA – Glycidal 
methacrylate HA 
Photocrosslinking  Extrusion 
hiPSC-derived 
hepatic progenitor 
cells 
(Ma et al., 
2016) 
GelMA 
HAMA 
Photocrosslinking  
Digital light 
processing 
Porcine 
chondrocytes 
(Lam et al., 
2019) 
Thiolated HA –
Thiolated gelatin 
Photocrosslinking 
PEG crosslinker 
Extrusion 
Human liver 
stellate cells and 
Kupffer cells 
(Skardal et 
al., 2015) 
HAMA 
Photocrosslinking  
PEG crosslinker  
Extrusion -  
(Ma et al., 
2020) 
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3.2.1 Agarose 
Agarose is a polysaccharide which undergoes gelation at low temperatures (Hospodiuk 
et al., 2017). Although agarose has good properties for printing, such as high viscosity, 
it does not have cell binding sites (Nadernezhad et al., 2019), which makes it unpopular 
material alone. Agarose has been used as a support material in 3D bioprinting (Kucukgul 
et al., 2015; Mirdamadi et al., 2019), however, to increase its cell-friendliness, it has been 
blended with other hydrogels, such as ColI (Tan et al., 2016; Kreimendahl et al., 2017) 
or Matrigel (Fan et al., 2016). The bioactivity and shear thinning behaviour of agarose 
can be increased for example by adding nanosilicate into the bioink (Nadernezhad et al., 
2019). Bioinks containing agarose have been used to bioprint for example hUVECs and 
human fibroblasts (Kreimendahl et al., 2017), hiPSCs (Gu et al., 2017) and human 
intestinal epithelial cells (Fan et al., 2016). 
3.2.2 Alginate 
Alginate is a polysaccharide found in the cell walls of brown algae and some bacteria, 
and it consists of β-D-mannuronic acid and α-L-guluronic residues, which create a block-
like structure (Abasalizadeh et al., 2020). The advantages of alginate are its affordability 
and availability in addition to nontoxicity, biocompatibility and biodegradability (Y. Zhang 
et al., 2019). The amount and ratio of these building blocks depend on the origin and 
growth conditions of the alginate. In addition, the molecular weigth and acetylation 
degree can vary, and for example, the viscosity of alginate increases, when the pH is 
decreased or the molecular weight is increased. (Abasalizadeh et al., 2020) Therefore, 
the molecular weigth affects the bioprintability of the alginate-based bioink and 
mechanical properties of the bioprinted structure (Freeman and Kelly, 2017). 
Alginate can form hydrogels in the presence of divalent cations, such as Ca2+ and Ba2+, 
and typical method to create alginate gel is to add calcium chloride (CaCl2) into alginate 
solution as crosslinker agent, resulting in ionic crosslinks (Abasalizadeh et al., 2020). In 
addition to CaCl2, for example calcium sulphate or calcium carbonate can be used, and 
the choice of the ionic crosslinker has been shown to affect the bioprintability and 
mechanical properties of the bioprinted structure (Freeman and Kelly, 2017). In addition 
to ionic crosslinking, alginate hydrogels can be created with chemical crosslinkers, such 
as glutaraldehyde. In addition, alginate can be methacrylated to create a 
photocrosslinkable hydrogel, or functionalized with thermosensitive polymer for thermal 
crosslinking or cell surface receptor -specific ligands to create cell crosslinked hydrogel. 
(Abasalizadeh et al., 2020)  
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In 3D bioprinting, alginate has been studied as a bioink component for example in 
bioprinting cartilage tissue (Markstedt et al., 2015; Nguyen et al., 2017; Yang et al., 2018; 
Henrionnet et al., 2020), osteochondral tissue (Kilian et al., 2020) and skin tissue (Zidarič 
et al., 2020). In addition, alginate has been used to bioprint hiPSCs and differentiate 
them into neural tissue (Gu et al., 2017). Its advantages are rapid crosslinking and 
affordability, however, the cell adhesion and mechanical strength are poor (Parak et al., 
2019). 
3.2.3 Collagen 
Collagen is the most abundant ECM protein, which can form biocompatible hydrogels 
with shear-thinning properties. In addition, it is sensitive to pH and temperature, as it 
undergoes physical crosslinking when the temperature is increased over 30 °C. Shear-
thinning properties and the possibility to control its crosslinking with pH and temperature 
make collagen a potential component for bioinks, even though the mechanical properties 
are weak without further crosslinking. (Włodarczyk-Biegun and del Campo, 2017) There 
are several different collagen types, of which some are fibril-forming collagens whereas 
some form networks. Collagen types I, II and III are the most abundant, and they all form 
fibrils. ColIV is an example of a network-forming collagen, and it is typically present in 
basement membranes. (Mienaltowski and Birk, 2014) 
ColI is the most widely studied type of collagen in 3D bioprinting, and for example, it has 
been used in engineering cartilage tissue (Yang et al., 2018), cardiac tissue (Kim and 
Kim, 2019), small intestine (Kim and Kim, 2020) and liver tissue (Mazzocchi et al., 2018). 
In addition, bioprinting bioinks containing collagen have been shown to promote stem 
cell differentiation of for example human adipose stem cells (Lee et al., 2015) and 
mesenchymal stem cells (Duarte Campos et al., 2016). Due to the tendency to form 
fibrils, ColI has been studied to bioprint aligned cells, such as myoblasts, preosteoblasts, 
cardiomyocytes and human adipose stem cells (Kim and Kim, 2019).  
3.2.4 Decellularized tissue 
ECM is produced by the cells to create a suitable environment for their adhesion, 
migration, differentiation and maturation. The interaction between the ECM and the cells 
is dynamic and mutual, as the cells produce the surrounding ECM, which again 
influences the behavior of the cells. The tissue-specificity of ECM is due to the 
composition of its components, including proteins, biomolecules and proteoglycans, as 
it varies between tissues. As ECM creates the required microenvironment for the cells in 
the native tissue, decellularized ECM derived from the native, tissue-specific ECM is a 
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promising material to provide appropriate, native-like biochemical cues and proteins for 
the 3D bioprinted cells. (Dzobo, Motaung and Adesida, 2019)  
Decellularization is an important step to decrease the risk of inflammatory and immune 
response, leading to possible tissue rejection. However, decellularization needs to 
eliminate only the cellular components, and thus maintaining the native composition of 
the ECM. (Kabirian and Mozafari, 2020) Decellularization methods include various 
physical, chemical and enzymatic approaches (Kabirian and Mozafari, 2020), as were 
described previously. 
Pig is the major source of decellularized ECM due to its availability, similarities in 
anatomy and physiology to humans and short gestation period (Kabirian and Mozafari, 
2020). However, using xenogeneic ECM source can cause immunological reactions 
(Dzobo, Motaung and Adesida, 2019), and there is a change of xenozoonoses 
development (Kabirian and Mozafari, 2020). Human tissue is a better source for 
decellularized ECM, and for example, human adipose tissue is well available, as it 
produced as medical waste from liposuctions. Even though the biocompatibility and the 
native-like properties of decellularized ECM are its major advantages, the challenges in 
using decellularized ECM -based bioinks include difficulties in scalability, batch-to-batch 
variation and possible immune reaction. (Dzobo, Motaung and Adesida, 2019) 
Decellularized ECM have been used to 3D bioprint adipose tissue (Pati et al., 2015), 
cardiac tissue (Jang et al., 2017; Yu et al., 2019), liver tissue (Lee et al., 2017; Yu et al., 
2019; Mao et al., 2020), skeletal tissue (Choi et al., 2016), skin tissue (B. S. Kim et al., 
2018), pancreatic tissue (J. Kim et al., 2019), blood vessel -like structure (Gao et al., 
2017) and small intestine villus structure (Kim and Kim, 2020). In addition, decellularized 
ECM has been studied for bioprinting cornea (H. Kim et al., 2019). If stem cells are used, 
their differentiation can be guided with the tissue-specific decellularized ECM -based 
bioink (Pati et al., 2015; Choi et al., 2016; Jang et al., 2017; Lee et al., 2017; H. Kim et 
al., 2019; Yu et al., 2019). 
3.2.5 Fibrinogen and fibrin 
Fibrinogen and fibrin are proteins found in ECM, and they have a key role in blood clotting 
and wound healing. Fibrinogen is synthetized in the liver, and a protease called thrombin 
causes it to hydrolyze and polymerize into fibrin. Fibrin is chemically crosslinked by 
calcium ions, which stabilizes its structure. They are derived from blood, which can be 
autologous. (Włodarczyk-Biegun and del Campo, 2017) The use of fibrinogen provides 
enhanced cell adhesion and integrity of printed structure, which is a major advantage in 
3D bioprinting (Tröndle et al., 2019; Henrionnet et al., 2020). In addition, the advantages 
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of fibrin include the promotion of cell proliferation, differentiation and angiogenesis, good 
mechanical properties and fast gelation. However, fibrin is degraded fast by proteases, 
which is why protease inhibitors may be needed. (Włodarczyk-Biegun and del Campo, 
2017) 
Fibrinogen has been studied in 3D bioprinting for example hiPSC-derived neural tissue 
(de la Vega et al., 2018; Abelseth et al., 2019; Sharma et al., 2020), hMSC-derived 
cartilage tissue (Henrionnet et al., 2020) and hiPSC-derived cardiomyocytes (Anil Kumar 
et al., 2019). In addition, human endothelial cells (Tröndle et al., 2019) and human 
dermal fibroblasts (Freeman et al., 2019) have been embedded in fibrinogen-based 
bioink in order to 3D bioprint vascular constructs. 
3.2.6 Gelatin 
Gelatin is derived from collagen through denaturation due to chemical treatment or 
change in temperature, and the denaturation is irreversible (Marques et al., 2019). 
Gelatin contains innate adhesive peptide sequences, enhancing the adhesion and 
spreading of cells, and thus resulting in high biocompatibility (Lim et al., 2020), which is 
important quality for bioink components. In addition, gelatin is widely studied in 3D 
bioprinting because it is cost-effective, well available and considered safe by the FDA 
(Van Hoorick et al., 2019).  
Gelatin is highly temperature-dependent, which affects its use as a bioink component. 
The dissociation temperature for gelatin is 30 – 35 °C, and whereas it dissolves at higher 
temperatures, hydrogels are formed at lower temperatures due to hydrogen bonding and 
physical crosslinking (Van Hoorick et al., 2019). Subsequently, it liquifies at physiological 
temperatures (Parak et al., 2019). By modifying gelatin, its properties, such as stability, 
can be altered, and typical crosslinking and modification methods for gelatin are 
methacrylation, thiolation and norbornene functionalization (Lim et al., 2020). 
Photocrosslinkable gelatin, gelatin methacrylate (GelMA), has become the golden 
standard in bioinks (Van Hoorick et al., 2019), and there are several commercially 
available GelMA-based bioinks (CELLINK; Sigma Aldrich; Allevi).  
In 3D bioprinting, gelatin has been studied as a bioink component for example to bioprint 
hASCs (Sakai et al., 2018) and hMSCs (Henrionnet et al., 2020), and its methacrylated 
form has been studied for bone marrow stem cells (Yin et al., 2018), osteoblasts (McBeth 
et al., 2017), chondrocytes (Schuurman et al., 2013), hUVECs (Jia, Selcan Gungor-
Ozkerim, et al., 2016; Liu et al., 2017) and hMSCs (Gao et al., 2015; Jia, Gungor-
Ozkerim, et al., 2016; J. Liu et al., 2019). Moreover, GelMA has been studied in 3D 
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bioprinting tenocytes and myoblasts as co-culture to generate muscle-tendon tissues 
(Laternser et al., 2018). 
3.2.7 Hyaluronic acid 
HA is a hydrohilic polymer and a common component in ECM, however, its concentration 
depends on the tissue type. It is a glycosaminoglycan composed of D-glucuronic acid 
and N-acetyl D-glucosamine linked via glycosidic bonds. In aqueous solutions, HA binds 
water molecules, forming a viscoelastic substance, and its major functions are to 
lubricate, hydrate and transport water in tissues. In addition, the large size of HA enables 
it to provide structural and biochemical support. HA is biologically synthesized in 
vertabrates by integral membrane proteins, which produce low- or high-molecular weigth 
HA. In addition, HA can be synthesized in laboratory from synthetic materials, which 
decreases the batch-to-batch variation. (Yazdani et al., 2019) 
HA can be used to create very soft hydrogels, however for 3D bioprinting applications, 
HA can be too soft to hold its 3D shape after printing (Serban and Skardal, 2019). 
Therefore, the possibility to chemically modify HA is essential for altering its physical 
properties and to enhance the printability. For example, it can be modified with 
metyhacrylate, norbornene, tyramine, thiol and acrylate groups (Lim et al., 2020), and 
different crosslinking strategies, such as thiolation and photocrosslinking via 
methacrylation have been studied to increase the stiffness of HA (Lam et al., 2019). 
Enzymatic crosslinking has been studied to pre-crosslink the HA-based bioink to make 
it extrudable (Petta et al., 2018). In addition, combining HA with other bioink components 
can enhance the mechanical properties of the bioprinted structure (Skardal et al., 2010; 
Schuurman et al., 2013; Rajaram, Schreyer and Chen, 2014; Constantini et al., 2016; 
Nguyen et al., 2017; Kiyotake et al., 2019; Lam et al., 2019; Antich et al., 2020). Chemical 
modification of HA and its combination with other polymers provide an attractive 
biomaterial for stem cell -based therapy and TE, and the number of clinical trials using 
HA-based materials with stem cells is increasing (Galvez-Martin et al., 2019). 
HA is a major component of native cartilage, and thus it has been widely studied as a 
bioink component for 3D bioprinting cartilage tissue (Constantini et al., 2016; Nguyen et 
al., 2017; Lam et al., 2019; Antich et al., 2020). HA has been used to bioprint stem cells, 
such as hiPSCs (Nguyen et al., 2017), hMSCs (Constantini et al., 2016) and hASCs 
(Sakai et al., 2018). As examples of using modified HA, hyaluronic acid methacrylate 
(HAMA) has been used as a bioink component in 3D bioprinting cartilage (Duchi et al., 
2017; Lam et al., 2019) and bone tissue (Michelle T. Poldervaart et al., 2017), and 
thiolated HA to 3D bioprint liver tissue (Mazzocchi et al., 2018). 
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3.2.8 Laminin 
Laminins are heterotrimeric glycoproteins and abundant in basement membranes 
(Wilson, Torricelli and Marino, 2020), and shown to enhance cell adhesion and migration 
for example with hESC-derived neural stem cells (Barros et al., 2019), hiPSC-derived 
spinal sheroids (Besser et al., 2020) and human epithelial organoids (Broguiere et al., 
2018). However, there are quite few studies of laminin in bioinks, even though there are 
commercially available laminin products suitable for 3D bioprinting. Laminin is a primary 
component in Matrigel (Corning), which is a mixture of basement proteins from 
Engelbreth-Hol-Swarm mouse sarcoma (Corning Matrigel Matrix), and it has been used 
in 3D bioprinting of human breast cancer cells (Nerger, Brun and Nelson, 2019), human 
melanoma cells (Schmidt et al., 2019) and human alveolar cells (Berg et al., 2018). 
Sorkio et al. used human recombinant laminin to 3D bioprint hESC-LESCs (Sorkio et al., 
2018). In addition, laminin-based bioinks have been recently commercialized (GelX 
LAMININK; CELLINK LAMININK).  
3.2.9 Nanocellulose 
Cellulose is a polymer, which can be derived from plants or bacteria. Plant-based 
cellulose has a partially crystalline, micro- and nanofibril form, which main function is to 
act as a loadbearing structure. Thus, it has good mechanical strength and flexibility. The 
fibrils can be isolated, and the term nanocellulose is defined as the diameter of the fibrils 
in nanoscale. Nanocellulose can be categorized into bacterial nanocellulose, cellulose 
nanofibrils and cellulose nanocrystals, of which the two latter can be derived from 
biomass by breaking the bonds between fibrils with mechanical force, or combining the 
mechanical force with acidic, enzymatic or chemical oxidation. Whereas nanocrystals 
consists of the crystal regions alone, nanofibrils contain both crystalline and non-
crystalline regions. Bacterial nanocellulose is synthezised via oxidative fermentation in 
microbial culture. (Wang, Wang and Xu, 2020) 
Nanocellulose has gained attention in 3D bioprinting due to its porosity and interconnect 
framework within the hydrogel, as well as the shear-thinning properties for extrusion-
based bioprinting. In addition, the nanocellulose fibrils seem to have similarities with 
collagen and fibronectin fibrils in native ECM. (Wang, Wang and Xu, 2020) Nanocellulose 
fibrils has been used in 3D bioprinting to enhance the properties of low viscosity bioinks 
by providing shear thinning behaviour (Markstedt et al., 2015; Müller et al., 2017; Shin et 
al., 2017; Ojansivu et al., 2019) and increasing the structural and mechanical support of 
the bioink (Nguyen et al., 2017). It has been studied for example in 3D bioprinting of bone 
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(Ojansivu et al., 2019) and cartilage tissue (Markstedt et al., 2015; Nguyen et al., 2017), 
and in wound healing applications (Xu et al., 2019). 
3.3 Crosslinking strategies of hydrogel based bioinks 
Hydrogels are a widely studied material for 3D bioprinting as they provide an aqueous 
environment for the embedded cells (Chimene, Kaunas and Gaharwar, 2020). As any 
hydrogel, a hydrogel based bioink requires crosslinking for maintaining the stability of 
the printed structure (Cui et al., 2020). There are almost unlimited possibilities to modify 
hydrogels, create new combinations and study different crosslinking strategies, which 
enables the discovery of new properties for bioinks.  
Crosslinking can be done by creating physical or chemical interactions, and there are 
several different methods to crosslink the hydrogel based bioink (Figure 9). Physical 
crosslinking is non-covalent and reversible, and it includes electrostatic interactions 
(ionic crosslinking), hydrophobic interactions and hydrogen bonding interactions, of 
which the hydrophobic interactions and hydrogen bonding can depend on temperature. 
In chemical crosslinking, the network is created with covalent bonds, and the mechanical 
stability is usually better than with physical crosslinking. (Hospodiuk et al., 2017) The 
covalent bonding requires the presence of chemically reactive functional groups, which 
create chemical crosslinks with the polymer network (Cui et al., 2020). Chemical 
crosslinking includes for example different chemical crosslinkers and photocrosslinking. 
Moreover, enzymes can be used as crosslinkers for chemical crosslinking of hydrogels 
(Cui et al., 2020), however, it is not discussed in detail in this thesis. 
Different cell types prefer different environments, and the mechanical properties of the 
bioink should mimic the natural environment of the cells (Williams et al., 2018). By 
increasing the crosslinking density, the strength and stiffness of the hydrogel can be 
increased because of the increase in the number of polymer chains and decrease in the 
length of individual chains. However, too high density can affect the cells due to decrease 
in porosity and permeability, which is why one of the key aspects in designing bioinks is 
to find a balance in the crosslinking density. (Chimene, Kaunas and Gaharwar, 2020) 
Thus, the optimization of the crosslinking strategy and parameters has a considerable 
effect on the bioprinted cells. Usually multiple components or modifications are combined 
to design hybrid bioinks, which enables the use of different crosslinking methods to utilize 
their advantages and develop novel, tunable bioinks (Ouyang et al., 2016; Petta et al., 
2018; Zhu et al., 2018; Kajave et al., 2020; Shin et al., 2020). 
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Figure 9. Schematic of the typical crosslinking methods used in hydrogel bioinks, 
including physical crosslinking (A-C) and chemical crosslinking (D-G). Modified from (Cui 
et al., 2020) and (Lim et al., 2020). 
3.3.1 Chemical crosslinkers 
Chemical crosslinkers are used to create covalent bonds between the polymer chains, 
and the crosslinking density depends for example on the concentration of the crosslinker. 
Schiff’s base formation is one of the most studied chemical crosslinking methods (Figure 
9 D). There, the crosslink is formed between an amine containing and an aldehyde 
containing polymers. This crosslinking method results in hydrogels with shear thinning 
behaviour, however, the aldehyde groups can react with the amine groups in the ECM. 
(Cui et al., 2020) 
Physical crosslinking Chemical crosslinking 
  
  
  
  
(A) Electrostatic interaction 
(B) Hydrophobic interaction 
(C) Hydrogen bonding 
(E) Thiol-ene (photo)crosslinking 
(D) Schiff’s base 
 
(G) Free-radical chain photopolymerization 
(F) Enzymatic crosslinking 
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A common crosslinker is glutaraldehyde, however, as it might induce cytotoxicity, other 
crosslinkers have been studied (Hospodiuk et al., 2017). Sodium bicarbonate has been 
used to crosslink collagen type I (Ng et al., 2018), and genipin has been used to crosslink 
for example gelatin (Zhu et al., 2018) and collagen type I (Kim, Lee and Kim, 2016; 
Kajave et al., 2020). Figure 10 illustrates the chemical crosslinking and formation of a 
covalent bond between a polymer with hydroxyl functional groups and glutaraldehyde 
crosslinker. 
In addition to previously mentioned crosslinkers, polyethylene glycol (PEG) -based 
crosslinkers have been studied. For example, PEG crosslinker containing an acrylate 
group, can be used to crosslink HAMA (Ma et al., 2020) or GelMA (Jia, Selcan Gungor-
Ozkerim, et al., 2016). In addition, a thiolated polymer can be crosslinked with PEG 
crosslinkers (Rutz et al., 2019), or PEG-based crosslinkers, such as polyethylene glycol 
diacrylate (PEGDA) and 8-arm PEG alkyne (Skardal et al., 2016). Rutz et al. used PEG 
crosslinkers to create crosslink gelatin, and Skardal et al. used both PEGDA and 8-arm 
PEG with thiolated HA and thiolated gelatin together with tissue-specific ECM digest 
solution to bioprint liver spheroids. With PEGDA, a spontaneous crosslinking reaction 
between the thiol and acrylate groups, resulting a soft gel. With 8-arm PEG alkyne, a 
thiolated polymer needs UV irradiation to activate photocrosslinking, resulting a stiffer 
gel. (Skardal et al., 2016) 
Figure 10. Illustration of a chemical crosslinking of a polymer containing hydroxyl 
groups by using glutaraldehyde as a crosslinker, resulting in covalent crosslinks. 
(Capri, 2011) 
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3.3.2 Crosslinking based on thiolation 
A thiolated polymer is a polymer with covalently attached thiol groups (Leichner, 
Jelkmann and Bernkop-Schnürch, 2019). Thiolated polymers can be utilized in hydrogel 
crosslinking in disulfide bond formation (Figure 11 A) (Gajendiran, Rhee and Kim, 2018), 
free-radical thiol-ene reaction (Figure 11 B) or Michael-type addition reaction (Figure 11 
C). The most common polymers for thiolation are gelatin, collagen and HA (Holmes et 
al., 2017), and there are two approaches to fabricate thiolated polymers, ring-opening 
addition of thiolactone-based reagents and N-(3-dimethylaminopropyl)-N’-
ethylcarboiimide/N-hydroxysuccinimide (EDC/NHS) coupling reaction. In EDC/NHS, the 
carboxylic acid and the amine groups react, and the reaction occurs between the 
thiolating agent and the selected polymer. The most widely used thiolating agent is 2-
iminothiolane, also known as Traut’s reagent. (Gajendiran, Rhee and Kim, 2018) In 
addition to Traut’s reagent, there are several other thiolating agents (Leichner, Jelkmann 
and Bernkop-Schnürch, 2019). The thiolation via ring-opening of ColI is presented in 
Figure 12. 
Figure 12. Thiolation reaction of collagen type I with Traut’s reagent and dithiothreitol 
(DTT). (Holmes et al., 2017) 
(A) Disulfide bond 
formation 
(B) Free-radical thiol-ene 
(photo)crosslinking 
(C) Catalyst-mediated 
Michael-type addition 
Figure 11. Overview of the crosslinking chemistries for thiolated polymers. (A) Disulfide 
bond formation (purple), and thiol-ene crosslinking (red): (B) Free-radical thiol-ene 
photocrosslinking and (C) catalyst-mediated Michael-type addition. Modified from (Van 
Hoorick et al., 2019). 
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Thiolated polymers form disulfide bonds (C-S-S-C) (Figure 11 A) between the thiol 
groups in oxidative environment, which is reversible process depending on oxidation and 
reduction (Van Hoorick et al., 2019). The polymer chain length, flexibility and charged 
substructrures affect the ability of the reactive groups to come close to each other, and 
subsequently the bond formation and crosslinking (Leichner, Jelkmann and Bernkop-
Schnürch, 2019). In addition, the degree of thiolation affects the crosslinking (Leichner, 
Jelkmann and Bernkop-Schnürch, 2019), and the degree of thiolation and the number of 
thiol groups can be determined with Ellman’s reaction (Gajendiran, Rhee and Kim, 2018).  
Thiol-ene reaction is a chemical crosslinking method, where the thiolated polymer 
undergoes thiol-ene coupling due to reaction between a thiol and a carbon-carbon 
double bond (‘ene’) (Stichler et al., 2017), and is also referred as a thiol click reaction 
(Hoyle and Bowman, 2010). Thiol-ene reactions can be divided into a free-radical thiol-
ene reaction (Figure 11 B) and Michael-type addition (Figure 11 C)  (Holmes et al., 2017). 
The free radical thiol-ene reaction is usually initiated by light in thiol-ene 
photocrosslinking (Figure 13) (Van Hoorick et al., 2019). Both of these reactions result 
in the formation of thioether linkage (C-S-C) (Holmes et al., 2017), and the advantages 
relatively mild conditions, controllability, high chemical yield and relative inertness 
(Nguyen et al., 2015). 
A 
B 
Figure 13. Thiol-ene (photo)crosslinking. (A) General mechanism and (B) schematic for 
radical-mediated thiol-ene photocrosslinking. Modified from (Lim et al., 2020). 
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Michael-type addition reaction is catalyst-mediated, and there the thiol reacts with an 
electron-deficient ‘ene’, such as (meth)acrylate. The catalysts can be for example 
amines, acting as a nucleophiles. (Hoyle and Bowman, 2010) The reaction can occur at 
physiological pH, however, there is no spatiotemporal control due to fast reaction profile 
(Van Hoorick et al., 2019).  
In a free-radical thiol-ene reaction, a thiyl radical propagates across the ‘ene’ functional 
group, resulting a chain-transfer reaction, abstraction of a hydrogen radical from the thiol 
and step growth polymerization. As a net reaction, the thiol and ‘ene’ functional groups 
are combined in a exothermic reaction, which can be initiated by light in radical-mediated 
thiol-ene photocrosslinking. (Holmes et al., 2017) There, the formation of the free radical 
is light-induced in the presence of a photoinitiator. Figure 13 A presents the steps in the 
thiol-ene (photo)crosslinking, where the reactive thiyl radical reacts with the ‘enes’ after 
initiation, which can result in chain transfer and step growth polymerization or 
homopolymerization. The reaction is terminated when all the reactive groups are 
consumed. (Lim et al., 2020) The thiol-ene reaction can occur either between an ‘ene’-
functionalized polymer (e.g. norbornene-functionalized gelatin) and a thiolated 
crosslinker (e.g. dithioretinol, DTT), as it shown in Figure 13 B, or between a thiolated 
polymer and a ‘ene’ crosslinker (e.g. PEGDA). The advantages of this method are the 
higher conversion of the functional groups, the possibility to control the time and location 
of the light-mediated activation, rapid reaction rate and low polymer shrinkage. (Van 
Hoorick et al., 2019) In addition, the thiol-ene photo click crosslinking is not oxygen 
inhibited and requires lower concentration of free radicals (Stichler et al., 2017). 
In 3D bioprinting, thiol-ene crosslinking has been done for example by crosslinking 
thiolated HA with PEGDA, and combining the crosslinked HA-PEGDA with type I and II 
collagens and human fibroblasts (Walimbe et al., 2019), and it has been applied for 
example to bioprint hMSCs (Galarraga, Kwon and Burdick, 2019; Xin et al., 2019), 
hASCs (Tytgat et al., 2019) and human articular chondrocytes (Soliman et al., 2020). 
Galarraga et al. used norbornene functionalized HA, combined it with a photoinitiator and 
a crosslinker DTT, and used visible light to activate the thiol-ene photocrosslinking 
reaction. Xin et al. used norbornene-functionalized PEG and a thiolated PEG as a 
crosslinker, and applied UV light after printing. Tytgat et al. combined norbornene-
functionalized and thiolated gelatin with a photoinitiator under UV light. Soliman et al. 
used DTT and thiolated PEG as crosslinkers for thiol-ene crosslinking of allyl-
functionalized gelatin. They used this primary crosslinking before bioprinting and applied 
thiol-ene photocrosslinking after printing.  
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3.3.3 Ionic crosslinking 
In ionic crosslinking, the opposite charges of the mixed materials attract each other, 
which creates the non-covalently crosslinked network (Figure 9 A) (Hospodiuk et al., 
2017). This interaction can occur either between two polyelectrolytes with opposite 
charges, or between a polyelectrolyte and a small charged molecule. Electrostatic 
interactions in ionic crosslinking can be affected with controlling the pH of the solution, 
as the pH affects the protonation of the charged functional groups. (Cui et al., 2020) One 
advantage of ionic crosslinking is its reversible nature, which enables the possibility to 
use the physically crosslinkable component as a structural support for the 3D structure 
and remove it after bioprinting. Therefore, the desired polymer with relatively weak 
mechanical properties, such as gelatin, can be used to create a stable 3D structure with 
the help of ionically crosslinked template polymer. (Zhu et al., 2018) 
Typically, ionic crosslinking is utilized by crosslinking alginate with CaCl2 (Pan et al., 
2016; Gu et al., 2017; Raddatz et al., 2018; Sarker et al., 2018; Zhu et al., 2018), as 
alginate contains negatively charged carboxylic acid groups (Hospodiuk et al., 2017). 
There, alginate acts as a polyelectrolyte with negative charge. When using divalent 
calcium ions together with a negatively charged groups of the polymer, they form a bridge 
due to the electrical attraction (Hospodiuk et al., 2017). The ionic crosslinking between 
a calcium ion and the carboxylic acid groups of alginate is shown in Figure 14. Often 
alginate-based structure is immersed in CaCl2 after printing (MacCallum et al., 2020). 
However, the CaCl2 concentration and dispersion time can have negative effects on the 
cells, which is why fast completion of the process and careful wash are required (W. Liu 
et al., 2018). 
Figure 14. Illustration of ionic crosslinking between the carboxylic acid groups of 
alginate and a calcium ion. (Capri, 2011) 
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3.3.4 Photocrosslinking 
Photocrosslinking is a chemical crosslinking method, and it is initiated by a photoinitiator 
when precursor bioink containing the photoinitiator is exposed to light (Lim et al., 2020). 
Photocrosslinking is irreversible, covalent and can be coupled with other crosslinking 
methods, such as reversible thermal crosslinking (Yin et al., 2018). There are three main 
photocrosslinking mechanisms, free-radical chain polymerization, thiol-ene and 
photomediated redox. (Lim et al., 2020) The thiol-ene (photo)polymerization is discussed 
later in a separate chapter. The biggest advantage of photocrosslinking is the 
spatiotemporal control over the reactions and the possibility to crosslink the bioink 
before, after or during printing, which enables precise building of the 3D structure (Lim 
et al., 2020). The main disadvantage of photocrosslinking is oxygen inhibition, which 
causes incomplete crosslinking. When the photoinitiator undergoes photolysis caused 
by light, radicals reacting with photocrosslinkable groups are formed. However, due to 
oxygen inhibition, some of these radicals are modified into peroxyl radicals due to oxygen 
molecules, which do not react with the photocrosslinkable groups. (Knowlton et al., 2017) 
Therefore, oxygen inhibition decreases polymerization rate and final conversion ratio 
(Choi et al., 2019).  
Free-radical chain polymerization (Figure 9 G) has three stages (Figure 15 A). In the 
initiation stage, the photoinitiator is transformed into a reactive radical due light exposure. 
(A) Free-radical chain polymerization 
 
1. Initiation 
I 
ℎ𝑣
ሱሮ I• (Dissociation) 
I• + M → M• (Association) 
2. Propagation 
M• + M → M1•  
M1• + M → M2•  
3. Termination 
Mn• + Mm•  → Pn+m (Coupling) 
Mn• + Mm•  → Pn + Pm (Disproportination) 
Mn• + HX  → Pn-H + X• (Chain transfer) 
(B) Photomediated redox crosslinking 
 
Photo-oxidation and crosslinking 
I 
ℎ𝑣
ሱሮ I*  (Photosensitization) 
I* + R-OH ↔ I•- + R-O• + H+ (Oxidation) 
R1-O• + R2-O• → R1-O-R2 (Crosslinking) 
 
Oxygen-mediated side reactions 
I* + 3O2 → I + 1O2 (Energy transfer) 
I•- + 3O2 → I + O2•-  
2 I•- + 2 H+ → I + I-H2  
I-H2 + 3O2 → I + H2O2 (Coupling) 
Figure 15. General mechanisms of (A) free-radical chain polymerization and (B) 
photomediated redox crosslinking. (A) Free-radical chain polymerization includes three 
stages, initiation, propagation and termination. (B) Photomediated rexod crosslinking  
includes exication of oxygen by a photosensitizer and its pairing with another free radical 
oxygen. There are different possible side reactions: energy transfer between an exited 
photosensitizer and a ground state oxygen, a reaction of the radical derivatives of a 
photosensitizer, resulting in a superoxide, or photosensitizer intermediate radical species 
coupling, resulting in hydrogen peroxide. Based on figures from (Lim et al., 2020). 
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The rate of the transformation depends for example on the efficiency and concentration 
of the photoinitiator. The photoinitiator, now as a free radical, reacts with the functional 
groups of the selected polymer, creating covalent bonds and reactive radical 
intermediates. In the propagation stage, these intermediates react with the subsquent 
reactive groups, propagating the radical species through unreacted carbon-carbon 
double bonds. The most common functional groups crosslinking via free-radical chain 
polymerization are (meth)acrylate and N-vinyl amide. Finally, the reaction progresses in 
the termination stage, where there are three termination options. The free radicals can 
be coupled to result in combination of two polymer chain ends. Another option is the 
disproportionation, which results in two polymer chains, one with a saturated terminal 
group and another with a nonsaturated terminal group. The third option is the chain 
transfer, where radicals are transferred away from the polymer chain. (Lim et al., 2020) 
The main aspects to consider in photocrosslinking are the selection of the photoinitiator, 
the wavelength and intensity of the light and exposure time (Lim et al., 2020). The used 
wavelength of light depends on the absorption peak of the selected photoinitiator, as it 
affects the efficiency of the photoinitiator (Knowlton et al., 2017), and higher intensity or 
exposure time increases the photocrosslinking rate and density (Lim et al., 2020). 
Moreover, the concentration of the photoinitiator and the reactive groups of the 
photocurable polymer affect the photocrosslinking efficiency, and by increasing either of 
the concentrations, the photocrosslinking rate and density can be increased (Lim et al., 
2020). Since the crosslinking density affects the mechanical properties of the hydrogel 
(Chimene, Kaunas and Gaharwar, 2020), the desired mechanical properties of a 
photocurable hydrogel bioink can be achieved by optimizing these parameters, which 
are summarized in Figure 16. 
The typical light sources are ultraviolet (UV) light (200 – 400 nm) and visible light (400 – 
800 nm) (Choi et al., 2019). In addition, possible cell cytotoxicity and the penetration 
efficiency affect the selection of the wavelength (Knowlton et al., 2017), and it has been 
shown that both UV A (320 – 400 nm) and UV B (290 – 320 nm) radiation can cause 
Figure 16. Parameters affecting the photocrosslinking efficiency. 
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genomic instability in the cells (Dahle, Kvam and Stokke, 2005). Usually the used 
wavelength in photocrosslinking is 365 nm, which is close to the visible light range, and 
thus the cytotoxicity and genotoxicity are minimized (Lim et al., 2020). Due to the limited 
penetration depth of UV, the photocrosslinking efficiency of larger constructs might be 
affected (Lim et al., 2016). Moreover, the photoinitiator concentration and addition of a 
photoabsorber decrease the penetration depth (Lim et al., 2020). 
There are several photoinitiators, and two most widely used commercially available ones 
are 2-hydroxy-1-[4-hydroxyethoxyphenyl]-2-methyl-L-propanone (Igracure 2959) and 
lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) (Lim et al., 2020). There are 
other Igracure photoinitiators in addition to 2959, however, Igracure 2959 has shown the 
best cytocompatibility, and thus it is the most used Igracure to fabricate cell-laden 
hydrogels (Bryant, Nuttelman and Anseth, 2000). Lim et al. have made an extensive 
review of research done using Igracure 2959 and LAP as photoinitiators in 3D bioprinting, 
where the photoinitiator concentration range is 0.01 – 1 wt%, and the UV exposure time 
varies from 2 s per layer (Stichler et al., 2017) to 10 min after bioprinting (Shi et al., 2017) 
or to continuous exposure during bioprinting (Tigner et al., 2020). Both Igracure 2959 
and LAP are type I photoinitiators, which go through homolytic cleavage caused by light, 
resulting in free radicals, and therefore photopolymerization process described 
previously. There are type II photoinitiators as well, however, their photocrosslinking 
mechanism is more complex. (Lim et al., 2020) Type II photoinitiators are not as widely 
used, and they are not discussed further in this thesis. 
Igracure 2959 is hydrophilic, however, it absorbs light within the range of 200-370 nm, 
254 nm being the most efficient (Van Hoorick et al., 2019). Thus, at higher wavelengths, 
its efficiency decreases. Lower wavelengths are not used due to the mutageneicity and 
phototoxicity for the cells, and thus the options for increasing the polymerization 
efficiency are to increase the Igracure 2959 concentration, light intensity or light exposure 
time to compensate the low efficiency at higher wavelengths. (Lim et al., 2020) 
Compared to Igracure 2959, LAP absorbs more light at 365 nm, resulting in more rapid 
polymerization, is able to absorb light within the visible light range (> 400 nm) and has 
greater water solubility (Fairbanks et al., 2009). Moreover, LAP has been shown to result 
better stability of the 3D bioprinted structure (Tigner et al., 2019).  
Photomediated redox crosslinking (Figure 15 B) is used with polymers containing phenol 
groups. A photosensitizer is used, and they are usually light-absorbing dyes or additives, 
such as eosin-Y or rose bengal. The photosensitizer oxidates the reactive group of the 
selected polymer, which then can react with another oxidized group, creating crosslinks. 
Side reactions can occur in the presence of oxygen, such as energy transfer between an 
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exited photosensitizer and a ground state oxygen, which results in electrophilic, excited 
singlet oxygen spieces, possible to oxidize hydroxyl, sulfide and amine groups. Another 
possible side reaction is the electron transfer or hydrogen abstraction, which results in  
radical derivatives of a photosensitizer. These radical derivatives can undergo a reaction 
resulting in a superoxide, or coupling, resulting in hydrogen peroxide. (Lim et al., 2020) 
Methacrylation is a widely studied method to modify the properties of the bioink and make 
the bioink photocrosslinkable (Skardal et al., 2010; Pereira and Bártolo, 2015; Michelle 
T Poldervaart et al., 2017; Yin et al., 2018; Xu et al., 2019; Ma et al., 2020). Many 
hydrogels can be methacrylated by adding methacrylate functional groups to the 
backbone of the polymer, such as gelatin or HA (Chimene, Kaunas and Gaharwar, 
2020). Figure 17 illustrates the methacrylation and photocrosslinking of HA and gelatin.  
GelMA and HAMA are synthesized by using for example methacrylic anhydride to 
substitute the amine side groups of gelatin (Figure 17 A) (Choi et al., 2019) or hydroxyl 
Gelatin 
GelMA pre-polymer 
Photocrosslinked GelMA 
(A) 
(B) 
 
Hyaluronic acid HAMA pre-polymer 
Photocrosslinked HAMA 
PI 
Light 
PI 
Light 
PBS 
50 °C 
Water 
pH 8.5 
Figure 17. Methacrylation and photocrosslinking via free-radical chain polymerization of 
gelatin (A) and hyaluronic acid (B). Briefly, the methacrylated gelatin (GelMA) or 
hyaluronic acid (HAMA) is photocrosslinked by a photoinitiator (PI) in the presence of 
light. Modified from (Choi et al., 2019). 
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groups of HA (Figure 17 B) (Michelle T Poldervaart et al., 2017) with methacrylate 
groups. By increasing the methacrylation degree or the GelMA/HAMA concentration, 
more crosslinking sites are created. The modulus in mechanical properties is increased 
and thus, it is possible to adjust the mechanical properties of the material. (Choi et al., 
2019; Spearman et al., 2020) The compressive or elastic modulus of the hydrogel can 
be increased and the decradation rate decreased, when the methacrylation degree, 
polymer concentration or light exposure time is increased (Choi et al., 2019). In addition, 
the viscosity of the material is affected (Spearman et al., 2020) which affects the 
printability of the bioink. 
3.3.5 Thermal crosslinking  
Temperature-induced crosslinking is a reversible non-covalent crosslinking method and 
can be used for thermo-sensitive polymers, such as collagen type I (Drzewiecki et al., 
2017; Moncal et al., 2019), gelatin (Pan et al., 2016; Gu et al., 2018; Luo et al., 2020) or 
methylcellulose (Shin et al., 2020). It is based on temperature-dependent hydrophobic 
interactions (Figure 9 B) and hydrogen bonding (Figure 9 C), which create the 
crosslinked network. Hydrogen bonds are formed between oxygen and hydrogen atoms, 
and thus they occur between polymer chains containing for example hydroxyl or carboxyl 
groups (Cui et al., 2020). Hydrogen bonding is strongly affected by temperature and pH, 
which influences the crosslinking density (Wang et al., 2018). In the case of hydrophobic 
interactions, an increase in temperature can cause the hydrophobic domains in the 
polymer to aggregate, as the contact area between hydrophobic domains and water is 
minimized (Cui et al., 2020). For some hydrogels, the crosslinking occurs at low 
temperatures, as the polymer chains have more ordered conformations and form 
junctions (crosslinks) between the chains (Hospodiuk et al., 2017).  
Because 3D bioprinting uses living cells, it is important to keep the temperature between 
1 °C and 37 °C (Eswaramoorthy, Ramakrishna and Rath, 2019). In thermal crosslinking, 
there is no need to use additional, possibly cytotoxic crosslinking agents (Moncal et al., 
2019), however, the mechanical properties of a thermally crosslinked hydrogel are 
usually too weak (Shin et al., 2020). Therefore, another crosslinking method, such as 
photocrosslinking, is usually combined to create dual-crosslinked hydrogel. This enables 
the possibility to use both physical and chemical crosslinking and change between the 
crosslinking methods flexibly. (Shin et al., 2020) 
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4. 3D BIOPRINTING OF OCULAR TISSUE 
Traditional techniques, where cells are seeded afterwards on the prefabricated scaffold, 
do not provide homogenous cell seeding or appropariate adhesion (K. W. Kim et al., 
2018). The characteristics of the cornea include high cell density, a structure with 
multiple layers and cell types as well as curved shape, and therefore the fabrication of 
corneal substitutes require a technique capable of controlling the shape and structure of 
the produced tissue. Even though the curved shape still remains a challenge, 3D 
bioprinting has the possibility to fabricate precise shapes with the desired 3D structure. 
Moreover, it is a presice, repeatable and customizable fabrication technique, and offers 
a possibility to overcome issues of using donor tissue, such as tissue shortage and risk 
of rejection. In addition, various different materials and cells can be integrated by 3D 
bioprinting to mimic the complexity of the native tissue, which enables building an 
accurate 3D model of the cornea. (B. Zhang, Xue, Li, et al., 2019)  
Due to accessibility and immune priviledge, meaning that the normal inflammatory 
reponse is limited (Boyd, 2018), the eye has attracted attention in developing and 
implementing 3D bioprinting solutions in ophtalmology (Sommer and Blumenthal, 2019). 
Especially, the characteristics of the cornea, including the absence of vascularization, 
relatively homogenous cellular level and low metabolic demand, have made it an 
appeling tissue for 3D bioprinting (Sommer and Blumenthal, 2019), and there is an 
increasing number of studies (B. Zhang, Xue, Hu, et al., 2019; H. Kim et al., 2019) and 
newsarticles done in 3D bioprinting cornea (Biomedical Research Team in Spain 
Working on 3D Printed Corneas to Make Up for Lack of Donors, 2017; Corneas Could 
Be the First Mainstream Application of Bioprinting, 2018). In addition, different parts of 
the cornea has been studied in 3D bioprinting, such as endothelium (K. W. Kim et al., 
2018), stroma (Isaacson, Swioklo and Connon, 2018; Sorkio et al., 2018; Duarte Campos 
et al., 2019; Kilic Bektas and Hasirci, 2020; Kutlehria et al., 2020; Mahdavi, Abdekhodaie, 
Kumar, et al., 2020) and epithelium (Wu et al., 2016; Sorkio et al., 2018). The research 
done in 3D bioprinting corneal tissues is summarized in Table 4. In addition to cornea, 
retina has been studied in 3D bioprinting of ocular tissues, however, the number of 
studies is smaller and mainly biomaterial-free approaches are used (Shi et al., 2018; 
Masaeli and Marquette, 2020; Masaeli et al., 2020), and therefore 3D bioprinting retina 
is not discussed futher in this thesis. 
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Table 4. Summary of research in the field of 3D bioprinting cornea. hCKs = Human 
corneal keratocytes, hCSCs = Human corneal stromal cells, hCEnCs = Human corneal 
endothelial cells, hCEpCs = Human corneal epithelial cells 
Target tissue 
3D bioprinting 
technique 
Cell type 
Main bioink 
components 
Reference 
Corneal 
endothelium 
Extrusion hCEnCs Gelatin 
(K. W. Kim et al., 
2018) 
Corneal stroma DOD hCKs ColI with agarose 
(Duarte Campos et 
al., 2019) 
Corneal stroma 
Pneumatic 
extrusion 
hCKs 
Alginate with 
methacrylated ColI 
(Isaacson, Swioklo 
and Connon, 2018) 
Corneal stroma 
Pneumatic 
extrusion 
hCKs GelMA 
(Kilic Bektas and 
Hasirci, 2020) 
Corneal stroma 
Pneumatic 
extrusion 
hCKs 
ColI – Gelatin - 
Alginate 
(Kutlehria et al., 
2020) 
Corneal stroma SLA hCSCs GelMA 
(Mahdavi, 
Abdekhodaie, 
Kumar, et al., 
2020) 
Corneal 
epithelium 
Extrusion hCEpCs 
ColI – Gelatin – 
Alginate 
(Wu et al., 2016) 
Corneal 
epithelium and 
corneal stroma 
LIFT 
hESC-
LESCs 
Laminin-521 with HA 
(Sorkio et al., 
2018) 
hASCs 
ColI with human 
plasma and thrombin 
Cornea Extrusion hCEpCs Alginate – Gelatin 
(B. Zhang, Xue, 
Hu, et al., 2019) 
Cornea 
Pneumatic 
extrusion 
hMSCs 
Cornea-derived 
decellularized ECM 
(H. Kim et al., 
2019) 
Cornea Not mentioned 
hMSC-
derived 
cells 
Collagen 
(Biomedical 
Research Team in 
Spain Working on 
3D Printed 
Corneas to Make 
Up for Lack of 
Donors, 2017) 
Cornea LIFT hCEpCs Collagen 
(Corneas Could Be 
the First 
Mainstream 
Application of 
Bioprinting, 2018) 
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All the main 3D bioprinting techniques have been used in 3D bioprinting corneal tissues, 
inkjet-based DOD bioprinting (Duarte Campos et al., 2019), laser-based LIFT bioprinting 
(Sorkio et al., 2018), lithography-based SLA bioprinting (Mahdavi, Abdekhodaie, Kumar, 
et al., 2020) and pneumatic extrusion-based bioprinting (Isaacson, Swioklo and Connon, 
2018; Kilic Bektas and Hasirci, 2020; Kutlehria et al., 2020). Several different bioink 
components have been used, such as agarose (Duarte Campos et al., 2019), alginate 
(Wu et al., 2016; Isaacson, Swioklo and Connon, 2018; Kutlehria et al., 2020), ColI (Wu 
et al., 2016; Isaacson, Swioklo and Connon, 2018; Sorkio et al., 2018; Duarte Campos 
et al., 2019; Kutlehria et al., 2020), decellularized cornea (H. Kim et al., 2019), gelatin 
(Wu et al., 2016; K. W. Kim et al., 2018; Kutlehria et al., 2020), GelMA (Kilic Bektas and 
Hasirci, 2020; Mahdavi, Abdekhodaie, Kumar, et al., 2020) and laminin (Sorkio et al., 
2018).  
The crosslinking of the 3D bioprinted ocular structures after printing have been made 
with temperature (Duarte Campos et al., 2019; H. Kim et al., 2019) and CaCl2 (Wu et al., 
2016; Isaacson, Swioklo and Connon, 2018; Kutlehria et al., 2020), or via 
photocrosslinking (K. W. Kim et al., 2018; Kilic Bektas and Hasirci, 2020; Mahdavi, 
Abdekhodaie, Kumar, et al., 2020). In addition, 3D bioprinting has been done without 
further crosslinking for epithelial cells and with fibrin-thrombin coagulation for stromal 
cells (Sorkio et al., 2018). Kilic Bektas and Hasirci used UV light at 365 nm for 15% 
GelMA bioink with 0.5% Igracure 2959 photoinitiator to photocrosslink the 3D bioprinted 
structure. K. W. Kim et al. used Gel4Cell (Bioink Solutions, Inc., Sout Korea) bioink kit, 
which contains gelatin-based hydrogel and a photosensitive Gel-linker, and is 
photocrosslinked with UV light at 365 nm. The UV exposure times were 5 s (Kilic Bektas 
and Hasirci, 2020) and 15 s (K. W. Kim et al., 2018), and in both studies, 
photocrosslinking was done after bioprinting all the layers. Mahdavi et al. used visible 
light instead of UV light and eosin Y with triethanolamine as a photoinitiator. The 
photocrosslinking was done layer-by-layer with the exposure time of 5 min.  
Most of the current research in 3D bioprinting corneal tissues use low cell density in the 
bioink, from 1 million cells per ml (Wu et al., 2016; Duarte Campos et al., 2019; H. Kim 
et al., 2019) to 2 (Isaacson, Swioklo and Connon, 2018), three (K. W. Kim et al., 2018; 
Kutlehria et al., 2020) or 8 (Mahdavi, Abdekhodaie, Kumar, et al., 2020) million cells per 
ml. Since viscosity increases when the cell density in the bioink is increased (Chimene, 
Kaunas and Gaharwar, 2020), inkjet-based bioprinting cannot be used for high cell 
density bioinks (Hölzl et al., 2016). Instead, laser-based LIFT bioprinting has been used 
to bioprint bioink with 30 million cells per ml (Sorkio et al., 2018), however, it is costly 
technology and not as well available. Whereas extrusion-based bioprinting can be used 
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to bioprint high cell density bioinks, higher viscosity can cause the nozzle to clog and 
increases the shear stress, which can harm the cells and decrease cell viability (Cui et 
al., 2020). However, native-like cell density is essential for biologically functional corneal 
tissue equivalents, and for example, the cell density in corneal epithelium is high due to 
stratified epithelial cells connected through tight junctions (Sridhar, 2018). Therefore, to 
3D bioprint corneal tissues, suitable bioprinting technology and bioink with native-like cell 
density are needed. 
The cell viability has been shown to be high after printing with all four 3D bioprinting 
technologies (Wu et al., 2016; Isaacson, Swioklo and Connon, 2018; Sorkio et al., 2018; 
Duarte Campos et al., 2019; H. Kim et al., 2019; Kilic Bektas and Hasirci, 2020; Kutlehria 
et al., 2020). Typically, the cell morphology has been round-shaped after printing (Wu et 
al., 2016; Isaacson, Swioklo and Connon, 2018; K. W. Kim et al., 2018; Sorkio et al., 
2018; Duarte Campos et al., 2019; Kutlehria et al., 2020), and depending on the cell 
type, the morphology has changed into elongated (Duarte Campos et al., 2019; Mahdavi, 
Abdekhodaie, Kumar, et al., 2020), hexagonal (K. W. Kim et al., 2018) or polygonal 
(Sorkio et al., 2018) during culture. However, also round-shaped morphology has been 
reported after 7 days (Isaacson, Swioklo and Connon, 2018) and 14 days (Kutlehria et 
al., 2020) post-printing, which is not desired for corneal cells.  
One challenge in bioprinting cornea is its curved shape, and that has been tried to 
accomplish in some of the studies. Isaacson et al. used 3D printed plastic support 
structure to mimic the curvature of the cornea, and filled it with gelatine slurry to facilitate 
the printing of low viscosity bioink. The gelatin slurry was aspirated after incubation and 
crosslinking of the printed structure at 37 °C. Mahdavi et al. used also gelatin as a 
supportive sacrificial material during bioprinting. This was done layer-by-layer by 
removing the uncrosslinked bioink after photocrosslinking and adding sacrificial gelatin 
to the hollow part of the layer. Kutlehria et al. used SLA-based bioprinting to fabricate a 
supportive 6-well scaffold from clear resin and bioprinted corneal stromal structures in 
the curved wells. With DOD based bioprinting, Duarte Campos et al. were able to bioprint 
a curved structure without additional support. Other research has been done on flat 
surfaces, resulting in a flat 3D structure without curved shape. Typically the bioprinting 
has been done on a cell culture dish without any specific coating (Wu et al., 2016; H. 
Kim et al., 2019; Kilic Bektas and Hasirci, 2020), however, printing on bovine AM (K. W. 
Kim et al., 2018), ColIV and laminin coated polyethylene terephthalate (PET) film, 
Corning MatrigelTM and Matriderm (Sorkio et al., 2018) have been studied. 
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5. MATERIALS AND METHODS 
This chapter describes on the experimental part of the thesis, and Figure 18 illustrates 
the iterative workflow of the experiments. First, hPSC-LESCs were produced for 
bioprinting, and the bioink components were prepared. On the printing day, the bioink 
was prepared and printed with an extrusion-based bioprinter. Later, the cell viability, 
proliferation, differentation and maturation were analyzed from the bioprinted samples. 
The bioprinting parameters and conditions were optimized based on the response of the 
bioprinted hPSC-LESCs. After finding the most suitable parameters, the bioink without 
cells was characterized. 
Figure 18. The iterative workflow of the thesis. 1: First, the hPSC-LESCs used in the 
bioink were produced. 2: The bioink was prepared and characterized. 3: The bioprinting 
was done by using a extrusion-based 3D bioprinter, and the printing step included the 
optimization of the printing parameters. 4: The bioprinted samples were analyzed with 
PrestoBlue, LiveDead and immunofluorescence staining. 5: Finally, the gathered data 
was analyzed. 
Optimization of 
bioprinting 
parameters and 
conditions 
Material 
characterization 
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fluorescence 
staining 
5. Data analysis 
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5.1 Preparation of the materials 
Next, the materials needed in bioprinting and their preparation are described, including 
the production of hPSC-LESCs and the protocols for different coatings of the printing 
substrates. In addition, the preparation of the bioink and its components is described. 
The bioink composition is confidental, and thus its components are described in detail in 
Appendix A. Finally, the chapter represents the preparation of the 3D bioprinter and the 
3D model used in the bioprinting. 
5.1.1 Cell culturing 
The cells used in this thesis were hPSC-LESCs from two different cell lines, hESC-line 
Regea 08/017 (46, XX) and hiPSC-line 001b B2 HT (46, XX). The research group has 
an approval to derive hESC-lines from surplus embryos not used in infertility treatments 
(R05116) and to produce hiPSC lines for ophthalmic research (R14023) from the ethics 
committee of the Pirkanmaa hospital district. This thesis was carried out under the 
approval from the local ethics committee of the Pirkanmaa hospital district, Finland, that 
allows the derivation and expanding of hESC-lines from surplus embryos donated by 
couples undergoing infertility treatments and to use these cell lines for research purposes 
(R05116). New cell lines were not derived for this study. 
The differentiation of hPSC-LESCs is described elsewhere (Hongisto et al., 2017), and 
the differentiated hPSC-LESCs were provided for the thesis by the research group. The 
hPSC-LESCs were either fresh or from frozen-stock. The fresh hPSC-LESCs were used 
for the analysis of cell viability, proliferation, maturation and differentiation after 
bioprinting, and hPSC-LESCs from frozen-stock were used for the UV exposure studies 
and as a control for immunofluorescence. The different batches of hPSC-LESCs used 
for bioprinting, the cell densities of the bioinks and the analyses they were used are 
summarized in Table 5. 
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Table 5. The summary of the used cell lines, their stocks and densities in the bioink. 
 
The differentiated hPSC-LESCs were cultured on 100 mm culture dishes (CellBIND 
Culture Dish, surface area 55 cm2, Corning)  in serum-free Cnt-30 medium (CELLnTEC 
Advanced Cell Systems AG, Switzerland) in an incubator at 37 °C 5% CO2. The cells 
were fed every other day with 8 ml of fresh, pre-warmed medium. The hPSC-LESCs 
from frozen-stock used for bioprinting were thawed on the 100 mm culture dishes with 
the seeding density of 13 000 cells/cm2. The hPSC-LESCs for the immunofluroescence 
control, pre-coated 24-well plates (CellBIND Multiple Well Plate, surface area 1.9 cm2, 
Corning) were used with a seeding density of 29 000 cells/cm2. The fresh hPSC-LESCs 
were dissociated for bioprinting on Day 28 after starting the differentiation process, and 
the hPSC-LESCs from frozen-stock used for bioprinting were dissociated on Day 8 after 
thawing. The hPSC-LESCs used for the immunofluroescence control were fixed with 4% 
paraformaldehyde (PFA) on Day 6 after thawing. The fixing protocol is described in 
Chapter 5.5.2. 
The coating of the cell culture dishes and well plates used for hPSC-LESC expansion 
was done with laminin and ColIV to help the cells to attach the bottom of the dish. The 
native EBM beneath the corneal epithelium consists mainly of ColIV and laminins 
(Wilson, Torricelli and Marino, 2020), and subsequently, the coating composed of 5 
μg/cm2 of human recombinant laminin 521 (LN521, 100 μg/ml, BioLamina, Sweden) and 
0.5 μg/cm2 of collagen type IV from human placenta (ColIV C5533, 1 mg/ml, Sigma 
Aldrich, USA) diluted in phosphate buffered saline containing magnesium chloride and 
CaCl2 (PBS ++, Gibco). The coating solution was prepared by using the equation 1 
𝑉𝑆𝑡𝑜𝑐𝑘 =
𝐶𝐷𝑒𝑠𝑖𝑟𝑒𝑑
𝐶𝑆𝑡𝑜𝑐𝑘
∙ 𝐴,   (1) 
Cell line Stock Cell density (cells/ml) Used for 
hESC-line 08/017 Frozen - Immunofluorescence control 
hESC-line 08/017 Frozen 15 million 
UV exposure and printing 
substrate studies 
hESC-line 08/017 Fresh 3 million Printing substrate studies 
hESC-line 08/017 Fresh 9 million 
Cell viability, proliferation, 
maturation and differentiation 
analysis 
hiPSC-line  
001b B2 HT 
Fresh 8.8 million 
Cell viability, proliferation, 
maturation and differentiation 
analysis 
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where VStock means the needed volume of either ColIV or LN521, CDesired means the 
desired concentration of ColIV or LN521 in the coating solution, CStock means the initial 
concentration of ColIV or LN521, and A means the area of the coated surface. 3.5 ml of 
the coating solution was added onto the 100 mm culture dishes and 300 μl for the 24-
well plates. The dishes and plates were covered with Parafilm to prevent evaporation, 
and left over night at 4 °C. Before seeding the cells, the solution was removed and the 
dishes and plates were warmed in the incubator at 37 °C 5% CO2. 
Dissociation of the hPSC-LESCs for bioprinting was done with TrypLE (1X, Gibco). First, 
the medium was removed and 2 ml of warm TrypLE was added onto each dish for  5 
minutes. After this, TrypLE was removed and 2 ml Defined Trypsin Inhibitor (DTI, Gibco) 
was added to inactivate the enzyme and stop the cells to dissociate completely from the 
bottom of the dish. Then, the cells were scraped with a cell scraper from the bottom of 
the plates, transferred into centrifuge tubes through a filter, and the dish was rinsed with 
2 ml of medium. The cell suspension was centrifuged at 300 g for 5 minutes, and the 
cells were resuspended in the culture medium. The cells were counted by using a Bürker 
chamber. Thereafter, the cells were centrifuged and resuspended in 400 μl of Cnt-30 
medium for the bioink preparation. 15 μl of RevitaCell (100X, Gibco) was added into the 
cell suspension to help the cells to recover from the upcoming bioprinting process.  
5.1.2 Coating of the printing substrates 
Different coatings for the culture dishes (Falcon® 35 mm TC-treated Easy-Grip Tissue 
Culture Dish, Corning)  were tested as printing substrates. The coatings were ColIV with 
LN521, MatrigelTM (Growth Factor Reduced Basement Membrane Matrix, Corning), 
LinkCellTM ColI membranes (LinkoCare Life Sciences AB, Sweden) or nonporous 
polyethylene terephthalate (PET) membranes (ipCELLCULTURETM Track Etched 
Membrane, thickness 12 μm, it4ip, Belgium) coated with MatrigelTM or with ColIV and 
LN521. The coatings and the UV exposure times they were used with are presented in 
Table 6. 
MatrigelTM was chosen to provide better adhesion for the printed cells due to its 
transparency, hydrophilicity and previous use in 3D bioprinting of hASCs (Sorkio et al., 
2018). LinkCellTM membranes have previously been used in culturing hPSC-LESCs 
(Mikhailova et al., 2016), and porous PET membranes have been studied as a substrate 
in 3D bioprinting hPSC-LESCs (Sorkio et al., 2018). The ColI and LN521 coating was 
used in hPSC-LESC culture and expansion, and subsequently selected as a coating 
option for bioprinting as well. 
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Table 6. Different substrates which were tested for 3D bioprinting of the bioink and which 
UV exposure times were used. MatrigelTM coating of the culture dish and PET membrane 
as well as LinkCellTM membrane were tested with bioprinted hPSC-LESCs. 
 
The ColIV with LN521 coating was done as described in Chapter 5.1.1. 150 μl of the 
ColIV-LN521 solution was used for each 35 mm dish, and the dishes were left over night 
at 4 °C. Before use, the solution was removed. MatrigelTM coating was prepared by 
melting it quickly from the freezer, and diluting it in Cnt-30 medium as a 2:1 dilution. 150 
μl of the solution was used for each 35 mm dish, and the solution was quickly spread 
with a cell scraper (Greiner Bio-One GmbH, Germany). For the LinkCellTM and PET 
substrates, the membranes were punched into 15 mm pieces with a puncher 
(OmniCutter, NuVision Biotherapies Ltd.) and placed at the bottom of the dishes (Figure 
19). With the PET membranes, one drop of PBS was added to the bottom of the dish 
before placing the PET membrane to keep it in place. The coating of the PET membrane 
either with MatrigelTM or ColIV and LN521 coating was done as described previously. The 
coated dishes were left to warm up at 37 °C for 0.5 – 1.5 hours before printing.  
Coating and printing substrate 
Tested printing conditions 
(UV exposure time, s/layer) 
Used with cells 
ColI and LN521 0; 2; 5 No 
Nonporous PET membrane 
coated with ColI and LN521 
0; 2; 5 No 
Nonporous PET membrane 
coated with MatrigelTM 
0; 2; 5 Yes 
MatrigelTM coating 0; 2; 5; 15 Yes 
LinkCellTM collagen membrane 0; 2 Yes 
Figure 19. Nonporous PET membrane as a printing substrate. The membrane was 
punched with a 15 mm puncher and placed onto a culture dish. After printing, 300 – 400 
μl of Cnt-30 medium or 1X PBS was added to the edges of the dish to provide humid 
environment for the hydrogel and prevent it from drying. 
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5.1.3 Preparation of the bioink  
The bioink consisted of the hPSC-LESCs, a thiolated component X, methacrylated 
component Y and rheological modifiers increasing the biocompatibility and bioprintability 
of the bioink. The native cornea was used as a source for inspiration when choosing the 
bioink components. The bioink components, their dissolutions and volumes are 
described in confidental Appendix A. Other bioink components were ready for use 
without further preparation, except the methacrylated and thiolated components. The 
thiolation protocol is described next, and the more detailed description can be found from 
Appendix A. 
The component X was thiolated with Pierce Traut’s reagent (ThermoFisher Scientific). 5 
mM of ethylenediaminetetraacetic acid (UltraPure EDTA, ThermoFischer Scientific) was 
added to the component X solution, and its pH was adjusted to 8 – 9 with 10X PBS (pH 
8) and 1 M sodium hydroxide (NaOH, AnalaR NORMAPUR® ACS, Reag. Ph. Eur 
analytical reagent, VWR Chemicals). Traut’s reagent was dissolved in 1X PBS (pH 8.5) 
containing 2 mM of EDTA to prepare 112 mM solution. 26.4 μl/ml of Traut’s reagent 
solution was allowed to react with the component X solution for 1 h at room temperature 
A 
B 
C 
Figure 20. The preparation of the bioink. (A) The bioink components were mixed with 
two syringes attached with a luer-lock. (B) The bioink was transferred into a printing 
cartridge with a piston (yellow), a tip cap (green) and an air lock adapter (purple). (C) 
The cartridge was placed into the low-temperature dispensing head (far right). The UV 
head is also shown on far left.  
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before purifying the component X with Zeba spin desalting columns (ThermoFischer 
Scientific). After removing and discarding the storage solution, spin columns were 
purified with 1X PBS (pH 8.5) three times by centrifuging at 1000 g for 2 minutes. Next, 
the component X solution was applied into the column and centrifuged at 1000 g until 
most of the component X had been collected. The purified component X was aliquoted, 
some of the aliquots were stored at +4 °C to be used within 48 hours and some at -20 
°C for later use. 
The bioink was prepared in a laminar hood with lights out due to light-sensitivity of the 
methacrylated component Y. The printing consumables are listed in Table 7. First, all the 
components and consumables were cleaned with 70% ethanol and gathered into the 
laminar hood. First, the methacrylated component Y was slowly pulled into a 2.5 ml 
syringe with a luer lock tip (Terumo, Belgium) by using a needle (20 G, 1 ½ ‘’, KD-FINE, 
KD Medical GmbH Hospital Products, Germany). The medium containing the cells and 
other components of the bioink were pulled into another syringe. Needles were removed, 
excess air was pushed out and a luer-lock was attached in between the syringes (Figure 
20 A). Then, the bioink was carefully mixed by pushing the plungers alternately at least 
10 times. Finally, the bioink was transferred into the barrel with a tip cap on the bottom, 
and a piston was pushed in the middle of the syringe (Figure 20 B). The tip cap was 
changed into a printer needle, air lock adapter was attached, and the barrel was placed 
into the low-temperature printer head (Figure 20 C). 
 
 
Table 7. Printing consumables used in the 3D bioprinting 
Printing consumable Manufacturer 
32 G blunt needles, 0.50’’ CELLINK, Sweden 
Optimum® Syringe Barrels, clear, 30cc Nordson EFD 
Optimum® Pistons, red Nordson EFD 
Optimum® Tip Caps, blue Nordson EFD 
Optimum® Adapter Nordson EFD 
Female-Female Luer Locks Health Care Logistics, USA 
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5.2 The bioprinter and 3D model 
The extrusion-based 3D bioprinter used was 3D-Bioplotter Manufacturer Series 
(EnvisionTEC GmbH, Germany) shown in Figure 21. The bioprinter had two dispensing-
heads, with high (up to 250 °C) or low temperatures (2 – 70 °C), and a UV curing head 
(wavelength 365 nm). The 3D structure was designed with Perfactory RP software as a 
STL file. After determining the dimensions and placing the 3D structure, it was sliced in 
correspondece to the layer thickness, which was 80% of the inner diameter of the needle 
tip (80% of 100 μm). Finally, the STL file was saved as Bordland Package Library (BPL) 
file for the VisualMachines software, which is the executing software for controlling the 
material parameters, pattern design and the 3D bioprinter. In VisualMachines software, 
a new project was created and the 3D model as a BPL file was loaded in the Project 
Editor tab. The material parameters were selected in the Material Editor tab, and the UV 
program was designed in the UV Programs tab. Subsequently, the desired material was 
assigned for the low-temperature dispensing head in the Project Editor, and if using a 
UV program, it was assigned also in the Project Editor. 
Before preparing the bioink, the printing platform was cleaned with 70% ethanol, and the 
low-temperature dispensing head was heated at 37 °C in advance by selecting the 
correct material. The printing platform was cooled at 8 °C to prevent the printed structure 
to spread. This was done by using a separate temperature controller (Minichiller 300, 
Huber) shown in Figure 22 A. After the barrel containing the bioink was in place, the 
Figure 21. The 3D bioprinter used in this thesis (3D-Bioplotter, EnvisionTEC GmbH, 
Germany). The printing platform and base plate (red), the motor head with the camera 
and platform height control (blue), the purge station and needle calibration station 
(yellow) and printing heads (green) with the low-temperature head on far right. 
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needle was calibrated according to the instructions given by the manufacturer. Before 
printing, it was ensured that the bioink could come out through the needle by using the 
purging protocol. The bioprinter head was driven on top of the purge station (Figure 22 
B) and pressure was applied to make the material come out from the nozzle.  
5.3 Extrusion-based 3D bioprinting 
The bioprinting was done on the 35 mm culture dishes with different coatings described 
in Chapter 5.1.2. After bioink preparation and needle calibration, the dish was placed on 
the printing platform to cool down, and the previously created project was selected to 
start the print. If an UV program was selected, the printer changed the dispensing head 
to the UV head automatically after printing each layer. Two layers were printed with the 
printing speed of 15 mm/s, the pressure 0.6 bar and the distance between strands 0.2 
mm. The inner diameter of the 32G needle used for printing was 100 μm. Figure 23 
shows the bioprinter in action.  
Figure 23. 3D-Bioplotter bioprinting a corneal epithelium mimicking structure on a small 
culture dish. The cartridge containing the cell-laden bioink is inside the low-temperature 
dispensing head, set at 37 °C. Coated, empty dishes (right) are cooling before bioprinting 
on the printing platform set at 8 °C. 
Figure 22. The additional printing equipment. (A) The temperature controller of the 
printing platform. (B) The purge station (red) and the needle calibration station (yellow). 
B 
A 
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After printing was done, 300 – 400 μl of Cnt-30 medium was added to the edges of the 
dish as demonstrated in Figure 19, and the cell-laden structure was placed in an 
incubator at 37 °C 5% CO2. 2 ml of the medium was added 3 h later to cover the printed 
structure, or in case of the PET membranes, medium was added beneath the membrane. 
This was done to prevent the printed gel to be washed away, which occurred, if a larger 
amount of medium was added right after the printing directly on top of the structure. 
During these 3 h the cells had enough time to attach at the bottom of the dish and the 
structure was not washed away during cell culture. The medium was changed every 
other day during the culture of the bioprinted samples until fixing, described in Chapter 
5.5.2. If the printing was done without cells, PBS was used instead of Cnt-30 medium. 
5.4 Printability of the bioink 
The printability of the bioink was studied by printing the material without cells and UV 
exposure as two-layered filament structure and analyzing the effect of different pressures 
and printing speeds. In addition, the effect of the temperature of the printing plate was 
studied by testing printing of the filament on warm (23 °C) or cooled (8 °C) plate with 
constant pressure and speed (0.6 bar, 35 mm/s) and calculating the filament thickness 
and the distance between strands after printing two layers. The effects of the pressure, 
speed and platform temperature on the filament structure were analyzed visually by 
using the 3D-Bioplotter Manufacturer Series camera attached to the dispensing head 
mount to take a photo of the filament structure immediately after each layer was printed. 
This was done by setting the Image Taking Interval in the Project Editor at 1, meaning 
that the camera takes an image of the printing platform per one printed layer. The 
distance between strands was set at 1.5 mm for printing, and other printing parameters 
for printability tests are shown in Table 8.  
Table 8. The parameters for printing filaments and studying the bioink printability. The 
filament was printed with either changing the printing speed, printing pressure or the 
temperature of the printing platform. 
Parameter to be 
optimized 
Printing pressure 
(bar) 
Printing speed 
(mm/s) 
Printing platform 
temperature (°C) 
Printing speed Constant 0.6 10; 15; 20; 25; 30; 35 8.0 
Printing pressure 0.2; 0.4; 0.8; 1.0 Constant 15 8.0 
Platform temperature Constant 0.6 Constant 35 8.0; 23.0 
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To study the effect of the platform temperature, the filament thickness and the distance 
between strands was calculated from the photos taken with the 3D-Bioplotter camera. 
The filament thickness was calculated as an average of 10 individual filaments and the 
distance between strands as an average of 9 individual points. Figure 24 shows the 
printed filament structure with 13 individual filaments altogether. There, the filaments of 
which thicknesses were measured are shown in light orange and the points where the 
distance between strands was measured is shown in light green.   
5.5 Optimization of the bioprinting conditions 
After testing the printability of the bioink and selecting the optimal parameters and 
platform temperature, the bioprinting conditions were optimized for the hPSC-LESCs 
with substrate and UV exposure studies. They were performed with three experiments, 
which are summarized in Figure 25. The studies began by printing the bioink without 
cells on four different substrates and continued with bioprinting cells on the most 
promising substrates with different UV exposures. All the coatings and substrates were 
prepared as described previously. The first substrate tests (Figure 25 A) were done with 
MatrigelTM and ColIV and LN521 coatings, either by coating the plain culture dish or the 
PET membrane. No cells were used in this phase, and the UV exposures per printed 
layer were 0, 2 and 5 s. PBS was added after printing on top of the printed gels (samples 
without PET membrane) or beneath the PET membrane. On the next day, the analysis 
of the adhesion and stability of the gel was done visually and by gently moving the gel 
around inside the dish with a plastic pipette tip.  
Figure 24. The printed filament structure for the printability test. Thickness was 
measured from the filaments shown in light orange, and the distance between strands 
was measured from the points shown in olive green. 
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Two substrates from first substrate experiments without cells (MatrigelTM coated culture 
dish and MatrigelTM coated nonporous PET membrane) were selected for the second 
substrate and UV exposure study (Figure 25 B). Here, the hPSC-LESCs from frozen-
stock with cell density of 15 million cells/ml in the bioink were used. The goal of the UV 
exposure studies was to observe the effect of different UV exposure times on the cell 
viability and proliferation, and to find the most suitable UV exposure for the cells and the 
3D bioprinting. The performance of the coatings was observed meanwhile the bioprinted 
cells were cultured and analyzed until fixing on Day 6. 
For bioprinting on MatrigelTM coated culture dish, four different UV exposure times (0 s, 
2 s, 5 s, 15 s) were used to study if it influenced the cell viability. Two parallel samples 
of each UV exposure were bioprinted, and LIVE/DEAD analysis was performed for one 
of the two parallel samples. For the MatrigelTM coated PET membranes, three different 
UV exposure times (0 s, 2 s, 5 s) were studied, and one parallel sample of each UV 
exposure was bioprinted. No LIVE/DEAD analysis was performed for the samples 
bioprinted on PET membranes. The cell viability and proliferation on both substrates 
(C) 2nd test with fresh cells UV exposure 0 s, 2 s
MatrigelTM coated culture dish LinkCellTM collagen membrane 
(B) 1st test with cells from frozen-stock
MatrigelTM coated culture dish
UV exposure 0 s, 2 s, 5 s, 15 s
MatrigelTM coated nonporous PET membrane
UV exposure 0 s, 2 s, 5 s
(A) Testing without cells UV exposure 0 s, 2 s, 5 s
MatrigelTM coated 
culture dish
MatrigelTM coated 
nonporous PET 
membrane
ColI and LN521 coated 
culture dish
ColI and LN521 coated 
nonporous PET 
membrane
Figure 25. The three experiments with different printing substrates and UV exposures to 
optimize the suitable conditions for the final test series. (A) Four different substrates were 
tested with the same UV exposures and without cells. (B) Two substrates were selected 
from the first experiment for UV exposure studies. (C) Two substrates were studied with 
two UV exposure times to reduce the parameters further. 
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were observed visually with the phase contrast microscope in timepoints 1 h, 3 h and on 
Day 1 after printing. 
The third substrate and UV exposure study (Figure 25 C) included the comparison of 
MatrigelTM coated culture dish and the LinkCellTM membrane with UV exposure times 0 
s and 2 s. The bioprinting was done with fresh hPSC-LESCs with the cell density of 3 
million cells/ml, and the number of parallel samples per printing condition was 2-3. 
LIVE/DEAD analysis was done for the samples bioprinted on the LinkCellTM by analyzing 
one parallel sample. PrestoBlue analysis was done for both substrate options by 
analyzing one parallel sample per printing condition on Days 1, 3 and 6.  
5.6 Bioink characterization 
The bioink was characterized with Ellman’s reaction and by analyzing the swelling, 
transparency and rheological properties. The Ellman’s reaction, the swelling tests and 
the rheological measurements were done by using bioink containing the thiolated 
component X. Transparency analysis was performed for two different bioinks, either 
containing the fresh thiolated component X or the nonthiolated component X. No UV 
exposure or cells were used with any of the characterization methods. 
5.6.1 Ellman’s reaction 
Ellman’s reaction was used to quantitate the thiol groups from the thiolated component 
X. Ellman’s reagent (D8130, Sigma Aldrich) was dissolved in 10X PBS (pH 8) containing 
1 mM of EDTA to prepare 4 mg/ml solution. 1.25 ml of the same buffer and 25 μl of the 
Ellman’s reagent solution was pipetted into two tubes. 125 μl of the thiolated component 
X solution was added to the first tube and 125 μl of the buffer solution to the other. The 
solutions were mixed, incubated for 15 minutes at room temperature and transferred into 
cuvettes (polystyrene semi-micro cuvette, Sarstedt, Germany). Absorbance was 
measured with Lambda 35 UV/VIS spectrophotometer (PerkinElmer) with wavelength of 
412 nm. From the absorbance, the concentration of thiol groups (c-SH) in the thiolated 
component X was calculated according to the equation 2 
𝐶−𝑆𝐻 =
𝐴
1 𝑐𝑚 ∙14 150 𝑐𝑚−1𝑀−1
 ∙1.4 ∙10−3𝑙 
0.125 ∙ 10−3𝑙
   (2) 
where A is the measured absorbance.  
67 
 
5.6.2 Swelling behaviour 
The swelling behaviour of the bioprinted structure was studied by recording changes in 
the weight of the printed gels. Four different UV exposure times to see, how the 
crosslinking density affected the stability and swelling of the printed structure. The 
exposure times were 0 s, 2 s, 15 s and 30 s for each layer, and two layers were printed 
in each 3D structure. Three parallel replicates of each UV exposure time were prepared. 
The printing was done on pre-weighed culture dishes without additional coating. After 
printing, the gels were immediately weighed to determine the initial weigth. After 
weighing, the gels were immersed in 2 ml of 1X PBS and stored in an incubator at 37 °C 
5% CO2. The printed gel was weighed after 1, 3 and 24 hours post-printing, and before 
weighing, PBS was removed and excess liquid was gently wiped from the corners of the 
dish. The weighing was performed immediately after the removal of PBS to prevent 
evaporation and inaccurate results. After weighing, the gel was immediately immersed 
in PBS and placed back in the incubator at 37 °C 5% CO2. The swelling ratio (SR) was 
determined as relative water absorption with the equation 3 
𝑆𝑅 =  
𝑤𝑠𝑤𝑜𝑙𝑙𝑒𝑛−𝑤𝑖𝑛𝑖𝑡𝑖𝑎𝑙
𝑤𝑖𝑛𝑖𝑡𝑖𝑎𝑙
∙ 100%    (3) 
where winitial is the initial weight of the printed gel and wswollen is the gel weight after 
incubation in PBS. 
5.6.3 Transparency  
Bioink containing the fresh thiolated component X and bioink without the thiolated 
component X were used for transparency studies to determine if the thiolation affected 
the transparency of the bioink. The transparency was analyzed by measuring 
transmittance, which describes the ability of the material to transmit light. The higher the 
transmittance, the closer the passed intensity is to the intensity of the incident light. The 
transmittance measurement was performed by preparing 800 μl of the three bioink 
alternatives in the semi-micro cuvettes and measuring the transmittance with the Lamda 
35 UV/VIS spectophotometer. The same cuvettes and spectrophotometer were used to 
measure absorbance as in the Ellman’s reaction. The wavelengths used were ranging 
from 380 to 900 nm, and a cuvette filled with Milli-Q water (Milli-Q Advantage A10 Water 
Purification System, Merck) was used as blank. In addition, the transparency of the 
bioprinted sample was analyzed visually by evaluating the visibility and distortion of text, 
when the sample was placed on top of it. 
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5.6.4 Rheology 
For the rheological measurements, the bioink containing the fresh thiolated component 
X was used to study the microstructure of the bioink without UV exposure, which the 
cells sense immediately after extrusion. The rheological measurements were performed 
with a Discovery HR-2 hybrid rheometer (TA Instruments) by using a 20 mm parallel-
plate geometry measuring system with 1450 μm and 1180 μm gaps with fills of 350 μl 
and 300 μl, respectively. The rheometer was set at 25 °C. The bioink was prepared as 
described previously, and from one batch of bioink, four parallel samples were used for 
rheology in order to determine the storage modulus (G’) and the loss modulus (G’’). G’ 
describes the elastic properties and the solid-state behaviour of the material, and G’’ 
describes the viscosity and the liquid-state behaviour of the material (Anton Paar GmbH, 
2020b).  
The rheological measurements were done by performing the amplitude sweep and 
frequency sweep for the four samples. Amplitude sweeps were performed with 1 Hz 
frequency with the oscillation strain ranging from 0.01% to 100% to determine the 
maximum oscillation strain at the linear viscoelastic region (LVE). LVE region describes 
the strain range the experiment can be performed without breaking the microstructure of 
the material, and the maximum strain is typically determined at the point where G’ begins 
to decrease (Anton Paar GmbH, 2020a). The maximum oscillation strain based on the 
amplitude sweep was 0.6%, and it was used in frequency sweeps. The frequency range 
in frequency sweeps was 1 Hz to 10 Hz. With weak gels, it has previously been reported 
that phase seperation between gel parts with different densities can occur, and to obtain 
more accurate data, the highest frequency has been selected as the initial frequency 
(Bui et al., 2012). Therefore, the frequency was set to start from 10 Hz.  
5.7 Analysis of the bioprinted cells 
The viability, proliferation, maturation and differentiation was analyzed from the 
bioprinted hPSC-LESCs with different methods at different timepoints. The analyses 
included LIVE/DEAD on Day 1, PrestoBlue on Days 1, 3 and 6 and immunofluorescence 
on Day 3 and 6. For one sample type, immunofluorescence was done on Day 10. In 
addition, phase contrast microscope was used to visualize the cells at different 
timepoints to analyze their proliferation and migration. The viability and proliferation 
studies as well as the immunofluorescence staining with positive and negative controls 
are described next in detail. 
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5.7.1 LIVE/DEAD, PrestoBlue and phase contrast microscopy 
For cell viability studies, LIVE/DEAD Viability/Toxicity Kit for mammalian cells and 
PrestoBlue cell viability reagent (both from Thermo Fischer Scientific) were used. 
PrestoBlue reagent changes color in red due to the reducing environment of viable cells, 
and thus the change in fluorescence can be measured. The higher the fluorescence, the 
higher the cell proliferation. In LIVE/DEAD, the amount of live and dead cells is 
determined with a two-color assay, where the green-fluorescent calcein-AM indicates 
live cells and the red-fluorescent ethidium homodimer-1 indicates dead cells. 
LIVE/DEAD analysis was done on Day 1 to analyse the cell viability after bioprinting. 
LIVE/DEAD was done for 08/017 hESC-LESCs from frozen-stock and for fresh 001b B2 
HT hiPSC-LESCs. The staining solution for the analysis was done by mixing 1.25 μl of 
ethidium homodimer-1 (2 mM) and calcein AM (4 mM) into 10 ml of 1X PBS. The cell 
samples were incubated in 1 ml of the staining solution at 37 °C for 30 min and 
immediately imaged with Olympus IX51 fluorescence microscope with 4x and 10 x 
augmentations. The images were analyzed with ImageJ Fiji (2.0.0-rc-69/1.52p; Java 
1.8.0_172 [64-bit]), and the percentage of live cells was analyzed from 6-7 images per 
sample with ImageJ Fiji macro “live dead quantification” by Allevi3D (available at 
https://www.allevi3d.com/livedead-assay-quantification-fiji/). The average and standard 
deviation of the live cell percents were calculated and displayed in a bar graph. 
PrestoBlue staining was done on Day 1, 3 and 6 after bioprinting to analyse the cell 
viability. In addition, PrestoBlue was done for hESC-LESCs on Day 9 and for hiPSC-
LESCs on Day 10. PrestoBlue was performed for fresh bioprinted cells, and one sample 
per bioprinting condition was used. The staining solution was prepared by mixing 
PrestoBlue reagent and 1X PBS at 1:10 dilution. The culture medium was removed from 
the sample, 1 ml of the staining solution was added on each of the samples. In addition, 
one empty 35 mm dish without cells was used to determine the background 
fluorescence. The control was prepared the same way as the bioprinted samples. 
After adding the reagent solution, the samples were incubated for 30 min at 37 °C 5% 
CO2. The specimens were gathered on a 96 microwell plate (NuncTM MicroWellTM, 
NunclonTM Delta-Treated, Flat-Bottom, Thermo Fisher Scientific) by taking three parallel 
specimens from each sample, including the control. The microwell plate was covered 
with aluminium foil to prevent light from influencing the results until the fluorescence was 
measured. Wallac 1429 VICTOR2 plate reader (Perkin Elmer) with 0.1 s exposure time 
was used to measure the fluorescence from the specimens. The average of the three 
fluorescence values from the parallel specimens was calculated, and the average 
fluorescence of the control was subtracted to get the value without the background. In 
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addition, the standard deviation of the fluorescence was calculated for each sample, and 
the data was presented in a bar graph. 
In addition to LIVE/DEAD and PrestoBlue analyses, phase contrast microscopy was 
used as a simple and fast method to visualize the proliferation and migration of the 
bioprinted cells. Two different phase contrast microscopes were used, Nikon Eclipse 
TE2000-S and Zeiss Axio Vert A1 (Carl Zeiss AG, Germany). The first one was used to 
image the 3D bioprinted structures used for UV exposure studies, and the latter was 
used for the rest of the optical imaging. For the UV exposure studies, the bioprinted 
samples were imaged after 1 and 3 hours and again on Day 1 after bioprinting. The other 
samples were imaged on Days 1, 3 and 6, however, they were inspected daily with the 
phase contrast microscope. The images were analyzed with ImageJ Fiji. 
5.7.2 Immunofluorescence  
The proliferation, differentiation and maturation of the bioprinted samples was studied 
with immunofluroescence. In addition, hPSC-LESCs from frozen-stock were used as a 
control for immunofluorescence. Immunofluorescence utilizes fluroescent-labeled 
antibodies to detect specific target antigens, and in this thesis, primary antibodies and 
fluorescent-labeled secondary antibodies were used. The primary and secondary 
antibodies, other stainings and the mounting medium used in immunofluorescence 
analysis as well as their manufacturers and dilutions are presented in Table 9.  
Before the staining, the cells were fixed, which means they were killed to stop the 
morphological and chemical changes. In this thesis, fixing was done on Day 3, 6 or 10, 
depending on the bioprinting condition of the sample and the cell batch used for the 
bioprinting. The fixing of the bioprinted samples and well plates with the control was done 
with 4% PFA, which was prepared from 20% PFA (Electron Microscopy Sciences) and 
1X PBS. The culture medium was removed from the culture dishes/wells, and the cells 
were washed once with PBS before pipetting 1 ml 4% PFA onto the culture dishes/wells. 
PFA was left to affect for 10 minutes in room temperature before removing it and washing 
the cells twice with fresh PBS. Finally, 1 ml of PBS was pipetted per well/dish, parafilm 
was wrapped around the plates/dishes to prevent evaporation. The fixed bioprinted 
samples/well plates were stored at +4 °C before staining.  
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For immunofluroescence, the fixed cells were first permeabilized with TritonTM X-100 
(Sigma Aldrich) for 15 min to enable the antibodies to cross the cellular membrane. Next, 
the samples were blocked with 3% BSA (Bovine Serum Albumin heat shock fraction, 
Sigma Aldrich) for 1 h to reduce the unspecific binding of the antibodies. After 
permeabilization and blocking, primary antibody solution was prepared in 0.5% BSA in 
PBS, and the samples were left in the solution over night at +4 °C. On the next day, the 
samples were washed with PBS for 5 min three times, and the secondary antibody 
solution was prepared to match the primary antibody solution (anti-rabbit secondary 
antibody with primary antibody from rabbit and anti-mouse secondary antibody with 
primary antibody from mouse). The actin cytoskeleton stain and nucleic acid stain were 
added to the secondary antibody solution, since they did not bind to any primary antibody 
and contained the fluorescent label. The samples were left in the secondary antibody 
Table 9.  The primary and secondary antibodies, other stainings and the mounting 
medium used in the thesis to analyze the hPSC-LESCs after bioprinting. 
Staining Manufacturer Dilution Purpose 
Primary 
antibodies 
Rabbit anti-p63α 
Cell Signaling 
Tech 
1:200 Corneal progenitor marker 
Mouse anti-p40 BioCare Medical 1:200 Corneal progenitor marker 
Rabbit anti-CK12 Abcam 1:200 Maturation marker 
Mouse anti-CK14 R&D Systems 1:300 Stratified epithelium marker 
Mouse anti-CK3 Abcam 1:200 Maturation marker 
Rabbit anti-Ki67 Millipore 1:500 Proliferation marker 
Secondary 
antibodies 
Alexa Fluor 488 
donkey anti-rabbit 
IgG 
Molecular 
Probes 
1:500 
Visualization of the primary 
antibody from rabbit 
Alexa Fluor 568 
donkey anti-mouse 
IgG 
Molecular 
Probes 
1:500 
Visualization of the primary 
antibody from mouse 
Other 
AlexaFluor 647 
phalloidin 
Molecular 
Probes 
1:150 
Actin cytoskeleton 
visualization 
Hoecst 33342 
Molecular 
Probes 
1:3000 Nucleic acid stain 
 
ProLong Gold 
Antifade Mountant 
with DAPI 
Invitrogen  Mounting medium 
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solution for 1 h at room temperature, and after that, the samples were washed again with 
1X PBS three times. Finally, the samples were mounted with the mounting medium by 
pipetting 40 μl of the reagent on top of the bioprinted sample and covering it with a 30 
mm cover glass (VWR International). 
The immunofluroescence control was prepared as a positive and negative control to 
determine the immunofluroescence results for hPSC-LESCs in normal cell culturing 
conditions (positive) and how much background immunofluorescence there is (negative). 
The staining was done as described previously, however, for the negative control, only 
the solution with secondary antibodies was used. Hence, theoretically, there should not 
be seen anything in the negative control due to the absence of the primary antibodies. 
After staining and washing, the control samples were mounted with 30 μl of the mounting 
medium and covered with a 15 mm cover glass (Thermo Scientific). 
The stained and mounted samples/well plates were covered with aluminium foil, 
storaged at room temperature for 24 hours and visualized with Olympus IX51 
fluroescence microscope. Every sample/well was imaged with 4x and 10x 
augmentations from at least three areas, and different filters were used to visualize 
different fluorescent dyes. Later, the images were analyzed and merged with ImageJ Fiji. 
5.8 Statistical analysis 
The statistical significance of data from printability, swelling behaviour, LIVE/DEAD and 
PrestoBlue analyses was determined with Mann-Whitney U test, and p-values ≤ 0.05 
were considered statistically significant. The statistical data analysis was done with IBM 
SPSS Statistics software V25.0. 
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6. RESULTS 
6.1 Printability of the bioink 
Overall, the bioink extruded well without clogging the nozzle even after 30 min of printing. 
The printability of the bioink was further studied by printing the bioink without cells in 
filaments with different pressures and speeds (Figure 26) according to the parameter 
information in Table 8. In addition, the effect of the printing platform temperature was 
studied by measuring the filament thickness and the distance between strands as shown 
in Figure 24. The differences between the platform temperatures 8 °C and 23 °C are 
illustrated in Figure 27. 
The filament thickness decreased when the speed was increased (Figure 26 A-F), and 
there was less bulging in the filament. The lowest speed (10 mm/s, Figure 26 A) caused 
extensive spreading of the printed filament and merging of the individual filaments. With 
the speeds 25, 30 and 35 mm/s (Figure 26 D-F), the starting point of the structure 
delayed and the filament structure was incomplete. This phenomenon is called lag on 
(O’Connell et al., 2020) and is not desired. 
With the pressure of 0.2 bar, the filament did not extrude at all. When the pressure was 
increased, filament bulging occurred with pressures 0.4 and 0.6 bar (Figure 26 B and G, 
respectively), however, there was less bulging with 0.4 bar. When increasing the 
pressure up to 0.8 and 1.0 bar (Figure 26 H and I, respectively), the same phenomenon 
causing the merging of the filaments occurred as with the lowest printing speed.  
When studying the effect of the platform temperature on the filament, the difference in 
thickness was statistically significant (p ≤ 0.05). The filament thickness was bigger on 
the warmer platform (0.72 mm) compared to the cooled platform (0.62 mm) (Figure 27 
E). However, the distance between strands was not affected by the platform temperature, 
as it was 1.47 mm with both temperatures. In addition, it was close to the set distance 
(1.5 mm) with a difference of 30 μm.  
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Figure 26. The effect of printing speed and pressure on the printability. (A-F) Constant 
pressure 0.6 bar. Printing speed (A) 10 mm/s, (B) 15 mm/s, (C) 20 mm/s, (D) 25 mm/s, 
(E) 30 mm/s, (F) 35 mm/s. (G-H) Constant speed 15 mm/s. Printing pressure (G) 0.4 bar, 
(H) 0.8 bar, (I) 1.0 bar. Scale bars 10 mm. Platform temperature 8 °C 
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Figure 27. The effect of the temperature of the printing platform. Bioink was printed with 
printing speed of 35 mm/s and pressure 0.6 bar. (A, C) Platform temperature 8 °C. (B, 
D) Platform temperature 23 °C. (E) Average filament thickness (p* ≤ 0.05) and distance 
between strands (nfilament = 10, nstrand = 9) with platform temperatures 8 °C and 23 °C. The 
distance between strand was set at 1.5 mm for printing. (a1) Filament thickness and (b1) 
distance between strands  with platform temperature 8 °C. (a2) Filament thickness and 
(b2) distance between strands with platform temperature 23 °C. Scale bars 5 mm. 
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6.2 Optimization of the bioprinting conditions 
Different printing substrates and UV exposure times were tested to determine the optimal 
bioprinting conditions for hPSC-LESCs as described in Figure 25. The first substrate 
experiments were done without cells, and the UV experiments were carried out with the 
most promising substrates. In the UV experiments, hPSC-LESCs from frozen-stocks 
were used and their viability and proliferation was analyzed with LIVE/DEAD and 
PrestoBlue. 
6.2.1 Substrate and UV studies without cells 
The first substrate experiments were performed without cells, and the coating types were 
ColI and LN521 coating of the culture dish or PET membrane and MatrigelTM coating of 
the culture dish or PET membrane (Figure 25 A). The two coatings were selected to 
enhance the adhesion and biocompatibility of the plain culture dish surface or PET 
membrane. The PET membrane was tested due to the possibility to remove the 3D 
structure out from the culture dish for further analysis, since the membrane could be 
detached from the bottom of the dish. Moreover, the detachment enabled the addition of 
PBS or culture medium beneath the membrane. Subsequently, the PET membrane 
floated on the liquid surface, which resulted in better attachment of the printed structure 
compared to the structures printed onto the coated culture dish and immersed in PBS. 
Moving the membrane out from the culture dish did not disturb the printed structure, and 
it stayed attached on the membrane. When immersing the membrane with the structure 
in PBS, the gel printed with 0 s UV disappeared from the membranes. With 2 s and 5 s 
UV exposures, the gels stayed attached to the membrane even after the immersion. 
When comparing the two coatings, the combined ColI and LN521 coating seemed to 
cause the bioink to spread more after printing. The spreading occurred with all UV 
exposure times, and the results were the same with or without the PET membrane in 
between the culture dish and the coating. Hence, ColI and LN521 coating was not tested 
further with cells. When printing on MatrigelTM, there was not as significant spreading 
after printing, and the printed structure stayed in place after one day immersion in PBS. 
Therefore, MatrigelTM coated culture dishes were selected as one substrate for further 
studies, including the UV exposure studies. Even though the structures printed on 
MatrigelTM coated PET membranes showed some spreading of the bioink, the 
membranes were selected as the second substrate type for bioprinting hPSC-LESCs in 
the UV exposure studies to see, if the cell adhesion could decrease the spreading of the 
structure. 
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Figure 28. The effect of UV exposure time on cell viability. hPSC-LESCs from frozen-
stock were 3D bioprinted on MatrigelTM coated culture dishes with four different UV 
exposure times (0 s, 2 s, 5 s, 15 s), and the cell viability was analyzed on Day 1 with 
LIVE/DEAD. The average percentages and standard deviation of live cells were 
analyzed from 6-7 images per UV exposure time (nUV exposure time = 6 or 7).  
6.2.2 Substrate and UV studies with cells 
Based on the results from the substrate studies done without cells, the substrate and UV 
exposure studies with hPSC-LESCs from frozen-stock began with testing the selected 
two substrate types and different UV exposures as described previously (Figure 25 B). 
When comparing the printing substrates, MatrigelTM coated nonporous PET membranes 
showed promising results as the bioprinted structure was not washed away immediately 
after printing, enabling more time for the cells to attach the substrate. However, when 
the bioprinted hPSC-LESCs were observed with the phase contrast microscope, the cell 
adhesion and proliferation on MatrigelTM coated PET membranes did not seem to be as 
good as in the samples printed on MatrigelTM coated culture dishes. Subsequently, the 
samples printed on the PET membranes were not further studied, and the LIVE/DEAD 
analysis and imaging with the phase contrast microscope were performed only for the 
samples printed on MatrigelTM coated culture dish.  
The increased UV exposure time did not affect the cell viability significantly, and almost 
equal amounts of live and dead cells were detected with all the UV exposures (Figure 
28). The average cell viability was above 90% in samples with UV exposures of 2, 5 and 
15 s. However, the number of cells attached to the bottom of the dish was lower in the 5 
s and 15 s samples (Figure 29 C-D). The average viability in the 0 s sample (87.5%) was 
slightly lower than with the other sample types, however, the number of attached cells 
was higher (Figure 29 A). 
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Figure 29. The effect of UV exposure time on the hPSC-LESC viability on Day 1 after 
bioprinting on MatrigelTM coated culture dish. UV exposure times: (A) 0 s, (B) 2 s, (C) 5 
s, (D) 15 s. Scale bars 500 μm (left column) and 200 μm (right column). 
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Figure 30. The effect of UV exposure time on the gel stiffness when bioprinting on 
MatrigelTM coated culture dish. UV exposure times (A) 0 s, (B) 2 s, (C) 5 s, (D) 15 s. (E-
F) Gels were detached from the printing substrate: (E) 5 s, (F) 15 s. Scale bars 200 μm. 
 
  
A 
0 s 
   
B 
2 s 
   
C 
5 s 
   
D 
15 s 
   
 
  
 
80 
 
The stiffness of the printed structure was increased due to longer UV exposure and 
affected the cell migration and proliferation (Figure 30). The increase in stiffness was 
especially clear with the UV exposure times of 5 s and 15 s per printed layer. Due to 
stiffer material, the cells were not able to migrate or interact with each other, the printed 
filaments were visible 1 h after printing and the cells remained circular (Figure 30 C-D). 
The printed structure detached from the bottom of the printing substrate with higher UV 
exposure times (5 s and 15 s) during cell culture on Day 1. The cells in the detached 
structure remained circular (Figure 30 E-F), whereas the cells attached on the bottom 
could deform and migrate (Figure 30 C-D, Day 1). The detaching structure resulted in 
lower number of cells on the bottom of the dish compared to the samples with lower UV 
exposure. 
MatrigelTM coating was used to enhance the cell adherence on the printing substrate, 
and the bioprinted hPSC-LESCs on  MatrigelTM  showed significantly high cell 
proliferation (p ≤ 0.05) at all timepoints (Figure 31). However, already on Day 1, holes 
were seen in the formed epithelium (Figure 30 A, Day 1). The clustering and shrinkage 
of the MatrigelTM was observed especially with lower UV exposure times due to lower 
crosslinking density and softer structure. Due to the high proliferation and shrinkage of 
the MatrigelTM, the cells were able to rip the coating, which resulted in MatrigelTM surface 
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Figure 31. PrestoBlue data from bioprinted hPSC-LESCs (cell line 08/017) with four 
different conditions (ncondition = 3, p* ≤ 0.05): printing on Matrigel without UV exposure and 
with 2 s UV exposure per printed layer (MG 0s, MG 2s) and printing on Linkcell collagen 
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with holes. Since the cells were not able to adhere and proliferate on the noncoated parts 
of the dish, this finally resulted in nonhomogenous epithelium. 
Since the MatrigelTM coated nonporous PET membranes were not suitable as a printing 
substrate, LinkCellTM collagen membranes were tested in the third substrate study 
(Figure 25 C). The membranes were tested as a solution for the detaching masses from 
MatrigelTM due to higher stiffness of LinkCellTM membranes. Here, fresh hPSC-LESCs 
were used instead of the frozen-stock. The LinkCellTM membrane was stored in a liquid, 
resulting in firm attachment to the bottom of the dish, and thus the addition of the medium 
beneath the film was not possible. Even though the cell proliferation on MatrigelTM was 
significantly higher (p ≤ 0.05) than on LinkCell memrbane, the proliferation of the 
bioprinted fresh hPSC-LESCs increased during cell culture with all the conditions (Figure 
31). Moreover, the cell proliferation on LinkCellTM with 0 s UV at Day 6 was close to the 
proliferation on MatrigelTM. However, UV exposure in combination with LinkCellTM 
membrane seemed to result too stiff structure where cells were not able to migrate or 
proliferate as well, which explains the significantly lower fluorescence value from 
PrestoBlue analysis compared to other printing conditions. Subsequently, LinkCellTM 
membranes without UV exposure were selected as a second substrate option together 
with MatrigelTM coated culture dishes with UV exposures of 0 s and 2 s. Importantly, 
when using fresh hPSC-LESCs, there was not as significant detaching of the cell masses 
in the samples bioprinted on either MatrigelTM or LinkCellTM, which is why only fresh 
hPSC-LESCs were used in the final tests and MatrigelTM was selected as the other 
coating option despite the previously described challenges with it. 
6.3 Bioink characterization 
After optimizing the bioprinting conditions for the hPSC-LESCs, the bioink was further 
characterized with Ellman’s reaction, swelling and transparency analysis as well as 
rheology, which included amplitude and frequency sweeps. 
6.3.1 Ellman’s reaction 
Ellman’s reaction was used to determine the concentration of the thiol groups for the 
thiolated component X in the bioink according to the equation 2. The concentration of 
the thiolated groups was 44.64 μM.  
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6.3.2 Swelling behaviour  
The swelling behaviour of the bioink and the printed 3D structure without cells was 
studied visually and by weighing the structure after 1, 3 and 24 hours after printing and 
calculating the SR according to the equation 3. Significant swelling behaviour could 
already be detected visually after 3 h and 24 h from all the samples with different UV 
exposure times, and Figure 32 shows the visual swelling of the sample with 15 s UV 
exposure. The recordings of the weigths of the printed gels are shown in Figure 33. When 
weighing the gels after 1 h, there was a significant decrease in weight of the 0 s and 2 s 
gels (p ≤ 0.05, Figure 33 A), which indicated low crosslinking degree and stability. Thus, 
the weights of the 0 s and 2 s samples at the timepoints 3 h and 24 h were not be 
measured. However, gels with 15 s and 30 s UV exposure were stabile enough and 
weighing was possible even after 24 h in PBS.  
No significant swelling of the 15 s and 30 s gels was observed after 1 h (Figure 33). In 
fact, there was a slight decrease in weight in the 15 s sample compared to the initial 
weight (Figure 33 B), which indicated that some of the gel could have been washed away 
due to the removal of PBS. However, the decrease was minimal and the weight 
increased after 1 h. Even though the water absorption of the 30 s sample was higher 
after 3 h, the difference was not significant anymore after 24 h. 
 
 
 
Figure 32. The swelling of printed structure with 15 s UV exposure (A) 3 h after printing 
and (B) 24 h after printing. The gel is inside the red dashed line. 
A
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Figure 33. The swellin behaviour of the printed structures. (A) The change in weight (p* 
≤ 0.05) and (B) the swelling ratio as relative water absorption of the printed structure 
after 1, 3 and 24 hours. Printing was done without coating of the dish and four different 
UV exposure times were used (0, 2, 15 and 30 s, ncondition = 3). During timepoints the 
printed structure was immersed in 1X PBS at 37 °C. With two lowest UV exposure 
values, the structure was washed away during PBS change after 1 h, and thus the 
timepoints at 3 and 24 h were not measured. 
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6.3.3 Transparency  
The transparency of the bioprinted sample was analyzed visually by placing it on top text 
(Figure 34 A). The text was readible, clear and no distrotion was observed. In addition to 
visual analysis, transparency was analyzed by measuring the transmittance at 
wavelengths ranging from 380 to 900 nm with Milli-Q water as blank (Figure 34 B). The 
transmittance was measured from bioinks with the fresh thiolated component X and with 
the nonthiolated component X. The thiolation did not affect the transmittance except at 
the lower wavelengths. Ranging from 380 to 450 nm the transmittance of the bioink 
containing the nonthiolated component X was higher than the bioink containing the 
thiolated component X. At higher wavelengths, both bioinks acted similarly. At 
0
10
20
30
40
50
60
70
80
90
100
900800700600500400
Tr
an
sm
it
ta
n
ce
 (
%
)
Wavelength (nm)
Nonthiolated
Thiolated
Figure 34. The transparency of the bioink was analyzed visually (A) and by measuring 
transmittance (B). (A) Text was readible and shown without distortion through the printed 
gel, which indicates good transparency. (B) The transmittance of the bioink with and 
without the thiolated component X at wavelengths ranging from 380 to 900 nm was 65 – 
75%.  
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wavelengths 560 – 590 nm, 685 – 715 nm and 795 – 805 nm, the transmittances were 
not aligned, however, this might be due to the bioink not being completely homogenous. 
Altogether, the bioink showed good transparency based on the visual analysis and the 
transparency ranging from 65 – 75%.  
6.3.4 Rheology 
Without UV exposure, the bioink was extremely difficult to handle due to its liquid-like 
properties and low crosslinking degree. Thus, the rheological measurements were 
challenging to perform. Moreover, the sufficient gap fill was challenging to achieve due 
to liquid-like nature of the bioink and the limited amount of material. Nevertheless, 
amplitude and frequency sweeps were performed from four parallel samples of the 
bioink, and they are presented in Figure 35.  
From the amplitude sweeps, similar behaviour can be observed (Figure 35 A). At the 
beginning of the sweep, the G’ and G’’ values fluctuate, and after 0.2% strain they 
stabilize. After 0.6% strain, G’ begins to decrease, however, G’’ remains close to zero. 
Therefore, 0.6% strain was selected for the frequency sweeps, though a precise value 
for the maximum strain the material withstands without breaking could not be determined 
from the amplitude sweep due to the complexity of the material.  
When performing the frequency sweep, the G’ increased after 1.5 Hz. The increase of 
G’’ was significantly lower. Subsequently, this suggests the material is more liquid-like at 
resting state, and when shear is applied, the elastic properties begin to dominate viscous 
properties. This indicates more solid-like behaviour, however, the G’ value is still very 
low, around 15 Pa with 10 Hz frequency.  
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Figure 35. Amplitude (A) and frequency (B) sweeps for the bioink containing the 
thiolated component  X. Both measurements were performed for four parallel samples. 
Amplitude sweeps were done with 1 Hz frequency, and frequency sweeps were done 
with 0.6% oscillation strain. Amplitude sweeps are shown from every measurement, and 
frequency sweep is shown from the measurement with the most optimal gap fill. Parallel 
plate geometry (20 mm) with 1450 or 1180 μm gap were used with 350 or 300 μl fills, 
respectively. 
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6.4 Cell viability, proliferation and maturation after 3D 
bioprinting 
Based on the results from the preliminary substrate and UV exposure studies, the final 
experiments to study the viability, proliferation, maturation and differentiation of fresh 
hPSC-LESCs were performed with MatrigelTM coated culture dishes combined with 0 s 
and 2 s UV exposures and LinkCellTM membranes with 0 s UV exposure each layer. The 
3D bioprinted structure consisted of total two layers. These conditions were used with 
two different fresh hPSC-LESC lines, hESC-line 08/017 and hiPSC-line 001b B2 HT. The 
cell viability on Day 1 was studied with LIVE/DEAD analysis from the cell line 001b B2 
HT. When analyzing 6 or 7 images per bioprinted sample, the viabilities were above 90% 
for the MatrigelTM coated culture dishes with 2 s UV and the LinkCellTM membranes with 
0 s UV, and above 88% for the MatrigelTM coated culture dishes with 0 s UV (Figure 36). 
Thus, no significant differences in the cell viabilities between the printing conditions were 
detected.  
The cell proliferation was studied with PrestoBlue at several timepoints (Days 1, 3 and 
6, and for LinkCell samples additional  Day 9 or 10). The data from both cell lines (hESC-
line 08/017 and hiPSC-line 001b B2 HT) is presented separately (Figure 37). When 
analysing the PrestoBlue data, MatrigelTM seemed to offer a suitable substrate for the 
bioprinting of hPSC-LESCs from both investigated cell lines. The hESC-LESCs seemed 
to prefer MatrigelTM over LinkCellTM since the fluoresence values on Day 1 were 1 – 2.5 
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Figure 36. The cell viability of fresh hiPSC-LESCs after extrusion-based bioprinting on 
Day 1. Three different conditions were used: MatrigelTM (MG) coating with 0 s and 2 s 
UV exposure and LinkCellTM membranes with 0 s UV exposure. Cell line 001b B2 HT 
was used with the cell density of 8.8 million cells/ml in the bioink. The amount of live and 
dead cells was analyzed with ImageJ (ncondition = 6 or 7). 
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times higher on the MatrigelTM samples (p ≤ 0.05, Figure 37 A). At the later timepoints, 
the difference was slightly smaller, however, still significant. With the hiPSC-LESCs, the 
differences between MatrigelTM and LinkCellTM samples were not as considerable (Figure 
37 B), suggesting there was not as high preference of the printing substrate. 
Figure 37. PrestoBlue data from the bioprinted fresh hPSC-LESCs from two cell lines 
with three different conditions (ncondition = 3, p ≤ 0.05): printing on Matrigel without UV 
exposure (MG 0s), printing on Matrigel with 2 s UV exposure (MG 2s) and printing on 
LinkCell membrane without UV exposure (LinkCell 0s). (A) Cell line 08/017, cell density 
9 million/ml. (B) Cell line 001b B2 HT, cell density 8.8 million/ml.  
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The proliferation of the samples bioprinted on MatrigelTM was generally higher with the 
hESC-LESCs, however, the proliferation of the hESC-LESCs decreased during 
timepoints with both UV exposure times (Figure 37 A). On the contrary, the proliferation 
of the hiPSC-LESCs bioprinted on MatrigelTM increased until Day 6 with both UV 
exposure times (Figure 37 B). When comparing the samples bioprinted on MatrigelTM 
with 0 s UV exposure, there was no significant difference in the proliferation of the two 
cell lines on Day 6. However, with 2 s UV, the proliferation was higher with the hESC-
LESCs. Moreover, the 2 s UV resulted the highest proliferation of the hESC-LESCs on 
Day 1, 3 and 6. This did not occur with the hiPSC-LESCs, where the differences between 
printing conditions were generally smaller in all timepoints. 
Overall, the proliferation on the LinkCellTM increased during timepoints with both cell 
lines, even though the proliferation and its increase was lower with the hESC-LESCs 
until the last timepoint. When comparing the proliferation of the samples bioprinted on 
LinkCellTM, the value is higher with the hiPSC-line on Days 1, 3 and 6. In addition, 
whereas the difference between the cell lines is decreased on Day 6 when bioprinting on 
Matrigel with 0 s UV, the difference is increased in the case of the LinkCellTM samples. 
With the hiPSC-LESCs, the proliferation of the LinkCellTM sample on Day 6 is even higher 
than the proliferation of either of the MatrigelTM samples at the same timepoint, however, 
the difference is small. Though the hiPSC-LESCs showed higher proliferation at the 
earlier timepoints, the situation is the opposite at the last timepoint. There, the 
proliferation of the hESC-LESCs is higher, even though the timepoint  of the analysis 
was one day earlier than with the hiPSC-LESCs. Moreover, there was no change 
between Days 3 and 6, when observing the proliferation of hESC-LESCs or hiPSC-
LESCs. 
The cell proliferation, maturation and differentiation were studied with 
immunofluorescence staining. Fresh hPSC-LESCs were 3D bioprinted on MatrigelTM or 
on LinkCellTM collagen membrane as described previously, and depending on the 
printing substrate and cell line, samples at Days 3 and 6, or Day 10 were studied in 
immunofluorescence. The results of the two cell lines used are presented seperately, 
where Figures 38, 40 and 42 show the results of hESC-LESCs and Figures 39, 41 and 
43 show the results of hiPSC-LESCs. The results of the immunofluorescence control at 
Day 6 are shown in Figure 44, and the expression of the bioprinted samples is compared 
to the control.   
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Figure 38. hESC-LESCs (9 million cells/ml) 3D bioprinted on MatrigelTM without UV 
exposure. (A-B) Immunofluorescence staining of corneal progenitor markers p63 (green) 
and p40 (red) and phalloidin (yellow) illustrating the cell morphology on Day 3 and Day 
6 after printing. (C) Immunofluorescence staining of CK12 (green) and CK14 (red) 
illustrating the cell maturation on Day 6 after printing. (D) Phase contrast image of printed 
hPSC-LESCs on Day 6 after printing. (A-C) Nuclei stain DAPI (blue). Scale bars 200 μm.  
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Figure 39. hiPSC-LESCs (8.8 million cells/ml) 3D bioprinted on MatrigelTM without UV 
exposure. (A-B) Immunofluorescence staining of corneal progenitor markers p63 (green) 
and p40 (red), and phalloidin (yellow) illustrating the cell morphology on Days 3 and 6 
after printing. (C) Immunofluorescence staining of CK12 (green) and CK14 (red) 
illustrating the cell maturation on Day 6 after printing. (D) Cell viability on Day 1 after 
printing shown with LIVE/DEAD staining visualizing live cells with green and dead cells 
with red. (E-G) Phase contrast images of printed hPSC-LESCs on Day 1, 3 and 6 after 
printing. (A-C) Nuclei stain DAPI (blue). Scale bars 200 μm. 
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Figure 40. hESC-LESCs (9 million cells/ml) 3D bioprinted on MatrigelTM with 2 s UV 
exposure time. (A-B) corneal progenitor markers p63 (green) and p40 (red), and 
phalloidin (yellow) illustrating the cell morphology on Days 3 and 6 after printing. (C) 
Immunofluorescence staining of CK12 (green) and CK14 (red) illustrating the cell 
maturation on Day 6 after printing. (D) Phase contrast image of printed hPSC-LESCs on 
Day 6 after printing. (A-C) Nuclei stain DAPI (blue). Scale bars 200 μm. 
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Figure 41. hiPSC-LESCs (8.8 million cells/ml) 3D bioprinted on MatrigelTM with 2 s UV 
exposure time. (A-B) corneal progenitor markers p63 (green) and p40 (red), and 
phalloidin (yellow) illustrating the cell morphology on Days 3 and 6 after printing. (C) Cell 
viability on Day 1 after printing. Live cells are shown in green and dead cells in red. (D-
F) Phase contrast images of printed hPSC-LESCs on Day 1, 3 and 6 after printing. (A-
B) Nuclei stain DAPI (blue). Scale bars 200 μm.  
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Figure 42. hESC-LESCs (9 million cells/ml) bioprinted on LinkCellTM membrane without 
UV exposure. (A) Corneal progenitor markers p63 (green) and p40 (red), and 
morphology with phalloidin (yellow) on Day 3 after printing. (B) Proliferation with Ki67 
(green) and maturation with CK3 (red) on Day 3 after printing. (C) Phase contrast image 
of printed hLESCs on Day 3 after printing. (D) Proliferation with Ki67 (green), maturation 
with CK3 (red) and morphology with phalloidin (yellow) on Day 6 after printing. (E) 
Maturation with CK12 (green) and CK14 (red) on Day 6 after printing. (F) Phase contrast 
image on Day 6. (A-B, D-E) Nuclei stain DAPI (blue). Scale bars 200 μm. 
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Figure 43. Maturation of hiPSC-LESCs (8.8 million cells/ml) on Day 10 after bioprinting 
on LinkCellTM membrane without UV exposure. (A) Corneal progenitor markers p63 
(green) and p40 (red), morphology with phalloidin (yellow). (B) Maturation with CK12 
(green) and CK14 (red). (C) Viability of printed hLESCs on Day 1. Live cells in green, 
dead cells in red. (D) Proliferation with Ki67 (green) and maturation with CK3 (red). (E) 
Phase contrast image on Day 6. (A-B, D) Nuclei stain DAPI (blue). Scale bars 200 μm. 
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Figure 44. Immunofluorescence control of hPSC-LESCs at Day 6. (A) Corneal 
progenitor markers p63 (green) and p40 (red), morphology with phalloidin (yellow). (B) 
Matruation with CK12 (green) and CK14 (red). (C) Negative for primary antibodies 
originated from rabbit (p63, CK12, Ki67). (D) Proliferation with Ki67 (green) and 
maturation with CK3 (red). (E) Negative for primary antibodies derived from mouse (p40, 
CK14, CK3). (A-B, D) Nuclei stain DAPI (blue). Scale bars 200 μm.  
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Both cell lines express the corneal progenitor markers p63 and p40 in all the printing 
conditions (Figure 38 A-B, Figure 39 A-B, Figure 40 A-B, Figure 41 A-B, Figure 42 A and 
Figure 43 A). The increase in the expression of p40 between Day 3 and 6 can be seen 
in the samples bioprinted on MatrigelTM without UV expression (Figure 38-39) or with 2 
s UV expression (Figure 40-41), and even after 10 days, the bioprinted hPSC-LESCs 
express p63 and p40 (Figure 43).  
At Day 6, the bioprinted hPSC-LESCs show maturation towards corneal epithelial cells 
in all the printing conditions (Figure 38 C, Figure 39 C, Figure 40 C and Figure 42 E), 
however, the expression of the maturation markers CK12 and CK14 is not as strong on 
the LinkCellTM samples. Compared to the LinkCellTM sample at Day 6 (Figure 42 E), the 
expression of CK12 and CK14 has not changed at Day 10 (Figure 43 B). Moreover, the 
cells express the maturation marker CK3 (Figure 42 B, D and Figure 43 D) more strongly 
than the control (Figure 44 D), indicating maturation of the bioprinted cells towards 
mature corneal epithelium.  
The hPSC-LESCs bioprinted on LinkCellTM express the proliferation marker Ki67, 
however, compared to the control (Figure 44 D), the the expression is not as strong. For 
maturing tissue, the decrease in proliferation is typical. There is no visible change in the 
expression of Ki67 between Day 3, 6 and 10 (Figure 42 B, D and Figure 43 D). However, 
the images at Days 3 and 6 are from hESC-LESCs and the Day 10 from hiPSC-LESCs. 
The proliferation data from PrestoBlue analyses support this observation, since the 
fluorescence values are similar between hESC-LESCs at Days 3 and 6 and hiPSC-
LESCs at Day 10.  
The bioprinted hPSC-LESCs showed epithelial cell morphology in all conditions (Figure 
38 D, Figure 39 E-G, Figure 40 D, Figure 41 D-F, Figure 42 C, F and Figure 43 E). When 
examining the cell morphology illustrated with phalloidin, their nuclei stained with DAPI 
or the phase contrast microscope images, both investigated cell lines show areas of 
stratified epithelium on MatrigelTM without UV exposure (Figure 38-39). In addition, the 
cells proliferate and stratify more between the Day 3 and Day 6 (Figure 38 A-B and 
Figure 39 A-B). The hPSC-LESCs bioprinted on MatrigelTM with 2 s UV exposure have 
also stratified areas, however, they are not as large in size or in numbers. The same 
bioprinting condition with hiPSC-LESCs shows significantly less stratified areas, and 
both cell lines on LinkCellTM do not show any stratification.   
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7. DISCUSSION 
Severe LSCD can lead to blindness, which is traditionally treated with corneal 
transplantation. However, there are not enough corneal transplants for every patient who 
needs one. Moreover, corneal transplantation is unsuitable treatment for LSCD due to 
lack of functional LESCs. Thus, there is a severe need for artificial corneas. 3D 
bioprinting provides a strategy to fabricate precise, pre-designed structures with different 
combinations of cell types and materials. Therefore, it offers a possible solution to 
fabricate patient-specific, artifical corneas with functional LESCs. Currently, the 
development of biocompatible and printable cell-laden bioinks is the main challenge in 
the field of 3D bioprinting. In this thesis, the aim was to design a novel bioink and optimize 
the printing conditions for extrusion-based 3D bioprinting of stratified corneal epithelial 
tissue by using hPSC-LESCs.  
7.1 Printability of the bioink 
Printability is one of the most important characteristics for a bioink (Morgan, Moroni and 
Baker, 2020). In this thesis, printability was studied by printing the filament structure 
without cells on a non-coated substrate. Printing speed and pressure are known to affect 
the printability (Van Hoorick et al., 2019), which was demonstrated in this thesis by 
printing the filament with either increasing the speed or pressure. The filament thickness 
decreases when the printing speed is increased (Zhu et al., 2017), and in this thesis, it 
was determined by analyzing the filament structure and thickness at different printing 
speeds. The change in the filament structure was clear, and more smooth filament was 
extruded with higher speed. However, the extruded filament and the substrate could not 
make a contact at the beginning of the filament print with higher speed. This resulted 
inaccurate starting point of the filament print and incorrect printing result. Therefore, 
lower speed was used for bioprinting the cell-laden 3D stuctures. Another option to 
decrease the lag of the starting point would be to increase preflow to begin the filament 
extrusion before the nozzle starts to move. 
Higher pressure is needed if the bioink is highly viscous or the nozzle diameter is small 
(Kyle et al., 2017). Since the 3D-Bioplotter uses pneumatic pressure as the force to 
extrude the bioink, the increase in pressure was expected to increase the flow rate of the 
bioink. As a consequence, by increasing the printing pressure, the filament thickness 
increased, merging the separate filaments together. An increase in the flow rate 
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increases the shear stress, and thus is damaging for the cells (Cui et al., 2020). 
Therefore, the lowest pressure possible was desired, however, it was noticed that with 
too low pressure (0.2 bar), the filament did not extrude at all. When adding the cells, the 
viscosity of the bioink increased, and subsequently, higher pressure was required.  Since 
it was not desired to increase the pressure considerably, the printing pressure was 
optimized to the lowest possible pressure for the extrusion of the cell-laden bioink (0.6 
bar). Overall, since the bioink extruded well even with lower pressures, the viscosity of 
the bioink during extrusion was not high, which is know to be less damaging for the cells 
(Chimene, Kaunas and Gaharwar, 2020). Moreover, the low viscosity decreases the risk 
of nozzle clogging (Cui et al., 2020), which is one of the challenges in extrusion based 
bioprinting. Low viscosity can decrease the shape fidelity of the bioprinted filament and 
to cause the structure to collapse (Cui et al., 2020), however, this was not observed in 
this thesis. With sufficient printing parameters, the filament structure was clear and did 
not collapse after printing. 
The temperature-sensitivity of the bioink can affect the printability (Gu et al., 2018), and 
thus it was studied in this thesis by printing the bioink without cells on the platform, which 
temperature was either 8 °C or 23 °C (room temperature). The printing on a cooled 
platform was expected to enhance the shape fidelity of the bioink. The distance between 
strands in the filament structure did not depend on the platform temperature (average of 
1.47 mm with both temperatures) and was close to the set strand width (1.5 mm). 
However, the filament thickness was higher when printing on the room temperature 
platfrom (0.72 mm) compared to the thickness of the print on the cooled platform (0.62 
mm). Therefore, the bioink used in this thesis is temperature-sensitive, spreads due to 
decreased viscosity in higher temperatures, and thus requires cooled printing platform.  
7.2 Optimization of the bioprinting conditions 
In addition to printability, bioink requirements include supporting cell migration as well as 
tissue maturation and remodeling (Morgan, Moroni and Baker, 2020). The relevant 
mechanical properties of the bioink depend on the bioprinted cells, since they prefer 
different environments. Moreover, the mechanical stimuli provided by the bioink guides 
the proliferation and differentiation of the cells. (Williams et al., 2018) This needs careful 
consideration when designing bioinks and the crosslinking strategies. The substrate 
stiffness have been showed to affect the migration, proliferation and phenotype of LESCs 
(Gouveia, Vajda, et al., 2019). Softer substrate promotes the expression of limbal 
markers (Gouveia, Vajda, et al., 2019), and hence the optimization of the bioink stiffness 
was the most fundamental step in optimizing the bioprinting conditions for hPSC-LESCs.  
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In this thesis, two main crosslinking strategies were used, photocrosslinking and 
thiolation. In photocrosslinking, several parameters affect the crosslinking density, such 
as photoinitiator concentration, the wavelength and intensity of light and light exposure 
time (Lim et al., 2020), of which the latter was optimized in this thesis. UV is a common 
light source for photocrosslinking and the typically used wavelength is 365 nm (Lim et 
al., 2020), which was also used in this thesis. Since UV irradiation can damage the cells 
(Dahle, Kvam and Stokke, 2005), it was essential to study the viability of the bioprinted 
hPSC-LESCs after UV exposure. Several different UV exposure times have been studied 
in 3D bioprinting photocurable bioinks (Lim et al., 2020), and in this thesis, four different 
exposure times (0, 2, 5 and 15 s per layer) were chosen to examine the effect of the UV 
exposure time on the bioprinted cells. Due to bioprinting two layers and exposing each 
layer to UV after printing, the exposure for the bottom layer was increased by double. 
The cell viability studied with LIVE/DEAD staining at Day 1 did not show any significant 
differences in the viability between different UV exposure times. Even with the highest 
UV exposure (15 s per layer), the average viability was 91%, and thus the UV did not 
seem to damage the cells.  
When the UV exposure time increases, the crosslinking density and therefore the 
stiffness of the hydrogel increases (Chimene, Kaunas and Gaharwar, 2020). The 
response of the hPSC-LESCs to the UV exposure and the crosslinking density was 
analyzed by imaging the bioprinted cells with a phase contrast microscope after 1 and 3 
hours, and at Day 1 after printing. Already the increase in the UV exposure time to 5 s 
per layer had a visible effect on the hPSC-LESCs, as they remained circular and could 
not migrate in the printed structure. The increase of the UV exposure time to 15 s had 
similar effect. After 1 hour, the bioprinted filaments were visible in the 5 s and 15 s 
samples. After 3 hours, the filaments were still visible in the 15 s structure, however, they 
were not as visible in the 5 s structure. The cell morphology in both of the samples with 
higher exposure times was round-shape, which indicates that they cannot migrate well, 
and therefore UV exposures of 5 s or higher were not optimal for bioprinting corneal 
epithelium micking structures.  
In addition to the visibility of the bioprinted filaments, the bioprinted structure detached 
from the substrate at Day 1 in both 5 s and 15 s samples, potentially indicating poor 
interaction with the crosslinked printed structure and the culture substrate. Some of the 
cells had been able to migrate and attach to the bottom of the culture dish and showed 
typical epithelial morphology in a monolayer with high viability. However, most of the 
cells had remained in the detached structure, where they stayed round-shaped and did 
not interact with each other. Hence, the hPSC-LESCs seemed to be sensitive to subtle 
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changes in the material stiffness caused by the UV exposure time, and therefore, the 
two lowest UV exposure times were used for the rest of the experiments in order to 
achieve an extremely soft, liquid-like material. This type of material was intended to 
provide short-term support for the bioprinted cells and enable them to form stratified 
epithelial tissue. By selecting another cell type with the preference for more rigid 
environments, longer UV exposure times could be used with this bioink to result in stiffer 
and more solid gel. In addition, UV exposure could be utilized in designing experimental 
environments for the cells to analyze how they behave in non-native environments. As 
the ECM stiffness is important for maintaining tissue homeostasis, abnormalities in the 
mechanical properties of the tissue can lead to different diseases (Handorf et al., 2015). 
Thus, higher UV exposure could be used to bioprint stuctures that mimic the diseased 
environment and utilized in disease modeling. Moreover, the developed bioink with UV 
crosslinking could be potentially used for bioprinting stromal structures, where a stiffer 
environment is needed.   
Since the UV exposure was observed to affect the crosslinking density considerably and 
resulting in unsuitable environment for hPSC-LESCs, other crosslinking strategies were 
considered. For better optimization and customization of the bioink properties, a 
combinations of different crosslinking strategies have been used previously (Petta et al., 
2018; Kajave et al., 2020; Shin et al., 2020; Soliman et al., 2020). Thiolation is one option 
to make a hydrogel crosslinkable, and for example, thiol-ene photocrosslinking or 
Michael-type addition can be used as a crosslinking strategies for materials containing 
thiolated groups and ‘ene’s (Van Hoorick et al., 2019). In this thesis, the combination of 
the thiolated component X and methacrylated component Y was used for fine adjustment 
of the bioink stiffness. Subsequently, the addition of the thiolated component X seemed 
to provide the desired amount of increase in stiffness and resulted in soft, liquid-like 
material with enough viscosity to hold its shape after the extrusion even without UV 
exposure. To determine the actual crosslinking mechanism requires further research, 
however, the mechanisms could include the photocrosslinking between methacrylated 
groups and the thiol-ene photocrosslinking between the thiolated and methacrylated 
groups. Even though UV exposure was used to increase the crosslinking degree, the 
bioprinted structure was exposed to visible light after extrusion, which is likely to cause 
some crosslinking even without the UV exposure. Moreover, the concentration of the 
thiolated groups determined by Ellman’s reaction was low, which resulted in low 
crosslinking degree between thiolated and methacrylated groups. The crosslinking 
degree achieved in this thesis is not adequate by itself for bioprinting stabile 3D 
structures for long-term in vitro culture. Therefore, the role of the thiolated component X 
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in the crosslinking density of the bioink requires further research to obtain more stabile 
structure. 
In addition to the UV exposure and the stiffness of the bioink, the printing substrate was 
optimized in this thesis. MatrigelTM has been shown to be applicable in 3D bioprinting of 
hPSC-LESCs, however, shrinkage of the MatrigelTM has been reported (Sorkio et al., 
2018). In this thesis, the shrinkage began to occur already at Day 1 after printing, 
however, there was a significant difference between fresh hPSC-LESCs and hPSC-
LESCs from frozen-stock. Even though the shrinkage of the substrate and clustering of 
the cells occurred with both, the hPSC-LESCs from frozen-stock detached completely 
after clustering. The fresh hPSC-LESCs stayed attached in spite of the shrinkage and 
clustering, however, the end point analysis could not be done at late timepoints. 
Subsequently, at Day 6, the bioprinted hPSC-LESCs were not yet too clustered and the 
analyses were possible.  
Different substrate options for MatrigelTM were studied, and the MatrigelTM coated PET 
membrane and LinkCellTM collagen membrane showed the most promising results. 
Porous PET membrane have been previously used in bioprinting of hPSC-LESCs 
(Sorkio et al., 2018), and in this thesis, the PET membrane was nonporous. The cell 
adhesion and proliferation were not as good as with the MatrigelTM substrate. Since the 
PET membrane had MatrigelTM coating, the inferior performance of the PET membrane 
can be due to the nonporosity. Moreover, Sorkio et al. used a cell density of three times 
higher (30 million cells/ml), which increases the cells ability to form stratified tissue. 
Bioprinting on PET would have required more optimization of with the coating, and due 
to schedule limitations, it was discarded as a substrate option. Instead, LinkCellTM 
membrane was studied, since it has been used in hPSC-LESC culture (Mikhailova et al., 
2016). Their performance was better than the nonporous PET membranes, however, it 
was still not as good as with the MatrigelTM substrate. The reason for studying alternative 
substrates to maintain more stable substrate and avoid the shrinkage of MatrigelTM, and 
LinkCellTM successfully provided considerabely more stable substrate than MatrigelTM. 
However, the stratification of the bioprinted hPSC-LESCs was poor, and thus the 
MatrigelTM had the best performance of the studied alternatives. In the future, it would be 
beneficial to study more substrate and coating options to avoid the shrinkage of the 
substrate, provide more stable substrate and enhance the cell adhesion. Moreover, 
MatrigelTM is not optimal material for clinical applications since it is animal-derived. 
Even though the extremely soft material with low crosslinking degree was beneficial for 
the bioprinted hPSC-LESCs, the culturing of the bioprinted structure developed another 
problem. The soft, liquid-like material could not attach to the substrate without cells since 
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it was washed away when the medium was added. The cells were capable of preventing 
the structure from washing away, however, the bioprinted hPSC-LESCs required time 
for migration and adhesion. Thus, the medium was not added on top of the bioprinted 
structure immediately after printing. Instead, the medium was added around the edges 
of the culture dish, and after 3 h, the structure was immersed in medium. This provided 
the cells sufficient time to migrate in the structure and adhere to the printing substrate. 
Moreover, the late immersion in medium did not seem to decrease the cell viability, since 
it was around 90% with all the selected bioprinting conditions. Subsequently, the bioink 
itself provided a sufficient environment for the hPSC-LESCs for the first 3 h after 
bioprinting to promote the formation of stratified corneal epithelium micking structure. 
7.3 Bioink characterization 
There are multiple different characterization methods for bioinks (O’Connell et al., 2020), 
and previously, the bioink characterization in 3D bioprinting of ocular tissues has been 
done for example by analysing the water content (Kilic Bektas and Hasirci, 2020; 
Mahdavi, Abdekhodaie, Kumar, et al., 2020) and the transparency of the material (H. 
Kim et al., 2019; Kilic Bektas and Hasirci, 2020; Kutlehria et al., 2020; Mahdavi, 
Abdekhodaie, Kumar, et al., 2020), and with rheological measurements (Duarte Campos 
et al., 2019; H. Kim et al., 2019; Kutlehria et al., 2020). These methods were selected in 
this thesis for bioink characterization after optimizing it for bioprinting hPSC-LESCs. 
Hydrogels are highly hydrophilic, consist mainly of water and have the ability to swell 
(Chimene, Kaunas and Gaharwar, 2020). The swelling of the hydrogel bioink in this 
thesis was studied by immersing the 3D structure without cells in PBS and weighing it 
after 1, 3 and 24 hours without PBS. The weight of the material was expected to increase 
during timepoints due to the water absorption of the hydrogel. Four different UV exposure 
times were used (0, 2, 15 and 30 s per layer). However, the two lowest UV exposure 
times resulted in so soft and liquid-like structure that it washed away during the first 
weighing measurements, indicating low-degree crosslinking and poor stability in 
aqueous environment. Thus, only the results from the two highest UV exposure times 
were obtained from the later timepoints. After 1 hour, there was almost no change in 
weight compared to the intial weight. After 3 and 24 hours the weight was higher than 
the previous timepoint, as was expected. 
Since the UV exposure increases the crosslinking density of the photocurable bioink, 
resulting in stiffer structure (Chimene, Kaunas and Gaharwar, 2020), the water 
absorption was expected to decrease with higher UV exposure. Moreover, the water 
absorption and swelling were expected to increase faster with lower crosslinking degree 
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due to lower crosslinking density. However, there was no significant difference in the 
relative water absorption between 15 and 30 s UV. In addition, the water absorption after 
3 h was higher for the 30 s sample. This might be due to the fact that even the 30 s UV 
exposure per printed layer is relatively short time, even though the lower layer 
experiences 60 s UV altogether. Therefore, by increasing the photoinitiator concentration 
or the UV exposure up to minutes, the differencies in crosslinking density, stiffness and 
water absorption might be more distinguishable. 
Corneal tissue is transparent (DelMonte and Kim, 2011), and transparency is one of the 
most important characteristic of corneal scaffolds (Ahearne et al., 2020). In this thesis, 
the transparency of the bioink was analyzed visually and by measuring the transmittance 
with the UV/VIS spectrophotometer. The 3D bioprinted structure was visually transparent 
and did not show any hues, which has been a challenge in 3D bioprinting ocular tissues 
(B. Zhang, Xue, Hu, et al., 2019; Duarte Campos et al., 2019). Transmittance of the 
bioinks studied for corneal regeneration has been previously reported to be over 75% 
(H. Kim et al., 2019), 60 – 90% (Kutlehria et al., 2020; Mahdavi, Abdekhodaie, Kumar, 
et al., 2020) and 70 – 90% (Kilic Bektas and Hasirci, 2020). The transparency of the 
bioink used in this thesis was 65 – 75%, which is close to the previously reported values, 
however, lower than the transmittance of native cornea (Beems and Van Best, 1990). In 
addition, the transmittance has increased at higher wavelengths (H. Kim et al., 2019; 
Kilic Bektas and Hasirci, 2020; Kutlehria et al., 2020; Mahdavi, Abdekhodaie, Kumar, et 
al., 2020), which occurred during the transmittance measurements in this thesis. The 
transmittance of the bioink containing the thiolated component X was lower at 
wavelengths 380 – 450 nm, when compared to the nonthiolated bioink. Since the 
wavelength of visible light is 400 – 700 nm, this might be an issue when the bioink is 
used in clinical treatments. However, the difference was only 5%, and thus, the influence 
of the lower transparency would require in vivo studies.  
To further study the microstructure of the bioink without UV exposure, rheological 
measurements including amplitude and frequency sweeps were performed. Typical 
hydrogel bioink is viscoelastic (Chimene, Kaunas and Gaharwar, 2020), with the 
viscosity resisting the flow, and the elasticity responding and recovering from stress. In 
rheology, the G’ represents the elastic portion and the G’’ the viscous portion (Anton 
Paar GmbH, 2020b). The rheological measurements done for the bioink in this thesis 
suggest, that the material behaves as a very weak viscoelastic liquid, because the G’ 
and G’’ values are close to zero. Typical G’ values for hydrogels used as cell matrices 
range from 100 Pa up to hundreds of KPa (Zhong et al., 2020). However, lower G’ values 
have been reported for soft gels, such as 10 – 50 Pa for MatrigelTM with different 
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concentrations (Zaman et al., 2006), 15 Pa for aldehyde-modified 1% HA (Lou et al., 
2018) and 50 Pa for alginate-ColI gels (Branco de Cunha et al., 2014). The G’ value of 
the studied bioink is not more than 15 Pa even after applying stress. Subsequently, it 
remains liquid-like after injecting it onto the measuring plate and does not become a solid 
hydrogel.  
The bioink used in this thesis contains methacrylated and thiolated groups, and 
previously, thiolated and methacrylated components have been combined and 
crosslinked with Michael-type addition (Ravichandran et al., 2016). Ravichandran et al. 
observed that the gelation time without the addition of a catalyst is slow (> 8 h), and they 
performed the rheological measurements after 24 h post gelation. In this thesis, the 
rheological measurements were done immediately after mixing the bioink, and thus, 
there was probably not enough time for the bioink to fully crosslink. Since the rheological 
measurements suggest the bioink is not a typical viscoelastic hydrogel and remains 
liquid-like, it would be valuable to perform the measurements again after at least 8 hours 
of rest. Moreover, the concentration of the thiolated groups measured with Ellman’s 
reaction was low, which limits the crosslinking density and affects the rheological 
properties. Previously, the same thiolation protocol has been used with a new Traut’s 
reagent. Then, a higher conversion of primary amines to thiol groups than the conversion 
for the thiolated component X used in this thesis has been reported. This suggests that 
the Traut’s reagent used in this thesis might be ineffective, and the thiolation should be 
repeated with a new reagent.  
The frequency sweep of the bioink suggests that the elastic properties of the material 
become progressively dominating as the frequency increases. This may be due to the 
loss of relaxation time with high frequencies (Janmey, Georges and Hvidt, 2007). Even 
though the bioink is liquid-like, due to an increase in the G’ and G’’ values after 1.5 Hz, 
the bioink is not a simple liquid. Subsequently, it could be considered as a heterogenic 
structured fluid with a liquid phase containing solid particles (TA Instruments, no date). 
Some parts of the bioink could be crosslinked for example due to visible light to create 
the solid-like particles, and the rest of the bioink remains in liquid phase. Moreover, this 
heterogenic microstructure of the bioink could generate the fluctuation in the beginning 
of amplitude sweep.  
Structured fluids have complex flow behaviour, and to better understand the behaviour 
and rheology of the bioink used in this thesis, the rheological measurements require 
more repetition. In addition to letting the material set at least 8 hours before measuring 
in order to have higher crosslinking density, the rheological measurements should be 
repeated with a bioink containing the component thiolated with a new Traut’s reagent. 
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Moreover, to obtain reproducible data, the constant sample volume and gap are required 
to maintain between measurements. Therefore, the sample loading requires optimization 
in the future. If the samples would be solid enough after a suitable curing time, this could 
be achieved by preparing samples in molds with the same size as the measuring 
geometry. In addition, even though the rheological measurements were performed only 
for the bioink without UV exposure due to the better stratification of the bioprinted hPSC-
LESCs in that condition, the rheology of the bioink exposed to UV could be studied in 
the future. Nevertheless, the protocol used for the rheological measurements mimics the 
situation, which the bioprinted cells sense immediately after extrusion, as the bioprinting 
is done immediately after mixing the bioink.  
7.4 Cell viability, proliferation and maturation after 3D 
bioprinting 
The cell viability in extrusion-based bioprinting is known to be lower than in other 3D 
bioprinting techniques (Cui et al., 2020), which is why high cell density of the bioink is 
important to obtain enough viable cells (Matai et al., 2020). In this thesis, the cell density 
was higher than in several other research done in 3D bioprinting ocular tissues (Wu et 
al., 2016; Isaacson, Swioklo and Connon, 2018; K. W. Kim et al., 2018; Duarte Campos 
et al., 2019; H. Kim et al., 2019; Kutlehria et al., 2020). Moreover, the cell viability after 
extrusion-based bioprinting of ocular tissues has been previously reported to be over 
80% (B. Zhang, Xue, Hu, et al., 2019) or over 90% (Wu et al., 2016; Isaacson, Swioklo 
and Connon, 2018; Kilic Bektas and Hasirci, 2020; Kutlehria et al., 2020), which 
correlates to the cell viability obtained in this thesis. Previously, only Wu et al. and Sorkio 
et al. have reported bioprinting of corneal epithelium mimicking structures. Moreover, Wu 
et al. have done it by extrusion-based bioprinting, as was done in this thesis as well.  
Overall, the bioprinted hPSC-LESCs maintained good cell viability after extrusion-based 
bioprinting and showed high proliferation even with 100 μm nozzle. Wu et al. obtained 
over 90% cell viability of hCECs, however, the nozzle diameter is not reported. Moreover, 
they did not achieved any stratification of hCECs and the cell morphology remained 
rounded. Stratified corneal epithelial tissue has been successfully bioprinted with laser-
based 3D bioprinting (Sorkio et al., 2018), however, the cell density was over three times 
higher compared to this thesis. In addition, Sorkio et al. did not use any crosslinking 
strategy for the bioink, which requires high cell density. Due to high cost of producing 
hPSC-derived cells, it would be more optimal to need lower amount of hPSC-LESCs. To 
obtain stratified corneal epithelium mimicking structure with lower cell density, sufficient 
crosslinking degree of the bioink is required to provide support for the cell proliferation. 
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When further analyzing the viability and proliferation of the bioprinted hPSC-LESCs, the 
MatrigelTM seemed to be suitable substrate for the hPSC-LESCs, however, the culturing 
of the bioprinted samples could not be continued long-term due to the clustering and 
detaching of cells described previously. LinkCellTM membrane offered an alternative for 
long-term culture. In PrestoBlue, differences between the two cell lines could be 
observed. This might be due to the abnormal stem cell karyotype in the hiPSC-line at 
later passages, which was detected later during karyotyping of the cell line. In 
immunofluroescence analysis, there was no significant differences between the cell 
lines, and therefore the data was still used in this thesis. For further research, the cell 
line can be used only until passage 19. 
The polygonal cell morphology of the bioprinted hPSC-LESCs was typical for epithelial 
cells, and the expression of corneal progenitor markers p63 and p40 was high. The cells 
bioprinted on MatrigelTM showed higher expression of maturation markers CK12 and 
CK14 than the cells bioprinted on LinkCellTM, which contributes to the selection of 
MatrigelTM over LinkCellTM as a printing substrate. Stratified epithelium could be observed 
in MatrigelTM samples, and bioprinting without UV exposure resulted more and larger 
stratified areas. Sorkio et al. bioprinted stratified corneal epithelial tissue without 
additional crosslinking, which suggests the softness of the material achieved in this 
thesis was optimal for the hPSC-LESCs to form stratified epithelium. However, the 
softness of the MatrigelTM substrate remained a challenge as the cells were able to rip it 
during culture. Subsequently, the printing substrate requires further optimization to result 
better adhesion and suitable stiffness to maintain the stratified tissue. Moreover, with 
higher cell density, the cells would not have to migrate as far to interact with each other, 
which would support their ability to form stratified corneal epithelial tissue in the whole 
bioprinted structure. Yet, as was mentioned previously, production of hPSC-derived cells 
is costly. When developing clinical solutions for treating patients, higher production cost 
increases the price as well. Therefore, it would more beneficial to first optimize the 
printing substrate and the crosslinking degree to obtain stratified epithelium mimicking 
structure, without the need to produce more cells.  
7.5 Future perspectives 
The cornea has a curved shape, and culturing corneal epithelial cells on a curved 
substrate has been shown to support the adhesion, proliferation and stratification of the 
corneal epithelial cells (Gouveia, Koudouna, et al., 2017). 3D bioprinting provides a 
possibility to create the curved shape, and it has been done previously in 3D bioprinting 
corneal tissue (Isaacson, Swioklo and Connon, 2018; Duarte Campos et al., 2019; 
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Mahdavi, Abdekhodaie, Kumar, et al., 2020). However, in this thesis the bioprinted 3D 
structure was flat due to the extremely soft bioink and bioprinting without any mold. To 
result in a curved shape of the cornea, a mold or supportive bath is needed to support 
the unstable material while printing. Moreover, much higher crosslinking degree is 
required to maintain the printed shape. Thus, a permanent supportive stroma-like 
structure with curvature could be a potential substrate for bioprinting corneal epithelium 
mimicking structures. 
As a technology, 3D bioprinting enables dispensing multiple different materials and cell 
types into a same 3D structure (Matai et al., 2020). However, different cell types require 
different culture conditions, which brings a challenge. Previously, hPSC-LESCs and 
hASCs have been bioprinted by using a laser-based 3D bioprinter to mimick the corneal 
epithelium and stroma, however, long-term co-culture conditions need further 
optimization (Sorkio et al., 2018). Subsequently, the optimal co-culture conditions are 
required because it is essential to combine different cell types in order to 3D bioprint a 
full corneal mimicking structure. 
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8. CONCLUSIONS 
The aim of this thesis was to design a novel bioink for extrusion-based 3D bioprinting of 
stratified corneal epithelium mimicking structures by using hPSC-LESCs. The hPSC-
LESCs were observed to be very sensitive for the stiffness of the 3D environment and to 
prefer an extremely soft material with low crosslinking degree. In this thesis, this type of 
environment was fabricated by optimizing the composition of the photocurable bioink and 
the bioprinting conditions. The bioprinting conditions included the UV photocrosslinking 
degree, printing substrate and later addition of the culture medium. The soft material was 
intended to provide short-term support for the bioprinted cells and enable them to 
migrate, interact and form stratified epithelial tissue.  
Typically, extrusion-based bioprinting does not have as high resolution when compared 
to other bioprinting techniques. In this thesis, high resolution was achieved with 100 μm 
nozzle. The bioink was well extrudable even with low pressures and the cell viability after 
extrusion was high. Moreover, the UV exposure did not decrease the viability. The bioink 
had good transparency, which is an important characteristic for cornea applications. The 
bioprinting process did not seem to affect the proliferation or differentiation capability of 
the stem cells. After optimizing the bioink composition and bioprinting conditions, 
stratified corneal epithelium mimicking structures were succesfully bioprinted. However, 
the cells were able to tear the coating material acting as the substrate during culture, 
which resulted areas without stratified epithelium. Therefore, the printing substrate still 
requires further optimization to enable long-term cell culture.  
The rheological characterization of bioinks still remains a challenge and should be 
investigated in the future. In this thesis, the soft structure with low crosslinking degree 
was preferred by the hPSC-LESCs. However, it caused significant challenges in the 
sample loading of the rheological measurements. Subsequently, further optimization of 
the sample loading is required. 
Even though 3D bioprinting of corneal tissues have been studied previously, most of the 
studies focus on bioprinting stromal structures. Corneal epithelium is an essential part of 
the cornea, and therefore, bioprinting native-like corneal epithelial tissue is required to 
fabricate a functional corneal mimicking structure. This was the first study in which the 
stratification of hPSC-LESCs was observed after extrusion-based 3D bioprinting. The 
novel bioink studied in this thesis showed great potential for 3D bioprinting corneal 
epithelium mimicking structures and should be further studied in ocular surface 
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reconstruction. However, the 3D bioprinting conditions studied in this thesis are not 
sufficient enough to maintain the stratified corneal epithelium mimicking structures in 
long-term. Thus, more research in 3D bioprinting cornea, especially corneal epithelial 
tissue, is still needed. In addition, the co-culturing of corneal tissues require more 
consideration and research in the future, when 3D bioprinted corneal tissues are 
combined. Furthermore, bioprinting stem cells is a promising approach to develop 
perzonalized treatments and to provide sufficient amounts of desired cell types. 
However, the sensitivity, variability and cost are challenges in the production and 
bioprinting of stem cells, and are required to overcome.  
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